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 Abstract.
The production of milk by the mammary gland during lactation is generally 
regarded as a mechanism to support nutrition of the young before they are 
capable of digesting other types of food. Apart from breast milk’s nutritional 
value it also contains bioactive factors and peptides that have a role in 
development and growth of the infant, functions in host defence mechanisms 
and provides growth factors for development of mammary gland function. 
Therefore, exclusive breastfeeding of the infant is recommended for the first 
six months after birth. However, despite this recommendation some women 
are unable to continue breastfeeding due to infection. Mastitis is a common 
inflammatory condition of the mammary gland that can affect from 3-33% of 
lactating mothers and typically occurs during the early stages of lactation. 
Mastitis is usually caused by milk trapped in a blocked milk duct which can 
lead to bacterial infection, most commonly S. aureus. Studies have shown 
women with S. aureus mastitis can have poor lactation outcomes due to the 
symptoms of mastitis, and are more likely to cease breastfeeding early.
Despite the significant effect mastitis has on exclusive breastfeeding, there is 
very little known about how the breast responds to infection in order to reduce 
inflammation and provide antibacterial support for continued lactation.
There are limitations to study mastitis in the human such as poor tissue 
availability and patient access which has resulted in limited information to 
understand breast immune responses to infection, and so alternative methods 
are needed. Therefore, the aims of this thesis are to identify methods to study 
mastitis in the breast and define the innate immune response of the breast in 
response to infection and the potential role of milk derived bioactive peptides 
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 to fight infection. To achieve this two methods to study mastitis in the breast
were employed; the first using non-invasive techniques to isolate cells from 
breast milk to analyse breast function and the second to use a human 
mammary epithelial mammosphere culture model to better understand 
responses to bacterial challenge.
The mammosphere is a three-dimensional in vitro acini comprised of 
mammary epithelial cells that aggregate and then polarise, subsequently these 
structures have similar functionality to the secretory alveoli of the mammary 
gland. In this study human mammary epithelial cells (HMEC) were used to 
develop a mammosphere culture model. To do this mammospheres were
characterized using HMEC cultured on either geltrex or agarose. Experiments
showed HMEC mammosphere formation was regulated by the hormone 
insulin. HMEC mammospheres formed in the presence of insulin formed a 
lumen and expressed the milk protein gene ɴ-casein with the addition of 
FRUWLVRO ȕ-oestradiol and prolactin. Insulin also had a role in regulation of 
extracellular matrix (ECM) expression in the mammosphere cultures; collagen 
IV and laminin genes were expressed in mammospheres formed in the 
presence of insulin, but in the absence of insulin no ECM-related gene 
expression was evident. Microarray analysis of mammospheres under the 
regulation of insulin revealed integrin-linked kinase (ILK) signalling may be 
involved in the formation of HMEC mammospheres. Comparison of insulin and 
IGF-1 effects on mammosphere signalling showed that although IGF-1 could 
induce a spherical structure they did not polarize correctly and form a 
functional mammosphere. IGF-1 formed structures showed a down-regulation 
of the polarity marker gene scribble when compared to insulin formed 
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 mammospheres. This demonstrates a role for insulin in acinar development 
and differentiation, milk secretion and ECM regulation.
To study the immune response during mastitis in the breast two approaches 
were employed, mastitic breast milk cell analysis and also HMEC 
mammosphere challenge. Isolation of cells from the breast milk of women with 
mastitis was used for microarray analysis and this revealed an up-regulation 
of markers for immune cell populations suggesting there is an infiltration of 
lymphocytes and neutrophils into breast milk while the macrophage population
remains the same as seen in healthy women. These cells showed an increase 
in expression of inflammatory genes, antimicrobial genes and 
immunomodulatory genes in response to mastitis. Further pathway analysis 
revealed this immune response is mediated through interferon signalling and 
toll-like receptor signalling. The mammary epithelial immune response was 
defined using HMEC mammosphere cultures. Gene expression analysis was 
carried out using RT-PCR of mammospheres challenged with either 
lipopolysaccharide (LPS) from E. coli or lipoteichoic acid (LTA) from S. aureus 
for 4-24 hours. It was shown the mammospheres responded to challenge by 
up-regulating genes that encode for antibacterials defensin A1 (DEFA1), elafin 
(PI3) and secretory leukocyte protease inhibitor (SLPI), inflammatory cytokines 
tumour necrosis factor (TNF) and interleukin-1B (IL-1B) and chemokine 
interleukin-8 (IL-8). The transcription factor nuclear factor enhancer in B cells 
(NF-ț%ZDVDOVRREVHUYHGWREHXS-regulated in mammospheres challenged 
with both LPS and LTA. This correlation of gene expression patterns suggest 
that mammary epithelial cells play a role in immunity against infection.
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 Processing of milk proteins by proteases has previously been shown to release 
immunomodulatory peptides. Microarray analysis revealed there are 207 
protease genes expressed by cells isolated from breast milk and of these 72 
encode secreted proteases. In order to determine if these proteases can 
release peptides from milk proteins that could potentially aid in combatting 
mastitis, breast milk was incubated to mimic the phenomenon of milk stasis. 
The incubation of skim milk over a period of 7 days allowed for digestion of 
milk proteins by endogenous proteases. Analysis of resultant peptides showed 
PDLQO\ȕ-casein was digested with 2% remaining intact while other major whey 
proteins remained undigested. Mass spectrometry analysis confirmed 
SHSWLGHV ZHUH SUHGRPLQDQWO\ GHULYHG IURP ȕ-casein. Antibacterial assays 
showed that peptides produced by incubating milk had significantly increased 
antibacterial activity against mastitis causing S. aureus. Peptides formed at 
days 4 and 7 of incubation also showed anti-inflammatory activity towards the 
pro-inflammatory cytokine TNF compared to milk prior to incubation. This
suggests the digestion of milk proteins by endogenous milk proteases releases 
specific peptides to produce antibacterial and anti-inflammatory peptides.
These peptides may provide protection to the mother from infection during 
periods of milk stasis.
Taken together, the work performed in this thesis has demonstrated that breast 
milk cells are a non-invasive source of viable cells of the breast that can be 
used to identify an in vivo immune response to infection. The in vitro human 
epithelial mammosphere model defined in this thesis is also an alternative 
model to study alveoli development of the breast where tissue samples are not 
accessible and was shown to have an innate immune response when 
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 challenged. Collectively, the outcomes of this study showed the breast 
responds to mastitis with an array of genes that encode for inflammatory, 
antimicrobial and anti-apoptotic proteins in defence to pathogen detection. 
Processing of milk through endogenous proteases releases antibacterial and 
anti-inflammatory peptides which may aid in preventing mastitis in the breast.
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 Introduction
The concept that milk has a pivotal role in providing nutrition to the young is 
well established. Milk also plays a potential role in regulating mammary growth 
and death (Brennan et al. 2007; Nicholas et al. 2012; Sharp et al. 2008a; 
Topcic et al. 2009), can potentially signal development of the young such a gut 
maturation (Kwek et al. 2009; Morgan et al. 2014), and has the capacity to 
protect the mammary gland from infection (Tomasinsig et al. 2010; Wanyonyi 
et al. 2011; Watt et al. 2012).
Development of the mammary gland is defined as a cycle of proliferation, 
secretory differentiation and involution (Hennighausen 1997). The mammary 
gland represents a dynamic organ that undergoes significant growth and 
development which is not seen in other organs following initial development in 
utero. Maximal growth and development in the mammary gland is observed 
during pregnancy and lactation to produce milk for the infant (Neville et al. 
2002). This review will focus primarily on mouse mammary gland development 
as it’s the most well studied model with cross referencing to the human 
mammary gland where appropriate. 
Hormones play a major role in the development of the mammary gland. The 
endocrine system coordinates mammary gland development and function with 
reproductive state and the demand for milk from the young (Topper & Freeman 
1980). The levels of reproductive hormones which include oestrogen (E), 
progesterone (P), placental lactogen (PL), prolactin (PRL) and oxytocin 
change with reproductive state (for review see Neville et al 2001). All have a 
direct effect on the mammary gland; PRL acts on luminal epithelial cells to 
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 maintain milk secretion (Nguyen et al. 2001), PL has a role in epithelial cell 
differentiation (Akers 1985; Forsyth 1986; Schams et al. 1984) and E and P 
are required for proliferation and ductal morphogenesis (Brisken 2002; Delouis 
et al. ; Woodward et al. 1993). Another group of hormones, the metabolic 
hormones, are primarily responsible for synchronizing the body’s response to 
metabolic changes and stress, but often have direct effects on the mammary 
gland. Among these growth hormone (GH) is known to play a role in ductal 
development (Hovey et al. 2002), glucocorticoid and thyroid hormone are 
necessary for the process of milk secretion and mammary development 
(Blaxter et al. 1949; Cowie et al. 1980; Vonderhaar & Greco 1979). Insulin is 
reported to play a role a role in mammary gland epithelial cell differentiation in 
culture (Neville et al. 2013; Topper & Freeman 1980), particularly for the 
expression of the milk protein genes (Bolander et al. 1981; Kulski et al. 1983; 
Nicholas et al. 1983).
The production of milk by the mammary gland during lactation is generally 
regarded as a mechanism to support nutrition of the young before they are 
capable of digesting other types of food. Breast milk is a rich source of nutrients 
for the infant and contains proteins, lipids and carbohydrates, but increasing 
evidence suggests that milk components include additional bioactive factors
that function in host defence mechanisms (immune protection) (Goldman 
2007; Newburg 2005), and also helps with development and growth of the 
infant (Baldi et al. 2005; Donovan 2006). Milk also provides growth factors for 
development of mammary gland function (Brennan et al. 2007; Joss et al. 
2009; Topcic et al. 2009; Wanyonyi et al. 2011).
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 Exclusive breastfeeding of the infant is recommended for the first six months 
after birth (Amir et al. 2011). Breastfeeding is beneficial to the mother by 
protecting against premenopausal breast cancer (Beral 2002), rheumatoid 
arthritis (Jacobsson et al. 2003), increased weight loss postpartum (Sámano et 
al. 2013), decreased maternal depression and increased mother-infant bonding 
(Hart et al. 2003; Mezzacappa 2004) as well as a decreased risk of developing 
type 2 diabetes (Gouveri et al. 2011). The infant can benefit from breastfeeding 
by provision of extra protection against infections such as lower respiratory tract 
infection and gastrointestinal infection (Heinig 2001; Heinig & Dewey 1996).
There is a protective effect against childhood obesity (Arenz et al. 2004; Dewey 
2003), sudden infant death syndrome (SIDS) (McVea et al. 2000), type 2 
diabetes later in life (Owen et al. 2006) and breastfeeding has been shown to 
correlate with higher IQ in infants (Belfort et al. 2013).
Despite the recommendations for breastfeeding some women are unable to 
continue breastfeeding due to mammary infection (Contreras & Rodriguez 
2011). During the early stages of lactation mothers are more at risk of 
developing breast infections like mastitis that can impact on breastfeeding
(Kinlay et al. 1998). Mastitis is a common inflammatory condition during 
lactation that has been shown to affect from 3% to 33% of lactating mothers
depending on the study and is typically caused by milk accumulated in a 
blocked milk duct which can lead to bacterial infection (Arroyo et al. 2010; 
Michie et al. 2003; Osterman & Rahm 2000), typically the most commonly 
isolated pathogen associated with mastitis is Staphylococcus aureus (Bundred 
et al. 1985; Dixon & Khan 2011; Schoenfeld & McKay 2010). Mastitis causes
swelling, pain, fatigue and flu like symptoms which can result in lower milk 
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 production and is a leading cause of early weaning in mothers (Arroyo et al. 
2010). Despite the significant effects mastitis has on exclusive breastfeeding, 
there is very little known about how the breast responds to infection in order to 
reduce inflammation and provide antibacterial support for continued lactation. 
This review therefore focuses on the known mechanisms of response to 
infection in the mammary gland and highlights areas that require further 
investigation to better understand innate immunity in the breast.
1.1 Development of the mammary gland
1.1.1 The lactation cycle
Development of the mammary gland is defined as a cycle of proliferation, 
differentiation and involution (Figure 1.1). At each stage of development the 
mammary gland undergoes a significant amount of remodelling which is not 
seen in other organs following initial development in utero. The mammary 
gland is a complex structure of ductal networks embedded in stroma which 
consist of an outer myoepithelial cell layer that is attached to the basement 
membrane and luminal epithelial cells that line the ducts which produce milk 
during lactation (Neville et al. 2002; Polyak & Kalluri 2010).
1.1.2 Pregnancy
During the early stages of pregnancy mammary epithelial cells start to 
proliferate and change from a primarily ductal structure to form lobular alveoli 
(the secretory unit of the mammary gland) (Topper & Freeman 1980). The 
basic structure of the alveolar unit is a cluster of secretory cells (luminal cells) 
that secrete milk into a luminal space that are surrounded by myoepithelial 
cells (Figure 1.1b). These myoepithelial cells contract to “push” milk into the 
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 ductules (Riordan & Wambach 2010) to finally be delivered to the teat.
Lactogenesis has been divided into two stages; Lactogenesis stage I
(secretory differentiation) and Lactogenesis stage II (secretory activation).
Lactogenesis I is identifiable by the synthesis of milk components such as 
lactose and milk proteins (Neville et al. 2001; Nicholas & Hartmann 1981c).
Lactogenesis I can also be defined morphologically by the development of 
cytoplasmic lipid droplets in the mammary epithelium (Neville et al. 2002). The 
beginning of lactogenesis I varies across species but generally occurs during 
pregnancy (Hartmann et al. 1995; Nicholas & Hartmann 1981b; Nicholas & 
Hartmann 1981c; Nicholas & Topper 1980).
1.1.3 Lactation
Lactogenesis II in the cow begins 0-4 days before parturition, however in 
women this doesn’t occur until after approximately 2 days post-partum (Gao et 
al. 2013; Hartmann & Cregan 2001; Hartmann 1973; Neville et al. 2001; Parker 
et al. 2012). In the mouse further proliferation of the mammary epithelia occurs 
in the early stages of lactation along with alveolar cell tight junction closure 
(Hennighausen 1997; Neville et al. 2002) Lactogenesis II is defined by the 
initiation of copious milk secretion with an increase in milk protein gene 
expression and the movement of cytoplasmic lipid droplets and casein micelles 
into the alveolar lumen (Hartmann 1973; Neville et al. 2002; Neville et al. 
2001). In women initiation of lactogenesis II is correlated with a decline in 
progesterone which occurs after the placenta is removed (Meier et al. 2010; 
Neville & Morton 2001). The maintenance of copious milk secretion is referred 
to as galactopoiesis (Brisken & Rajaram 2006). Galactopoiesis is defined as 
maintenance of milk secretion which is under the control of hormones and is 
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 maintained by removal of milk from the mammary gland (Lacasse et al. 2012; 
Wilde et al. 1999). Galactopoiesis ceases with the onset of weaning which 
leads to the beginning of involution (Knight et al. 1998; Wilde et al. 1999).
1.1.4 Involution
The process of involution begins when breastfeeding frequency decreases 
during weaning and leads to milk stasis in the breast (Green & Streuli 2004).
In the mouse, involution has been defined as a process where milk synthesis 
ceases and apoptosis is initiated in the secretory alveoli cells (Li et al. 1997).
Following involution the mammary gland architecture returns to a simple ductal 
structure, which is similar to that found in a virgin animal (Figure 1.1d). 
Regeneration of the mammary gland following involution occurs during a
subsequent pregnancy so that lactation can begin again for the next 
reproductive cycle (Simpson & Nicholas 2002).
With the use of mouse models the involution process has been divided into the 
two phases “reversible” and “irreversible” (Lund et al. 1996; Watson 2006).
The reversible phase occurs during the first two days of weaning and is 
characterised by the mammary gland being able to revert back to a lactating
mammary gland if the pups are returned to the mother to suckle again. During 
this stage milk stasis causes a decline in milk synthesis, tight junctions are 
disrupted and apoptosis in the alveolar units begins (Watson 2006). The switch 
to the irreversible phase begins at day 3 of weaning and is characterised by 
the mammary glands inability to revert back to a lactating state even if the 
suckling stimulus from the pups is reintroduced. During this last stage there is 
increased apoptosis and phagocytosis, protease activation (Plasmin and 
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 MMPs) for ECM remodelling, vascular remodelling and immune cell infiltration 
which clears cell debris (Watson 2006; Watson 2009). After this phase the 
mammary gland is comprised mainly of adipocytes and a non-lactating 
architecture of ductal epithelia (Li et al. 1997; Lund et al. 1996).
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 Figure 1.1 Mammary gland cycle.
A whole mount of the mammary gland from the mature virgin (non pregnant) 
mouse (A) shows a ductal structure with end buds that grow to form alveoli. In 
pregnancy (B) the ductal epithelial cells begin forming lobular alveolar 
structures. In lactation (C) the alveoli become enlarged as the mammary gland 
synthesizes and secretes milk. During involution (D) the alveoli go through 
apoptosis and remodelling to return to the virgin like gland in readiness to 
restart the cycle (Hennighausen 1997).
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 1.1.5 Structure of the mammary gland
1.1.5.1 Lobule development
In the mammary gland, lobules are clusters of alveoli that secrete milk during 
lactation. In the human the lobules are divided into four types numbered 1-4
based on number and differentiation of the cells (Russo & Russo 2004).
Lobule 1 (lob 1) are the least developed of lobule types present in the breast 
of nulliparous women; lob 1 is characterized less than 11 lobules. Type 2 
lobules evolve from type 1 lobules in response to oestrogen and progesterone 
during menstrual cycles and show increased alveolar development that 
includes approximately 47 lobules. Lobule 2 (lob 2) further develop into lobule 
3 (lob 3) which contains approximately 80 lobules. Lobule 4 (lob 4) is the most 
developed of the lobules and has extensive ductal branching and high density 
of alveolar units. This later stage is characterized by the alveolar epithelial cells 
being differentiated to be able to secrete colostrum or milk (Figure 1.2) (Baer 
et al. 2009; Russo et al. 2001; Russo & Russo 2004).
In nulliparous women lob 1 is the predominant form present with only a small 
percentage progressing to lob 2 or 3 after hormonal stimulation during sexual 
maturity (Baer et al. 2009). However, parous women have predominately type 
2 and 3 lobules during pregnancy which progress to lob 4 prior to secretory 
activation and lactation. During involution the lobules revert back to a lob 3 
phenotype which will only become lob 1 or 2 during menopausal aging (Baer 
et al. 2009; Russo & Russo 2004).
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 Figure 1.2 Lobule structure in the breast.
Lobular structures of the human breast. Lobule 1 makes up the first type of 
identifiable lobules also termed terminal ductile lobular unit, this contains up to 
11 lobules. Lobule 1 develops into lobule 2 through influence of female 
hormones, and show increased alveolar development and contains around 47 
lobules. Lobule 2 develops into Lobule 3 which contains approximately 80 
lobules. Lobules 1-3 are found in cycling non-pregnant women. From (Russo 
& Russo 2004).
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 1.1.5.2 Alveolar units in the mammary gland
The alveoli are the secretory units of the mammary gland that function to 
synthesise and secrete milk into a central lumen (Riordan & Wambach 2010).
There are two types of epithelial cells in the mammary gland; these are the 
basal (myoepithelial cells) and luminal/ductal epithelial cells. The basal 
epithelial cells are the contractile cells which form the outer layer of the alveoli 
and the luminal epithelial cells which are the secretory cells of the alveoli, line
the ducts and inner layer of the alveoli (Figure 1.3) (Macias & Hinck 2012b).
These two cell types form bi-layered ducts and alveoli that under hormonal 
stimulation allows the luminal epithelial cells to synthesize and secrete milk 
into the lumen where it is stored. During milk let down the milk is ejected from 
the alveoli lumen through myoepithelial cells responding to oxytocin and
contracting to squeeze the milk into the ductules during breastfeeding (Riordan 
& Wambach 2010).
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 Figure 1.3 The structure of the mammary alveolus.
The alveolus is the secretory unit in the mammary gland and is comprised of 
secretory luminal cells that secrete milk into a central lumen. The milk is 
ejected from the lumen by the myoepithelial cells responding to oxytocin to 
contract and transfer the milk into the ductule. Modified from (Riordan & 
Wambach 2010).
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 1.2 Lactogenic hormones required for milk synthesis
The use of both in vivo and in vitro models have shown that the main lactogenic 
hormones regulating milk protein gene expression and milk protein synthesis 
are insulin, glucocorticoids and prolactin (Topper & Freeman 1980). Studies 
using in vitro cultures have been particularly useful in defining the minimal 
hormonal requirements of insulin, cortisol and prolactin necessary for induction 
of milk protein gene expression in mammary explants from a variety of species
(Andersen & Larson 1970; Bolander et al. 1981; Nagaiah et al. 1981; Sheehy 
et al. 2004). However, there is considerable variation in the hormones required 
for lactation in different species and very limited information highlighting the
requirement and role of these hormones in human breast development and 
lactogenesis.
1.2.1 Insulin
Elucidating the physiological role for insulin in mammary gland development 
has been problematic, as increasing plasma insulin levels or ablation of 
pancreatic islets which secrete insulin impairs metabolism in the whole animal 
(Neville et al. 2013). Insulin is  a common component of cell culture media to 
maintain mammary organoid cultures (Elias 1959). However, more recent 
studies using mouse, bovine and tammar wallaby mammary explant models 
showed that insulin was not required to maintain mammary tissue in culture
but needed for milk protein gene expression (Brennan et al. 2008). Therefore,
insulin has a primary role in differentiation of the mammary gland (Neville et 
al. 2013; Nicholas & Topper 1983; Topper & Freeman 1980; Topper et al. 
1984). In mice, insulin was required for expression of milk protein genes in 
both cultured cells and in explants (Neville & Morton 2001). More recently it 
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 has been shown in mice when the insulin receptor is deleted in mammary 
epithelial cells in an early pregnant mouse there is a decrease in lobuloalveolar 
development which is possible by a decrease in epithelial cell proliferation 
during early pregnancy (Neville et al. 2013). To determine if the ability of insulin 
to promote milk protein gene expression reflected a unique ability of the 
hormone to maintain the cells in culture, a number of alternative factors were 
tested for cell survival. A number of exogenous hormones such as epidermal 
growth factor (EGF) (Bolander et al. 1981), insulin-like growth factor 1 (IGF-I) 
(Bolander et al. 1981) and foetal bovine serum (FBS) (Kulski et al. 1983) did
not induce milk protein gene expression but they did maintain the cells 
potential for lactogenic response after delayed addition of insulin, cortisol and 
prolactin.
 
More recently, insulin has been shown to have a role in regulating the
transcription of milk protein genes by the expression of Stat5a which is a major 
milk protein transcription factor in the bovine (Menzies et al. 2009). In women 
with gestational diabetes it has been shown that insulin resistance results in 
delayed lactogenesis until sensitivity is regained after birth (Neubauer et al. 
1993). This suggests that in humans insulin most likely plays a major role in 
milk protein synthesis.
1.2.2 Glucocorticoids and progesterone
Glucocorticoids are required for mammary differentiation and milk secretion 
(Neville & Morton 2001; Nguyen et al. 2001). Early studies in the rat have 
shown cortisol was necessary for casein gene expression and stabilization of 
the casein mRNA  (Chomczynski et al. 1986). Other studies have shown that 
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 the use of a synthetic glucocorticoid (dexamethasone) to treat ketosis in dairy 
cows resulted in a depressed lactation and in another study where lactating 
cows injected with adrenocorticotropic hormone resulted in lowered milk 
secretion, suggesting that high therapeutic doses of a glucocorticoid had a
negative effect on lactation (Casey & Plaut 2007; Neville & Morton 2001; Shaw 
et al. 1955; Wierda et al. 1987).
Progesterone is a hormone that is secreted by the ovaries and placenta and 
maintains pregnancy (Macias & Hinck 2012a; Neville et al. 2002). Withdrawal 
of progesterone around the time of parturition is the initial process of the 
lactogenic trigger in most mammals (Meier et al. 2010; Neville & Morton 2001).
This process is correlated with the closure of tight junctions between mammary 
epithelial cells occurs during the onset of milk secretion in humans (Knight et 
al. 1998; Nguyen et al. 2001) but glucocorticoids and prolactin are required to 
complete and maintain the tight junctions (Nguyen et al. 2001; Zettl et al. 
1992).
1.2.3 Prolactin
Prolactin is a hormone that is secreted by the anterior pituitary and maintains 
the secretion of oestrogen and progesterone from the ovaries during early 
pregnancy in eutherians (Brisken 2002; Freeman et al. 2000). Prolactin also 
stimulates lobulo-alveolar development in the mammary gland during 
pregnancy (Brisken 2002). During pregnancy in the cow, prolactin is present 
at low concentrations but just prior to parturition peripheral prolactin exhibits a 
distinctive spike possibly to facilitate initiation of lactogenesis II (Newbold et 
al. 1991). Early experiments with mammary explants showed that prolactin 
required for the induction of milk protein synthesis (Devinoy et al. 1978; 
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 Houdebine & Gaye 1975; Kulski et al. 1983; Matusik & Rosen 1978; Nagaiah 
et al. 1981; Nicholas & Tyndale-Biscoe 1985; Sheehy et al. 2004). Prolactin 
regulates the transcription of milk protein genes and is necessary to initiate 
and maintain milk production in the mammary gland (Norman & Litwack 1997; 
Trott et al. 2008).
Prolactin induced the synthesis of milk proteins by binding to the prolactin 
receptor (PRLR), which results in activation of both the janus kinase (JAK)/
signal transducer and activator of transcription (STAT) and protein kinase-B
(PKB)/thymoma viral proto- oncogene (AKT) pathways (Bole-Feysot et al. 
1998) This signalling activates JAK2 and STAT5 transcription factors which 
DUHUHTXLUHGWRLQGXFHH[SUHVVLRQRIPRVWPLONSURWHLQJHQHVVXFKDVȕ-casein 
(Anderson et al. 2007; Neville & Morton 2001).
Bromocriptine is a dopamine agonist which is known to suppress prolactin 
release. In the cow and goat administration of bromocriptine before parturition 
reduced milk production postpartum (Akers 2002; Forsyth & Lee 1993), but if 
bromocriptine was administered when lactation has already been established 
there was little to no effect on milk production (Lacasse et al. 2010). However, 
in another study women who chose not the breastfeed their infants were 
administered bromocriptine over a 14 day period revealed lactation was 
suppressed in these women compared to women who were not administered 
bromocriptine (Kulski et al. 1978). Similar results were also observed in 
lactating rats (Nicholas & Hartmann 1981a). This highlights there is variation 
across species in the responses of mammary tissue to different hormones. For 
example the expression of milk protein genes in the mammary gland explants 
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 of the mouse and bovine requires insulin, cortisol and prolactin (Andersen & 
Larson 1970; Bolander et al. 1981; Nagaiah et al. 1981) whereas in the tammar 
wallaby mammary gland explants ɲ-lactalbumin and ɴ-lactoglobulin gene 
expression can be induced maximally by prolactin alone (Collet et al. 1991; 
Nicholas & Tyndale-Biscoe 1985). The bromocriptine studies by Kulski et al 
1978 in the human suggest prolactin is required for lactation but further studies 
are ethically challenging in the human, so in vitro models that mimic breast 
function to assess the hormonal requirements for lactation in the human are 
necessary.
1.3 Milk composition
Breast milk is the most optimal source of nutrition for an infant (Walker 2010).
It is a heterogeneous fluid that contains proteins, lipids, carbohydrates, 
minerals, vitamins and other bioactive factors that are tailored to the needs of 
the infant (Ballard & Morrow 2013; McManaman & Neville 2003). The overall 
composition of these milk constituents varies across species (Table 1.1) 
(Webb et al. 1974).
Although milk is a well-known source of nutrients for the infant, milk also has 
a more complex role in providing bioactives that play an important role in 
development and growth of an infant (Baldi et al. 2005; Donovan 2006; Kwek 
et al. 2009) and also provides growth factors for development of mammary 
gland function (Brennan et al. 2007; Joss et al. 2009; Topcic et al. 2009; 
Wanyonyi et al. 2011). Milk also plays a critical role in remodelling the 
mammary gland after the cessation of sucking (Khalil et al. 2011; Sharp et al. 
2008a; Watson 2006) and contains bioactives that function in host defence 
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 mechanisms (immune protection) (Goldman 1993; Newburg 2005), such as 
antimicrobials (lactoferrin and lysozyme) (Bellamy et al. 1992b; Ellison & Giehl 
1991; Goldman 1993; Lonnerdal 2003) and immune transfer through 
immunoglobulins (Hurley & Theil 2011).
Table 1.1 Compostition of milk from different species.
Species Protein (g) Fat (g) Carbohydrate 
(g)
Energy 
(kcal)
Cow 3.2 3.7 4.6 66
Human 1.1 4.2 7.0 72
Water Buffalo 4.1 9.0 4.8 118
Goat 2.9 3.8 4.7 67
Donkey 1.9 0.6 6.1 38
Elephant 4.0 5.0 5.3 85
Rhesus Monkey 1.6 4.0 7.0 73
Mouse 9.0 13.1 3.0 171
Whale 10.9 42.3 1.3 443
Seal 10.2 49.4 0.1 502
From (Webb et al. 1974).
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 1.3.1 Milk constituents 
 
1.3.1.1 Fat
Fat in milk is a major source of energy, essential fatty acids and bioactive lipids 
that includes triacylglycerides, diacylglycerides, saturated and 
polyunsaturated fatty acids and phospholipids (Bracco et al. 1972; German & 
Dillard 2006; German et al. 2002). In human milk the major class of lipids in 
milk fat are the triacylgylcerides which account for up to 98% of lipid (Pons et 
al. 2000); these are composed of three fatty acids which are covalently bound 
to a glycerol molecule by ester bonds (Innis 2011). Fatty acids such as butyric 
acid, docosahexaenoic acid (DHA) and conjugated linoleic acid which are 
present in milk and can have a range of bioactivities which include anti-cancer, 
antimicrobial and anti-inflammatory properties (German & Dillard 2006; Parodi 
1999; Weiss et al. 2013).
The fat content of milk is the most variable component between species (Table 
1.1) (Webb et al. 1974) which may result from diet, breed, stage of lactation, 
number of lactations and season (Khan et al. 2013; Schutz et al. 1990). Fat 
content also changes before and after sucking by the young. The fat content 
of milk for a high proportion of species, which includes humans and ruminants, 
lies within the range 3-12% (Webb et al. 1974). However, in some species 
such as seals and other species found in polar-regions milk may include up to 
50% milk lipid (Baker 1990; Sharp et al. 2005).
1.3.1.2 Carbohydrates
Carbohydrates in milk are made up of monosaccharides, disaccharides, 
oligosaccharides and polysaccharides. Human milk contains and abundance 
of complex oligosaccharides which is the third most abundant component of 
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 milk solids (Ward et al. 2006; Warren et al. 2001). The main carbohydrate in 
the milk of most species is lactose which is a disaccharide made up of glucose 
and galactose (Ballard & Morrow 2013; Guo & Hendricks 2008). Lactose is 
exclusively found in the mammary gland where it is synthesized in the golgi of 
mammary alveolar cells (Anderson et al. 2007). The synthesis of lactose from 
glucose and UPD-galactose is catalysed by lactose synthase which is 
composed of WZRVXEXQLWVȕ-galactosyltransferase, a catalytic unit and ɲ-
lactalbumin (LALBA) a regulatory cofactor (Anderson et al. 2007). In the
mammary alveolar cells, LALBA modifies ȕ-galactosyltransferase affinity 
towards glucose which leads to lactose production (Permyakov & Berliner 
2000). In most species, lactose has been shown to be necessary for osmolarity 
in milk which is necessary to transfer water from extracellular fluid (Vilotte 
2002).
Human milk oligosaccharide (HMO) concentration and composition varies
between women and over the course of lactation (Kunz et al. 2000). Colostrum
contains approximately 20-25 g/L HMO (Coppa et al. 1999; Gabrielli et al. 
2011). As milk production matures, HMO concentrations decline to 5-20 g/L 
(Coppa et al. 1999; Davidson et al. 2004; Gabrielli et al. 2011). Some studies 
have also shown that the composition of HMO changes based on Lewis blood 
group characteristics and secretor status which is determined by the activity of 
ɲ1-2-fucoslyltransferase (FUT2) and ɲ1-3/4-fucosyltransferase (FUT3) 
(Coppa et al. 1999; Johnson & Watkins 1992; Kumazaki & Yoshida 1984; 
Ruhaak & Lebrilla 2012; Thurl et al. 1997; Thurl et al. 2010; Viverge et al. 
1990).
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 HMOs selectively nourish the growth of specific strains of bifidobacteria which 
aids in establishing the development of gut microbiota in infants fed breast milk
(German et al. 2008; Harmsen et al. 2000; Ward et al. 2006). They also have 
more diverse functions as anti-adhesive antimicrobials which prevents 
pathogen attachment to infant mucosal surfaces (Kunz et al. 2000; Newburg 
et al. 2005) and lower the risk for viral, bacterial and protozoan parasite 
infections by resembling mucosal cell surface glycans and act as soluble 
decoy receptors which prevent pathogen attachment (Bode 2012; Gustafsson 
et al. 2006; Simon et al. 1997). HMOs may also modulate innate immune 
response to infection (Arslanoglu et al. 2008) and provide the infant with sialic 
acid which may be beneficial for brain development (Wang 2009).
1.3.1.3 Proteins
The majority of milk proteins (80-90% depending on species) are synthesized 
within the mammary epithelial cells and are packaged into secretory vesicles 
and released by exocytotic fusion of the vesicles with the apical plasma 
membrane (Franke et al. 1976). Human milk proteins has been divided into 
three fractions; the caseins, whey proteins and milk fat globule membrane 
proteins (López Alvarez 2007). The approximate ratio of whey to casein is 
60:40 (Kunz & Lönnerdal 1992) ZLWKĮ-lactalbumin, lysozyme, serum albumin 
and lactoferrin making up the major whey proteins (López Alvarez 2007; 
Rudloff & Kunz 1997).
1.3.1.4 Caseins
The total casein concentration and the secretion of individual casein proteins 
varies considerably between species (Ginger & Grigor 1999). Caseins are 
defined by the property that they precipitate at pH 4.6. The casein family of 
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 genes is comprised of four genes but not all four genes are expressed across 
different species (Ginger & Grigor 1999). In bovine milk there are the ɲS1-
casein, ɲS2-FDVHLQȕ-casein and ʃ-casein proteins present, whereas human 
milk contains  ɲS1-casein, ɴ-FDVHLQDQGț-casein (Burgoyne & Duncan 1998; 
Lönnerdal & Forsum 1985). The caseins are present in milk as a suspension 
of colloidal particles that make up the casein micelle (Farrell Jr et al. 2006; 
Phadungath 2005; Rollema 1992). There is a large amount of calcium
phosphate present within the casein micelle and so it is well accepted that it 
serves as a mechanism for calcium transfer in mammals (Patton 2004; 
Phadungath 2005). Caseins have been shown to have a degree of secondary 
structure but have an unordered tertiary structure making them vulnerable to 
proteolysis by protease enzymes (Phadungath 2005; Swaisgood 2003) and so 
through gastrointestinal proteolytic digestion releases casein peptides to 
function as a number of bioactives including ACE-inhibitors and opioids 
(Kampa et al. 1996; Koch et al. 1985; Wu et al. 2013).
1.3.1.5 Whey proteins
In contrast to the casein proteins in milk the whey fraction includes proteins 
that are mainly comprised of compact globular proteins that have a high level 
of secondary, tertiary and quaternary structures and also contain 
intermolecular disulphide bonds that stabilize their structure (Aimutis 2004). 
These proteins also remain in solution at pH 4.6 and are less sensitive to 
proteolysis by protease enzymes (DeMan 1999). The whey protein 
composition varies greatly across species. For example ɴ-lactoglobulin (BLG) 
and whey acidic protein (WAP) are pseudogenes in the human but are 
secreted in milk from other species such as the tammar wallaby, mouse, rat, 
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 pig and camel (Beg et al. 1986; Campbell et al. 1984; Nicholas et al. 1997; 
Nukumi et al. 2006). However, ɲ-lactalbumin (LALBA), immunoglobulins, 
serum albumin and lactoferrin (LTF) are present in the milk from human and 
other species (López Alvarez 2007). Some of these proteins, such as BLG, 
LALBA and WAP, are only synthesized in the mammary secretory cell, 
whereas others, such as serum albumin, immunoglobulins and transferrin (TF) 
are transferred from the blood (Jordan & Morgan 1970). LTF is synthesised by 
mammary epithelial cells, but is also found in many mucosal secretions such 
as tears and saliva (Levay & Viljoen 1995).
1.3.1.6 ɲ-lactalbumin
ɲ-lactalbumin (LALBA) is a protein that is synthesised by mammary epithelial 
cells and is present in the milk of most mammals (Lönnerdal & Lien 2003). In 
human milk LALBA makes up approximately 25-35% of total protein 
(Lönnerdal 2010; Lönnerdal & Lien 2003). LALBA functions as a regulatory 
subunit of lactose synthase alRQJZLWKȕ-1,4-galactotransferase and makes up 
the catalytic unit which results in the secretion of lactose in milk (Neville 2009).
It has also been suggested that LALBA has the potential to signal apoptosis in 
cells (Håkansson et al. 1995; Riley et al. 2008). This occurred  when the protein
was partially unfolded and bound to a fatty acid such as oleic acid to form a 
complex molecule termed HAMLET (Human ɲ-lactalbumin Made Lethal to 
Tumour Cells),  but the native form did not have any apoptotic function
(Hallgren et al. 2008; Svensson et al. 2003).
1.3.1.7 Immunoglobulins
The immunoglobulins are involved in the transmission of humoral immunity 
from mother to offspring (Hurley & Theil 2011). Multiple classes are present in 
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 milk and colostrum including IgG, IgA and IgM (Hurley & Theil 2011; Mehta et 
al. 1991). In species such as humans, transfer of IgG to offspring occurs by 
the placenta and so the principle immunoglobulin in the colostrum and milk is 
IgA (Palmeira et al. 2012). The IgA in milk results in improved immunity from 
infection in infants (Goldman 1993; Lönnerdal 2003; Telemo & Hanson 1996).
In species that transmit immunoglobulins through colostrum, such as the cow, 
the major immunoglobulin in milk is IgG (Przybylska et al. 2007).
1.3.1.8 Lactoferrin
Lactoferrin (LTF) is a glycoprotein synthesised by mammary epithelial cells 
and neutrophils (Levay & Viljoen 1995; Neville & Zhang 2000). LTF functions 
to bind and transport iron but also has antibacterial properties in milk (Adlerova 
et al. 2008; Neville & Zhang 2000; Schanbacher et al. 1993). LTF is an 
important milk bioactive that provides antibacterial, antiviral and antifungal 
defences in milk and the mammary gland (Andersen et al. 2001; Bellamy et al. 
1994; Berkhout et al. 2002; Neville & Zhang 2000; Rainard 1987; Yamauchi et 
al. 1993). The iron-binding properties of LTF are bacteriostatic for a broad 
range of micro-organisms, as a result of making iron unavailable to the 
organism (Bullen et al. 1978). LTF has also been shown to aid in the 
establishment of beneficial microflora in the gastrointestinal tract (Baldi et al. 
2005).
The LTF content in milk varies with the developmental state of the gland and 
also between species (Schanbacher et al. 1993). For example, during peak 
lactation in  cows the lactoferrin is present in milk at  low concentrations of 
approximately 0.1g/L (Sánchez et al. 1988) whereas human milk  has higher 
LTF content from 1-2g/L (Hennart et al. 1991; Lewis-Jones et al. 1985; Neville 
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 & Zhang 2000). In contrast, during the involution process both the bovine and 
human have increased LTF concentration (Hartmann & Kulski 1978; Pfaffl et 
al. 2003).
1.3.2 The peptidome: bioactive peptides released through proteolysis
The presence of bioactive components in breast milk has been well 
documented (D'Alessandro et al. 2010; Lonnerdal 2003; Lönnerdal 2010),
however increased attention has been directed to better identifying bioactive 
peptides that comprise the milk peptidome (Baldi et al. 2005; Dallas et al. 
2013a; Dallas et al. 2013b; Sedaghatia et al. 2014; Wu et al. 2013). The 
peptidome (also known as cryptome) is defined as a subset of the proteome 
that consist of peptides formed through the proteolysis of proteins to release 
latent bioactive peptides (Figure 1.4) (Autelitano et al. 2006; Meisel 2004; 
Pimenta & Lebrun 2007). This targeted proteolytic digestion of proteins can 
release peptides that have distinct activity compared to the precursor protein
(Autelitano et al. 2006; Pimenta & Lebrun 2007). The proteolysis directed 
towards proteins occurs through the catalytic activity of system protease 
enzymes and protease inhibitors. It is well known that protease activity is 
extremely selective and the enzyme is directed to a site-specific sequence of 
amino acids to be able to cleave the protein into multiple peptides; and in 
addition each individual protease has optimal conditions under which it can 
exert its activity (Shen & Chou 2009).
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 Figure 1.4 Schematic diagram of protein digestion to form peptides.
The peptidome is formed by digestion of a protein by proteases that produce 
peptides with bioactivities completely unrelated to the native protein.
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 1.3.2.1 Protease enzymes in milk
Protease enzymes are key regulators in the digestion of proteins into peptides. 
The activity of a protease is extremely selective and the enzyme is directed to 
a specific sequence of amino acids to be able to cleave the protein, and in 
addition each individual protease has optimal activity under specific conditions 
such as pH and temperature (Shen & Chou 2009). An example of this is 
pepsin, a well-studied protease from the gastrointestinal tract. Pepsin is most 
active at a pH of 1.5-2 between temperatures of 37°C to 42°C but the enzyme 
is inactive at a pH over 6.5 and can be irreversibly denatured at a pH over 8 
(Shen & Chou 2009).
Proteases are divided by their catalytic class and there are five classes of 
proteases; aspartic, metallo, cysteine, serine and threonine (Shen & Chou 
2009). Aspartic proteases are classified by having an aspartate residue for 
catalysis of their peptide substrates and usually have two highly-conserved 
aspartates in the active site of the protein. Usually they have a characteristic 
hydrophilic Asp-Thr-Gly-Ser at the N-terminal domain and a second 
hydrophobic Asp-Thr-Gly-Ser/Thr at the c-terminal domain (Davies 1990; 
Northrop 2001). Metallo proteases require a metal ion for their active site which 
is usually zinc dependent and typically there is a three ligand zinc binding motif 
that can consist of histidine, glutamate, lysine, aspartate and arginine  (Auld et 
al. 1997; Ra & Parks 2007). The role of the metal ion is to activate a water 
molecule that turns the water molecule into a nucleophile for catalysis (Wu & 
Chen). Cysteine protease activity requires a nucleophilic cysteine thiol in a 
catalytic active site dyad (Chapman et al. 1997; Otto & Schirmeister 1997). A 
serine protease has a nucleophilic serine amino acid in the active site that is 
typically found as a triad of Asp-His-Ser (Hedstrom 2002; Kraut 1977).
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 Threonine protease has a threonine amino acid in the active site (Seemüller et 
al. 1995). To add to the complexity of the protease system, proteases may also 
have their activity regulated by protease inhibitors that can limit or prevent 
unwanted proteolysis by the protease enzymes (Otto & Schirmeister 1997).
In the human genome proteases account for up to 2% of all genes (Autelitano 
et al. 2006; Shen & Chou 2009) and so far there have been 553 proteases 
identified. By class there are 21 aspartic proteases, 143 cysteine proteases, 
186 metallo proteases, 176 serine proteases and 27 threonine proteases 
(Puente et al. 2003). Recent studies have begun to shed light on protease 
activity in breast milk using a web based server (EnzymePredictor) 
(Vijayakumar et al. 2012) that predicts potential protease targets based on
cleavage sites of peptides. This approach showed that peptides identified in 
breast milk were likely cleaved by enzymes such as cathepsin D, proline 
endopeptidase, plasmin, pepsin, trypsin, chymotrypsin, glutamyl 
endopeptidase and elastase (Kitazawa et al. 2007). However, the limitation to 
this approach is that not all proteases are well characterized for activity and 
there is limited information on proteases that are present in the mammary 
gland other than the most widely studied milk protease plasmin (Heegaard et 
al. 1997; Ismail & Nielsen 2010; Politis et al. 1989). This limited information 
indicates a need to identify the number and types of proteases present in the 
mammary gland and to examine whether they are active in the release of 
bioactive peptides.
1.3.2.2 Functional milk-derived peptides
Milk contains bioactive proteins that have a multitude of functions but some of 
the bioactivities remain inactive until proteolysis releases the latent bioactive  
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 peptides (Lönnerdal 2010; Meisel 2004). There has been considerable work 
on peptides derived from the PDMRU ERYLQH PLON SURWHLQV Į-ODFWDOEXPLQ ȕ-
FDVHLQĮ-FDVHLQț-FDVHLQO\VR]\PHODFWRIHUULQDQGȕ-lactoglobulin (Kanda et 
al. 2007; Meisel 2004, 2005; Meisel & FitzGerald 2000; Schmelzer et al. 2007).
Typical methods to digest milk proteins usually involve incubating either milk 
or individual milk proteins with proteases that are found in the gut (pepsin, 
trypsin chymotrypsin) (Eriksen et al. 2010; Kitazawa et al. 2007; Morgan et al. 
2014; Picariello et al. 2010; Schmelzer et al. 2007). However, there is limited 
analysis of proteases found in milk and their role in milk protein digestion 
(Kitazawa et al. 2007). Bioactive milk peptides resulting from proteolytic 
digestion include functions such as immunomodulatory (Adel-Patient et al. 
2012; Qian et al. 2011), antimicrobial (Dallas et al. 2013a; Gifford et al. 2005; 
Liepke et al. 2001), antithrombotic (Chabancea et al. 1995; Fiat et al. 1993),
opioid agonists (Koch et al. 1985; Meisel & FitzGerald 2000; Migliore-Samour
et al. 1989; Teschemacher et al. 1997), ACE inhibitors (Wu et al. 2013) and 
proliferative (Kanda et al. 2007; Morgan et al. 2014).
A recent study by (Dallas et al. 2013a) showed that milk peptides are present 
in the breast milk before being digested in the infants gastrointestinal tract and 
these peptides exhibited antibacterial properties against Staphylococcus 
aureus (S. aureus) and Escherichia coli (E. coli). However, these activities 
were observed at concentrations higher than the overall concentration present 
in milk. Further studies are required to understand if these peptides have a role 
in immune protection in the breast or if allowing further proteolysis of the milk 
proteins will release more antibacterials in milk. 
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 1.3.2.3 Immune protective milk-derived peptides
Some milk proteins have known antimicrobial activity such as lactoferrin 
(Bullen 1972) and lysozyme (Iacono et al. 1980) but more recently peptides 
derived from milk proteins are being identified as immunomodulatory (Meisel 
2005). These SHSWLGHV LQFOXGHĮ-immunocasokinin, caseinophosphopeptide, 
ȕ-casomorphin- ȕ-casomorphin- ȕ-FDVRNLQLQ ȕ-LPPXQRFDVRNLQLQ ț-
immunocasokinin and lactoferricin (Bellamy et al. 1992a; Kampa et al. 1996; 
Kanda et al. 2007; Meisel 2005).
The most widely studied antimicrobial peptide is Lactoferricin which is 
produced by protease digestion of lactoferrin. This digestion is regulated by 
the gastric enzyme pepsin (Gifford et al. 2005). Lactoferricin has been shown 
to have greater antimicrobial activity than lactoferrin and to be active against a 
wide variety of gram positive and negative bacteria including Escherichia coli 
(Bellamy et al. 1992a; Yamauchi et al. 1993), Klebsiella pneumonia (Bellamy 
et al. 1992a), Pseudomonas aeruginosa (Bellamy et al. 1992b), Salmonella 
sp. (Dionysius & Milne 1997; Yamauchi et al. 1993), staphylococcal and
streptococcal sp. (Bellamy et al. 1992a; Dionysius & Milne 1997; Yamauchi et 
al. 1993) and Bacillus sp. (Bellamy et al. 1992a). In addition lactoferricin 
demonstrated anti-fungal, anti-parasitic and anti-viral activities that are 
directed against yeast such as Candida albicans (Bellamy et al. 1994) and 
Dermatophytes; parasites Eimeria stiedai (Omata et al. 2001), Giardia lamblia 
(Turchany et al. 1995) and Toxoplasma gondii (Omata et al. 2001; Tanaka et 
al. 1995) and also anti-viral activity against adenovirus (Di Biase et al. 2003)
and human cytomegalovirus (Andersen et al. 2001). As lactoferricin has a wide 
range of bioactivities it seems relevant to suggest other yet to be discovered 
31 
 
 peptides in milk peptides may also have diverse functions and could provide 
new options for prevention and treatment of infections like mastitis.
A milk derived peptide that has been shown to be an effective antibacterial 
against mastitis causing pathogens is isracidin; a peptide derived from the 
digestion of ĮS1-casein by the gastrointestinal protease chymotrypsin. This 
peptide was injected into the teats of cows with mastitis resulting from S. 
aureus and Streptococcus spp. and shown to be effective in treating the 
infection without additional antibiotics (Lahov & Regelson 1996). Studies to 
identify antibacterial milk peptides are typically through digestion by gut 
proteases. It is not known if these peptides form in the mammary gland by the 
action of mammary proteases to produce antibacterial effects as a 
preventative or therapeutic measure against infection such as mastitis. 
Understanding the role of proteases secreted in milk and the potential effects 
of peptides in milk could provide new insights into mammary gland immune 
function.
1.4 Lactational mastitis 
It is recommended that for the first six months after birth the infant should be 
exclusively breastfed (Amir et al. 2011; WHO 2001). However, during the early 
stages of lactation mothers are more at risk of developing breast infections that 
can impact on the duration of exclusive breast feeding. A study has identified 
that 75% of mastitis cases where identified in the first seven weeks after birth 
(Kinlay et al. 1998).
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 Mastitis is a common inflammatory condition of the breast that occurs during 
lactation that can affect from 3 to 33% of lactating mothers depending on the 
study and methods used (Arroyo et al. 2010; Michie et al. 2003; Osterman & 
Rahm 2000). Symptoms are usually characterized by swelling, nipple pain, 
fatigue and flu-like symptoms. Mastitis causes a reduction in milk secretion 
and it is one of the leading causes for a mother to start weaning her child early 
(Contreras & Rodriguez 2011). In severe cases mastitis can lead to the 
development of a breast abscess  (Amir et al. 2004).
The pathogen most commonly isolated from breast milk with infective mastitis 
is S. aureus which includes methicillin resistant S. aureus (MRSA) which was 
more common if the infection began in a hospital (Amir et al. 2011; Bundred et 
al. 1985; Dixon & Khan 2011; Schoenfeld & McKay 2010). Mastitis caused by 
these main bacterial isolates is becoming more difficult to treat with antibiotics 
as clinical isolates of these Staphylococcal species commonly have multidrug 
resistance and are able to form biofilms that aid in antibiotic resistance (Arroyo 
et al. 2010).
There have been multiple classifications of mastitis from cellulitis and adenitis 
(Gibberd 1953), to subclinical mastitis (Willumsen et al. 2000) and more 
recently infectious and non-infectious (Fetherston 2001). Supposedly non-
infectious mastitis has been classified to form from a blocked milk duct that 
results in milk stasis and subsequent infection when the milk isn’t removed. 
Infectious mastitis is from a bacterial infection (WHO 2000). However, 
Fetherston (2001) suggested that women with supposedly non infective 
mastitis have symptoms of a systemic response like pyrexia, rigors, and flu-
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 like symptoms (Fetherston 2001; Kvist 2010). More recent studies by Kvist et 
al. (2008) have supported the hypothesis by Fetherston (2001) and shown that 
85% of women with mastitis had recovered without the use of any antibiotic 
treatments. 
A study that identified bacterial content in breast milk of women with mastitis 
could divide mastitis into two groups. One group was mastitis associated with 
normal skin flora and the other group was mastitis associated with potentially 
pathogenic bacteria (Osterman & Rahm 2000). The group with skin flora 
isolated from breast milk did not require antibiotic therapy as emptying the 
breast resulted in resolution of symptoms, and these women had good 
lactational outcomes as they were able to continue to breastfeed their infant.
The women with mastitis associated with pathogenic bacteria had isolates of 
gram positive S. aureus DQGJURXS%DQG*ȕ-haemolytic Streptococci in the 
breast milk. The women with these strains of bacteria resulted in poor 
lactational outcomes with symptoms persisting for over a week and antibiotic 
therapy was necessary. As a consequence 31% of the women weaned their 
infant early due to the infection (Osterman & Rahm 2000). This study highlights 
the need for further investigation into S. aureus DQGȕ-haemolytic Streptococci
induced mastitis to understand the immune response in the breast to increase 
the lactational outcomes and prevent early weaning.
1.4.1 Immune cell infiltration during mastitis
Immune cell infiltration during mastitis has been well noted in the bovine udder.
During a bout of mastitis the mammary gland undergoes an infiltration of 
immune system cells such as lymphocytes, neutrophils and macrophages 
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 which are involved in protecting the gland from infection (Burton & Erskine 
2003). In cows the first response of the immune system is a neutrophil influx 
via chemotaxis to establish the inflammatory process (Akers & Thompson 
1987). Detection of pathogenic bacteria in the mammary epithelial cells and 
macrophages that are present in low numbers in the milk release 
chemoattractants to trigger the migration of leukocytes (mainly PMN) from the 
blood into the mammary gland which makes up approximately 90% of total 
milk cells (Bonnefont et al. 2011; Leitner et al. 2000; Riollet et al. 2002). The 
PMN are phagocytes which are normally present in the blood stream. PMN 
recruitment in the mammary gland during infection is primarily to engulf the 
pathogenic bacteria where they are eradicated through oxygen 
dependent/independent systems (Paape et al. 2003; Zhao & Lacasse 2008).
However, the immune cell infiltration in response to mastitis in the mammary 
gland of human is less understood (Delgado et al. 2011).
1.4.2 Mammary gland immune response
Immune response to mastitis has been well studied in the bovine (Barkema et 
al. 2009; Borm et al. 2006; Danielsen et al. 2010; Delgado et al. 2011; Günther 
et al. 2009; Lutzow et al. 2008; Strandberg et al. 2005). It has been shown that 
bovine mammary epithelial cells (BMEC) induce an immune response when 
challenged with Lipoteichoic acid (LTA) or Lipopolysaccharide (LPS) 
(Strandberg et al. 2005). LTA is a major cell wall component in gram positive 
bacteria and LPS is an endotoxin and a major component of the outer 
membrane of gram negative bacteria. This study showed a differential 
response to LTA and LPS with LPS resulting in an up-regulation of cytokines 
such as TNF and IL-8 that was sustained over a 24 hour time course. LTA 
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 showed an initial up-regulation of these cytokines but returned to resting levels 
after 8-16 hours of challenge (Strandberg et al. 2005). The authors concluded 
that the unsustained immune response seen in LTA challenged BMEC could 
explain why gram positive mastitis leads to chronic intra-mammary infection 
more so than a gram negative bacteria in the bovine. There are no studies 
identifying immune response to challenge in the human breast, but it could be 
speculated that in the human the gram positive S. aureus, being the main 
etiological agent causing mastitis, results in poor lactation outcomes in these 
women possibly due to an unsustained immune response to S. aureus LTA.
For example, it is not known how the human mammary gland responds to 
infection and what genes will be expressed in the immune response, and 
whether the immune response is maintained. Utilizing in vitro models to study 
immune response to infection would further our understanding of the human 
breast during infection and could identify pathways involved in the breast 
immune response and changes in milk composition that could provide 
antibacterials and anti-inflammatories in the milk.
1.5 Cell based models to study mammary gland 
biology
Studying lactational mastitis in humans has limitations due to ethical 
considerations associated with experimental design, assessing mammary 
tissue and storing data. However, there are non-invasive in vitro techniques 
that could shed light on breast immune function by two methods. (1) To utilize 
cells present in breast milk as representatives of mammary gland status, and 
(2) to use 3D human mammospheres the mimic the functionality of the 
secretory alveoli.
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 1.5.1 Breast milk cells
Milk has been shown to have heterogeneous populations of living cells (Figure 
1.5) (Boutinaud & Jammes 2002; Cregan et al. 2007; Hassiotou et al. 2013a).
These living cells that can be isolated from breast milk include epithelial, 
immune cells (lymphocytes, macrophages neutrophils) (Boutinaud & Jammes 
2002) and more recently stem cells (Cregan et al. 2007; Hassiotou et al. 
2013a). Studies have revealed that the breast milk population contains 50-90% 
epithelial cells, 6% neutrophils, 5-9% lymphocytes and 8% macrophages
(Boutinaud & Jammes 2002). However the distribution of cell types changes 
based on the stage of lactation (colostrum, early lactation, mid lactation, 
weaning) (Gaffney et al. 1976)
The epithelial cells that are shed into breast milk are predominantly viable. 
These epithelial cells have a phenotype of fully differentiated alveolar cells and 
express markers for CK14 which is a mature myoepithelial cell marker and 
CK18 a markers for mature secretory epithelial cells (Boutinaud & Jammes 
2002; Cregan et al. 2007).
The use of breast milk cells for primary culture provides a non-invasive method 
to study lactogenesis, mammary development and infection in humans. Also 
51$H[WUDFWLRQ IURPEUHDVWPLON FHOOV VKRZHGȕ-casein gene expression in 
epithelial cells isolated from human milk (Lindquist et al. 1994). Recent 
unpublished data (Sharp et al. 2014) has examined the breast milk cell 
transcriptome across colostrum, lactation and involution and identified 
transcription factors involved in milk synthesis. This data further supports the 
use of breast as a method to study breast development and lactogenesis.
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 Immune cells such as lymphocytes, neutrophils and macrophages are present 
in milk and are involved in protecting the mammary gland from infection such 
as mastitis (Burton & Erskine 2003). Changes in gene expression in milk cells 
when mastitis is present in the breast is yet to be analysed and may provide 
new insights into breast immune response and function.
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 Figure 1.5 Cells isolated from breast milk.
Isolated cells from breast milk. Taken from (Hassiotou et al. 2013a).
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 1.5.2 The mammosphere model
The mammosphere is a three-dimensional in vitro model comprised of 
polarised mammary epithelial cells that has similar functionality to the 
secretory alveoli (Mailleux et al. 2008; Romagnolo & DiAugustine 1994).
Typically mammospheres develop on an extra cellular matrix (ECM). When 
mammary epithelial cells are cultured on ECM the epithelial cells form a 
spherical structure that has a hollow lumen (Figure 1.6a) and after hormone 
induction with lactogenic hormones milk proteins are synthesized and secreted 
into the lumen (Mailleux et al. 2008; Romagnolo & DiAugustine 1994).
1.5.2.1 Mammospheres generated from breast cancer cell lines
In mammospheres generated using the MCF-10A cell line cultured on 
Engelbreth-Holm-Swarm (EHS) matrix, mammosphere formation follows an 
ordered sequence of events (Debnath & Brugge 2005). In the early stages of 
mammosphere culture, apical/basolateral polarization of MECs occurs in cell 
clusters before lumen formation between 3-4 days of culture (Debnath et al. 
2002). Between days 5-8 of culture there are two populations of cells within the 
acinus; the first is the outer layer of cells which is in direct contact with matrix 
and the second is an inner subset of cells that lacks contact with the ECM. The 
outer cell layer remains polarized with GM130 staining which is used to mark 
cell apical-basal polarity which is located in the luminal orientation of the golgi
(Nedvetsky et al. 2012; Privette Vinnedge et al. 2014) being present at the 
apical orientation observed by day 6 of culture (Debnath & Brugge 2005; 
Debnath et al. 2002). Also at day 6 of culture increased survival signals are 
observed in the outer layer of cells with the presence of Akt signalling which 
has no detectable signal in the centrally located cells. Akt is a serine-threonine 
kinase where activation by growth factors and extracellular matrix receptors 
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 provides survival signals (Brunet et al. 1999; Datta et al. 1999).By day 8 the 
cells in the centre of the acini begin to undergo apoptosis which occurs through 
caspase 3 activation and results in a hollow lumen (Figure 1.6b) (Debnath & 
Brugge 2005; Debnath et al. 2002). Other markers have also been used to 
show polarization of mammospheres using the MCF10A cell line. Staining 
showed that the Disk large protein, a protein involved in polarisation and which 
is located on the basolateral surface of a polarized mammosphere and 
ezrin/radixin/moesin (ERM) staining is enriched on the apical surface (Figure
1.7b) (Debnath et al. 2003).  More recently the MCF-10A mammosphere 
model has also been used to identify the involvement of cAMP in regulating 
lumen formation in these mammospheres (Nedvetsky et al. 2012).
 
1.5.2.2 Human mammary epithelial cell mammospheres
A study by Dontu et al. (2003) reported isolation of normal human mammary 
cells from reduction mammoplasties and the cells were cultured as
undifferentiated human mammary epithelial cells (HMECs) in suspension as 
mammospheres (Figure 1.7a) The cells were cultured on ultra-low attachment 
plates to select for non-adherent mammospheres which were dissociated and 
placed on an ECM component collagen for several days. Matrigel (mouse 
basement membrane matrix) was then layered over the cells prior to culture 
for a further 7 days. This allowed for differentiation of the mammospheres in 
media containing insulin, cortisol and prolactin to mimic fully functioning alveoli 
that secUHWHG ȕ-casein. However, they also showed that the cells in the 
mammospheres were secreting endogenous ECM as a precursor to 
differentiate the cells (Dontu et al. 2003).
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 1.5.2.3 Mammospheres grown on agarose
Interestingly, a study by Morales and Alpaugh (2009) reported a breast cancer 
model that mimicked in vivo cancer by using agarose as the substrate for 
cultured tumour cells (Morales & Alpaugh 2009). This method of producing a 
mammosphere without the use of any exogenous ECM provided new 
opportunities to have a simple human mammosphere model by not adding any 
mouse matrix to form mammospheres. However this method of preparing 
mammospheres hasn’t been examined using primary human breast epithelial 
cells to determine if the cells differentiate to the secretory state to express 
milk proteins.  
1.5.2.4 Advantages of 3-D cultures of human MECs and future
opportunities
The three-dimensional epithelial mammosphere culture provides overcomes 
some of the limitations seen in either the two-dimensional monolayer cell 
cultures, mouse models or human tissues. Firstly, two-dimensional in vitro
cultures result in limited response to endocrine stimuli where as 
mammospheres are responsive to hormones such as prolactin signalling for 
milk protein synthesis (Li et al. 1987; Streuli 1993). Three-dimensional 
mammospheres are also easily manipulated for varying experimental 
conditions and easily used for microscopic analyses. Lastly mammospheres 
form acinar structures of glandular epithelium seen in vivo (Alcaraz et al. 2004; 
Debnath & Brugge 2005). Therefore, characterization of a three-dimensional 
model that mimics the morphology of the secretory alveoli in the mammary 
gland was regarded as a huge leap forward in in vitro mammary models to 
study breast function (Kozlowski et al. 2009).
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 The characterization of a normal primary human mammosphere culture model 
derived from human mammary cells utilizing either mouse ECM or agarose 
would be beneficial for studying normal mammary alveolar development, 
hormonal regulation by lactogenic hormones and also studying potential 
epithelial immune responses infections like mastitis.
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 Figure 1.6 The mammosphere model.
(A). Mammary epithelial cells on an extracellular matrix form a spherical 
structure (mammosphere) that has a central lumen. Upon addition of 
lactogenic hormones milk is secreted into the lumen (B). Diagrammatic 
representation of the development of mammospheres cultured on ECM. 
During the early stages of 3D culture, apico/basal polarization forms within cell 
clusters. Two populations of cells become evident within each acini; an outer 
layer of cells in direct contact with the matrix and an inner subset of cells 
lacking matrix contact. The outer cell layer remains polarized. Signalling 
dichotomies between these two populations is also observed. The centrally 
located cells undergo cell apoptosis. This cell death leads to the formation of 
a hollow lumen. Modified from (Romagnolo & DiAugustine 1994) and (Debnath 
& Brugge 2005).
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 Figure 1.7 Human mammospheres.
A. Mammosphere morphology after 15 days of cultivation of HMEC. B. Day 20 
MCF-10A mammosphere immunostained with ERM (ezrin/radixin/moesin) in 
green and human discs large in red and counter stained with DAPI nuclei stain 
in blue. Modified from (Dontu et al. 2003) and (Debnath et al. 2003).
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 1.6. Summary
Utilizing cells from breast milk will detect changes in immune response and 
identify pathways of the breast immune response to mastitis. Defining a normal 
human mammosphere model to further study immune response to infection 
will provide a controlled in vitro method that can be manipulated to further 
elucidate breast epithelial responses. This method could be used for other 
studies to identify dose response to infection and could be used to understand 
other inflammatory breast conditions. In addition, defining the role for milk 
peptides produced from hydrolysis of milk proteins by breast milk proteases 
for immune protection could identify new mechanisms for milk processing 
during milk stasis (blocked milk duct) and better define how the mammary 
gland releases peptides to protect itself from infection.
1.7 Aims 
The innate immune response of the mammary gland is poorly understood. 
Based on the current literature, further investigation is required to define in 
vitro methods to study breast function, more specifically to infection and the 
role of milk derived peptides to aid in the fight against mastitis-induced 
infection. The broad aims of this study were to examine the suitability of a 
mammosphere model to mimic human mastitis and to subsequently examine 
the mammosphere response to bacterial challenge. As milk peptides have 
recently been shown to possess anti-bacterial bioactivity, and may also be 
involved in regulating an immune response, the effect of peptides on 
bacterially challenged mammospheres was also examined.
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 The following specific aims were proposed:
Defining human mammospheres
x Establish a normal human mammosphere utilizing ECM or Agarose
x Define the role of lactogenic hormones required for mammosphere 
formation and polarization
x Demonstrate mammosphere functionality through hormone induction 
for milk protein synthesis
Immune response to mastitis
x Generate a comprehensive data set of gene expression profiles using
microarray of breast milk cells from women with mastitis 
x Identify potential immune response pathways involved in breast 
infection
x Establish a list of candidate genes expressed specifically during mastitis
x Challenge human mammospheres with LTA and LPS and determine 
the immune responses
x Compare the immune response to mastitic breast milk cells and 
challenged human mammospheres
Bioactive milk peptides
x Identify predicted secreted proteases and protease inhibitors expressed 
by breast milk cells
x Determine if milk is capable of processing itself through incubation over 
time to release milk peptides
x Identify immune protective bioactivity of peptides resulting from 
proteolysis in milk
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 Chapter 2 : Defining a human 
mammosphere model using human 
mammary epithelial cells (HMECs)
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 2.1 Summary
Mammospheres are three-dimensional in vitro acini comprised of mammary 
epithelial cells (MECs) that aggregate and then polarise. The structure 
subsequently develops a central lumen and has functionality similar to
secretory alveoli in the mammary gland.
In this study a mammosphere model has been characterized using human 
mammary epithelial cells (HMECs) grown on mouse extracellular matrix 
(geltrex) or on agarose. Under the influence of insulin the HMECs clumped, 
polarised and formed a hollow central lumen that is characteristic of 
mammospheres. The addition of cortisol, ȕ-oestradiol and prolactin to media 
led to expression of the milk protein gene, ȕ-casein. In contrast, in the absence 
of insulin mammosphere formation was not observed. Insulin was also shown 
to regulate the synthesis of extracellular matrix (ECM) which was secreted 
around the cells as part of the formation of mammospheres. Collagen IV and 
laminin gene expression was evident in mammospheres. Identification and 
analysis of genes involved in mammosphere formation was investigated by 
microarray analysis. Biofunction analysis of mammospheres formed in the 
presence of insulin revealed an up-regulation of differentiation, cell-cell 
junctions and cytoskeleton organization functions, and an up-regulation of 
genes for the major polarity complexes Scribble (SCRIB) and Crumbs3 
(CRB3) and cell adhesion markers Integrin A6 (ITGA6) and Tight junction 
protein 1 (TJP1). 
In addition to insulin, the insulin receptor (IR) can also bind insulin growth 
factor-1 (IGF-1) and elicit similar effects. Comparison of insulin and IGF-1
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 effects on mammosphere signalling showed that although IGF-1 could induce
a spherical structure, mammospheres did not polarize correctly and were not 
functional. This was demonstrated by the absence of ȕ-casein expression and
down-regulation of SCRIB when compared to mammospheres formed in the 
presence of insulin. This demonstrates a role for insulin in acinar development 
for secretory differentiation to express milk protein genes such as ɴ-casein and 
ECM regulation.
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 2.2 Introduction
Mammospheres are three-dimensional in vitro models that form by 
aggregation and polarization of mammary epithelial cells and have similar 
functionality to the secretory alveoli in the lactating breast (Mailleux et al. 2008; 
Romagnolo & DiAugustine 1994). Under the influence of lactogenic hormones 
insulin, glucocorticoids and prolactin, milk proteins are synthesized and 
secreted into the luminal space (Dontu et al. 2003; Mailleux et al. 2008; 
Romagnolo & DiAugustine 1994).
Mammosphere formation has been shown to follow a series of events in MCF-
10A cell lines (Debnath & Brugge 2005; Debnath et al. 2002). When cultured 
on ECM the MCF-10A cells form spherical structures where apical/basolateral 
polarity begins at approximately 3-4 days. Two populations of cells are 
observed in the acinar structure; one which is in contact with the ECM (outer 
cells) and the other, where the cells have no contact with ECM (inner cells of 
the acinus) (Debnath et al. 2002). Once polarization is established in the outer 
layer of cells which are in contact with ECM, the cells begin to express survival 
signals by inducing Protein kinase B (Akt) signalling (Brunet et al. 1999). The 
cells in the centre of the acinus are not in contact with the ECM thus Akt
signalling is not present and around the eighth day of culture these cells 
undergo apoptosis for luminal clearance (Debnath & Brugge 2005; Debnath et 
al. 2002). This model has defined the events of mammosphere formation to 
produce polarized structures with a central lumen. However, MCF-10A does 
not have a karyotype considered normal since it is near-diploid and also has a 
deletion of the p16 locus (Cowell et al. 2005; Debnath et al. 2003; Soule et al. 
1990). Another limitation of MCF-10A models is these cells are negative for 
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 the oestrogen receptor and express cytokeratin’s associated with basal 
epithelium which is not representative of the secretory luminal epithelia present 
in the  multiple cell types of normal breast (Debnath et al. 2003; DiRenzo et al. 
2002; Soule et al. 1990).
Other studies by Dontu et al. (2003) isolated human mammary cells from 
reduction mammoplasties and propagated undifferentiated human mammary 
epithelial cells (HMEC) in suspension as mammospheres. The cells were 
cultured on ultra-low attachment plates to select non-adherent 
mammospheres which were dissociated and placed on collagen, a component 
of the ECM, for several days. Matrigel (mouse basement membrane matrix) 
was then layered over the cells prior to culture for a further 7 days to allow for 
mammosphere formation and with the addition of lactogenic hormones, these 
mammospheres were able to synthesise WKHȕ-casein protein. A more recent 
study by Morales and Alpaugh (2009) described a breast cancer model that 
mimicked in vivo cancer using agarose as the substrate (Morales & Alpaugh 
2009). This method of producing mammospheres without the use of any 
exogenous ECM provides an opportunity to define a simple functional human 
mammosphere model in the absence of mouse matrix. However this model 
has not yet been defined in the normal human mammary epithelial cell 
mammosphere culture systems and it is not known if these structures will be 
able to differentiate to express milk proteins.
Three-dimensional mammosphere cultures provide advantages over the 
limitations seen in two-dimensional monolayer cell cultures, mouse models or 
human tissues. For example, two-dimensional in vitro cultures have a reduced 
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 response to endocrine stimuli such as response to lactogenic hormones (Li et 
al. 1987) most likely due to a lack of polarized epithelium as typically observed 
in milk secreting alveoli (Li et al. 1987; Streuli 1993) whereas mammospheres 
are responsive to prolactin signalling for milk protein synthesis. 
Currently there are limited studies defining human mammospheres models 
comprised of HMECs that mimic breast functionality. This chapter investigated
the role of hormones necessary for the development of functional human 
mammospheres that are capable of differentiating into a secretory state to 
express milk protein genes. Comparison of the mouse ECM and agarose as a
substrate to support formation of functional 3-dimensional acini was also
investigated to define the need of exogenous ECM for polarization of 
peripheral acinar cells.
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 2.3 Materials and Methods
2.3.1 Reagents
HuMEC Ready Medium kit, Bovine pituitary extract, geltrex, Tryple select, 
Goat anti-mouse Alexa 594, Swine anti-rabbit Alexa 488, ProLong antifade 
reagent, SYBR safe and PureLink RNA extraction kit were all from Life 
Technologies (VIC, Australia). Human recombinant insulin and human 
recombinant Epidermal Growth Factor (EGF) were from Lonza (VIC, 
Australia). Human prolactin pituitary derived (AFP6266B) was provided by Dr. 
A.F Parlow, National Hormone and Pituitary Program (USA).
Hexamethyldisilazane, Collagen I, Bovine holo-WUDQVIHUULQ&RUWLVRO2YLQHȕ-
oestradiol, Hoechst 33542, Isoproterenol hydrochloride, Paraformaldehyde,
Triton-x100 and Bovine serum albumin were from Sigma (NSW, Australia). 
NVP-AEW541 (Adooq), Rabbit anti-Human Cytokeratin 14 and rabbit anti-
Human E-Cadherin were from (Epitomics) and purchased from Sapphire 
Biosciences (VIC, Australia). Matrigel and Mouse CAM-5.2 were from Becton 
Dickinson (NSW, Australia). Mouse anti-Human Fibroblast clone B5 and 
mouse anti-human Collagen-IV were from Dako (VIC, Australia).  GoTaqGreen 
master mix and agarose were from Promega (VIC, Australia). iScript reverse 
transcriptase supermix was from Bio-Rad (VIC, Australia) and phosphate 
buffered saline was from Astral Scientific (NSW, Australia).
2.3.2 HMEC cell culture
Primary human mammary epithelial cells (HMECs) were purchased from Life 
Technologies (n=2). Cells were grown in serum free HuMEC Complete
Medium kit which contained 50ug/ml bovine pituitary extract and a HuMEC 
supplement mix containing insulin, cortisol, epidermal growth factor, transferrin 
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 and isoproterenol (Life Technologies). HMECs were first grown in a T75cm² 
(Corning) flask until 80% confluence to the suppliers specifications. Every two 
days media was changed until 50% confluence then changed daily thereafter. 
Cells were maintained in an incubator at 37°C and 5% CO2. To subculture cells 
media was removed from cells at 80% confluence and washed twice with 1x 
Phosphate buffered saline (PBS), then 5ml 1X Tryple  was added to cover the 
cell surface and the flask placed back into the incubator for 5 min at 37°C.
Flasks were gently swirled and lightly tapped to encourage detachment of 
cells. The cell suspension was transferred to a 15ml centrifuge tube and 
centrifuged at 200 g for 5 minutes to pellet cells. Pelleted cells were 
resuspended in 3ml media and pipetted to produce single cell suspensions. 
1ml of cell suspension was added to each of three T75cm² flasks with 13ml 
media and kept in an incubator at 37°C and 5% CO2.
2.3.3 HMEC mammosphere formation 
At 80% confluence cells were dissociated using 1x Tryple and pelleted by 
centrifugation at 200 g for 5min. Cells (1x104) were resuspended in 100μl of 
the following media combinations as indicated; 1. No hormone-NH (basal 
medium with 50μg/ml Bovine pituitary extract, 2μg/ml transferrin, 2ng/ml EGF) 
2. Insulin media (I) (basal medium with 50μg/ml Bovine pituitary extract, 2μg/ml 
transferrin, 2ng/ml EGF and 100ng/ml insulin) 3. Insulin/cortisol media (IF)
(basal medium with 50μg/ml Bovine pituitary extract, 2μg/ml transferrin, 2ng/ml 
EGF, 100ng/ml insulin and 50ng/ml cortisol) 4. IGF-1 media (basal medium 
with 50μg/ml Bovine pituitary extract, 2μg/ml transferrin, 2ng/ml EGF, 50ng/ml 
IGF-1) and 5 IGF-1, cortisol (IGF-1F) (basal medium with 50μg/ml Bovine 
pituitary extract, 2μg/ml transferrin, 2ng/ml EGF, 50ng/ml IGF-1 and 50ng/ml 
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 cortisol) and plated on substrates collagen I, geltrex, matrigel or agarose for 7
days. The substrates were prepared by plating 40μl on the bottom of a 96-well 
plate and allowed to set by incubating at 37°C for 1hr. After 7 days 
mammospheres in IF media were induced with prolactin by adding IFE2Prl 
media containing insulin 100ng/ml, cortisol 50ng/ml, prolactin 1μg/ml and ȕ-
oestradiol 100pg/ml. Also mammospheres cultured in IGF-1F media were 
induced using IGF-1FE2Prl media containing 50ng/ml IGF-1, 50ng/ml cortisol, 
1μg/ml prolactin and 100pg/ml ȕ-oestradiol for a further 3 days. Cultures were 
incubated in a 37°C incubator at 5% CO2. Mammosphere formation was 
visualized using Ti-eclipse microscope. Mammosphere formation experiments 
were conducted in triplicate.
2.3.4 NVP-AEW541 IGF-1R blocking 
Before plating HMECs monolayers were conditioned with media in the 
absence of hormones for 3hours. Cells (1x104) were plated on geltrex in media 
with either Insulin (I) or insulin-like growth factor-1 (IGF-1) plus NVP-AEW541 
at concentrations of 0μM, 0.1μM, 0.5μM, 1μM and 2μM. Cells were imaged at 
4 days of culture and performed in duplicate.
2.3.5 HMEC cell marker immuno-staining
HMECs (n=3) were plated in a 96 well plate at a density of 4x103 cells/well.
After 24 hours the cells were fixed in 4% paraformaldehyde for 20min, washed 
3 times with 1xPBS, then permeabilized with 0.1% Triton-x100 for 5min and 
further washed 3 times in 1xPBS. The cells were blocked in blocking buffer 
(2% serum/1% BSA) for 1hour at RT, then the primary antibody (table 2.1) was 
added in blocking buffer at 4°C overnight. After primary antibody incubation 
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 the cells were washed 5 times with 1xPBS then the secondary antibody was 
added in blocking buffer for 1hour at RT. The cells were then washed 3 times 
with 1xPBS and counterstained with Hoechst nuclei stain at 1μg/ml for 10min, 
washed 3 times in 1xPBS and cells were covered using ProLong antifade 
reagent. Cells were imaged using a Ti-eclipse fluorescent microscope with 
Nikon camera at 100x magnification.
Table 2.1 Antibodies used in this study.
Antibody Clone ID Dilution
Primary
Rabbit anti-Human Cytokeratin 14 EPR1612 1:100
Mouse anti-cytokeratin CAM 5.2 Neat
Rabbit anti-Human E-Cadherin EP700Y 1:100
Mouse anti-Human Fibroblast 5B5 1:100
Mouse anti-human Collagen IV CIV22 1:500
Secondary
Goat anti-mouse Alexa 594 1:400
Swine anti-rabbit Alexa 488 1:400 
2.3.6 Scanning electron microscopy 
Mammospheres (n=2) were fixed in 4% paraformaldehyde for 30 min then 
washed 3 times in 1xPBS. Mammospheres were dehydrated by serially 
increasing EtOH concentrations; 30% EtOH for 10min, 50% EtOH for 10min, 
60% EtOH for 10min, 70% EtOH for 10min, 80% EtOH for 10min, 90% EtOH 
for 10min, 100% EtOH for 10min. To dry the mammosphere, 100% 
Hexamethyldisilazane (HMDS) was added for 10min then removed and the 
mammospheres were allowed to air dry overnight. Mammospheres were
mounted on to carbon tape fixed to a stub and subsequently gold coated by 
sputter coating for 90sec, and visualized using a scanning electron microscope 
(Leica).
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 2.3.7 Confocal imaging
Mammospheres (n=3) were fixed in 4% paraformaldehyde for 30min then 
washed 3 times in 1xPBS and permeabilized in 0.1% Triton-x for 10min and 
washed 3 times in 1xPBS. Mammospheres were then stained with Hoechst 
nuclei stain at 1μg/ml for 15min and further washed 3 times with 1xPBS. 
Stained mammospheres were visualized under a Leica confocal microscope 
using z-stack of 5μm to image through the mammosphere.
2.3.8 RNA extraction
RNA was extracted from mammospheres (n=10) using a PureLink RNA 
extraction kit following the manufacturer’s instructions. Mammospheres were 
lysed and homogenized by adding 300μl Lysis buffer aspirated through a 21 
gauge needle five times. EtOH (70%, 300μl) was added to the cells and mixed 
by vortexing. The mix was then passed through a spin cartridge and
centrifuged at 12,000 g for 15sec. Bound RNA in the column was washed with 
700μl wash buffer I and centrifuged 12,000 g for 15sec, then 500μl wash buffer 
II was added and centrifuged 12,000 g for 15sec and repeated once. The spin 
cartridge was dried by centrifugation 12,000 g for 1min, and RNA was eluted 
with addition of 50μl RNase-free water to the spin cartridge followed by
centrifugation at 12,000 g for 2min.
2.3.9 Microarray analysis
Total RNA from mammosphere cultures in the presence of insulin (n=4) and in 
the presence of no hormones (n=4) was analysed on the Agilent 2100 
bioanalyzer (appendix 1) to ensure RNA integrity and total RNA (~1.2μg) was 
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 used to hybridize to an Illumina HumanHT-12 v4 Expression BeadChip under 
contract through the Australian Genome Research Facility (AGRF),
Melbourne, Australia. Data was normalised using the Affy package of 
Bioconductor (Gautier et al. 2004), and standard RMA technique (Irizarry et al. 
2003). Differential analysis was conducted using the lima package (Smyth 
2004). To identify differentially expressed genes between mammospheres 
formed in the presence of insulin and cells grown in the absence of insulin a
two sided t-test was used with a significance threshold of P<0.05. Datasets 
were analysed for function using the Ingenuity Pathways Analysis software 
(http://www.ingenuity.com) and the DAVID Bioinformatics tool 
(http://david.abcc.ncifcrf.gov/summary.jsp).
2.3.10 PCR analysis of mammospheres
cDNA was synthesized from RNA extracted from mammospheres following the 
iScript protocol. Briefly 5μl of total RNA was mixed with 4μl 5x iScript reaction 
mix and 11μl nuclease free water. cDNA was synthesized by thermo cycling 
incubation at 25°C for 5min, 42°C for 30min and 85°C for 5min. cDNA 
concentrations were measured using a nanodrop 1000 (Thermo fisher) and
stored at -20°C until required. Reverse transcriptase polymerase chain-
reaction (RT-PCR) was used to identify gene expression of the milk protein 
gene ȕ-casein, ECM markers, polarity markers and cell adhesion markers. 
Primers were designed for genes of interest using the Primer 3 program 
(http://bioinfo.ut.ee/primer3-0.4.0/) where primer size range of 18-23 bases 
with an optimal tm of 60°C. Genes of interest were collagen IV (COLA4A1) 
(NM_001845.5), laminin alpha 3 (LAMA3) (NM_198129.2ȕ-casein (CSN2) 
(NM_001891.3), tight junction protein 1 (TJP1) (NM_003257.4), crumbs 3 
(CRB3) (NM_139161.3), scribble (SCRIB) (NM_182706.4), integrin alpha 6 
59 
 
 (ITGA6) (NM_001079818.1) and housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (NM_002046.5). cDNA (1μg) was used 
in the PCR and was performed using GoTaqGreen master mix along with 1μM 
each of a gene specific forward and reverse primer (Table 2.2). PCR conditions 
XVHG ZHUH LQLWLDO GHQDWXUDWLRQ Û& IRU  PLQ IROORZHG E\  F\FOHV Û&
30secÛ&Vec DQGÛ&Vec IROORZHGE\DILQDOH[WHQVLRQRIÛ&IRU
min in a BioRad C100 Thermocycler. The PCR products were electrophoresed 
at 100v for 45min on a 1.5% agarose gel in a 1xTAE buffer and subsequently 
the agarose gel was stained with SYBR safe (Life technologies, Australia). The 
PCR products were visualized under a UV light by a ChemiDoc XRS+ Imaging 
system (Bio-Rad). Densitometry semi-quantitation was performed using the 
ChemiDoc software. Gene expression analysis was conducted in triplicate.
Table 2.2 Primers used in RT-PCR.
Primer Product size Sequence 5’-3’
GAPDH-fwd GTCAGTGGTGGACCTGACCT
GAPDH-rev 245 TGCTGTAGCCAAATTCGTTG
CSN2-fwd AAGGTCCTCATCCTCGCCT
CSN1-rev 386 AAGGACAGGCATCACTCTGC
COLA4A1-fwd TGGAGTGAAGGGACAAAAGG
COLA4A1-rev 420 GCCATTGCATCCTGGAATAC
LAMA3-fwd CCTGATCTTTGGGTCTTGGA
LAMA3-rev 212 TGCCTTGGTAAACTCCCTCA
ITGA6-fwd CATGCTCAGTCTCTCCACCA
ITGA6-rev 204 GGCGGTGTTATGTCCTGAGT
SCRIB-fwd GCACTGAGGAGGAGGACAAG
SCRIB-rev 296 AGAGCCACACCATTCACCTC
CRB3-fwd CACTGTTTTGCCTTCATCCA
CRB3-rev 390 CACCTGCTCCTCGCTACT
TJP1-fwd AACGCTATGAACCCATCCAG
TJP1-rev 347 CGGTTTGGTGGTCTGAAAGT
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 2.3.11 Statistics
Statistical analysis was carried out on RT-PCR gene amplicons using 
densitometry measurements and a two tailed t-test. Significance was 
considered with P<0.05.
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 2.4 Results
2.4.1 Characterization of Human Mammary Epithelial Cells (HMECs)
HMECs were grown as a monolayer and morphology was examined in culture 
which showed the presence of multiple cell types. The cell population 
comprised elongated cells typical of fibroblasts and cuboidal cells that 
resembled cobblestones typical of epithelial cells (Figure 2.1).
The cell types present in HMECs cultures were further defined by 
immunostaining with antibodies directed to specific cell markers. The cell 
population comprised of cells staining positive for pan-cytokeratin and 
fibroblast B5 indicating the presence of fibroblast and epithelial cells (Figure 
2.2a) as well as positive staining for the epithelial marker E-cadherin (Figure 
2.2b). Cytokeratin 8 was present indicating the presence of luminal/secretory
epithelial cells but cytokeratin 14 staining was not observed indicating the 
absence of basal/myoepithelial cells (Figure 2.2c).
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 Figure 2.1 Morphology of HMEC monolayers.
Phase contrast images of HMECs grown on plastic imaged at (A) 40x 
magnification and (B) 100x magnification. Cells growing as a monolayer 
resemble a mixture of elongated cells (red arrows) and cuboidal cells (yellow 
arrows).
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 Figure 2.2 Characterization of HMEC cell types.
HMEC monolayers (n=3) were immunostained for mammary cell markers. (A) 
Pan-cytokeratin (green) fibroblast B5 (red). (B) E-cadherin for epithelial
(green). (C) Cytokeratin 8-luminal epithelial (red) Cytokeratin 14-basal 
epithelial (green). Nuclei are shown blue.100x magnification.
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 2.4.2 Mammosphere formation: Substrate optimization
Previous studies have shown that species-specific effects influence the way in 
which mammospheres form on different extracellular matrix (ECM) substrates. 
For example mouse and bovine MECs form mammospheres on matrigel 
(Dong et al. 2013; Kozlowski et al. 2009; Riley et al. 2010), while seal and 
wallaby MECs have been observed to require their own ECM for 
mammosphere formation as they form stellate structures on matrigel (Sharp et 
al. 2006; Wanyonyi et al. 2013). In the current study HMECs were tested for 
their ability to form mammospheres on a range of substrates.  HMECs were 
plated directly onto either matrigel (mouse ECM), geltrex (mouse ECM), 
collagen I (a major mammary ECM component) or 1% agarose (absence of 
ECM, blocks cell attachment) and cultured for 7 days in commercial HuMEC 
complete medium which contains the hormones insulin, cortisol and EGF. 
HMECs cultured on collagen attached on the collagen after 24 hours, and by 
day 4 HMECs formed monolayers that spread across the collagen and did not 
form mammospheres, and there was no visible clumping (Figure 2.3A). HMEC 
plated on agarose were unable to attach to the agarose and formed rounded 
cell structures (one per well on a 96 well plate) after 24 hours of culture. By
day 7 mammospheres appeared to shrink in size and formed tightly organized 
spherical structures that were dark in colour with smooth outer edges (Figure 
2.3B). HMECs on geltrex formed unstructured clumps with no defined shape 
after 24 hours but at 4-7 days of culture dark and tightly organized spherical 
mammospheres were observed (Figure 2.3C). These structures were visibly 
similar in shape to the mammospheres formed on agarose, however, multiple 
mammospheres of various sizes were present in each well. HMECs cultured 
on matrigel formed structures with no defined shape or structure by 24 hours.
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 At days 4-7 cells formed a loosely packed rounded structure with a rough 
perimeter (Figure 2.3D).
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 Figure 2.3 HMEC growth and organisation on different substrates.
HMECs mammosphere formation was optimized using different substrate 
conditions over 7 days of culture in HuMEC complete medium. (A) Growth on 
collagen failed to promote mammosphere formation, while (B) agarose
promoted rounded structures after 24 hours and by 7 days mammospheres
were observed. Growth on (C) Geltrex and (D) Matrigel caused cell 
aggregation by 24 hours and structures became rounded and formed 
mammospheres by 7 days. The experiment was conducted in triplicate.
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 2.4.3 Mammosphere formation: Minimal hormone requirements 
Mammosphere cultures have typically formed in media containing multiple 
hormones such as insulin and cortisol, and the addition of prolactin has been 
added to media to induce milk protein synthesis (Debnath et al. 2003; Dong et 
al. 2013; Murtagh et al. 2004; Neville et al. 2013). To identify hormones 
necessary for mammosphere formation of HMECs  were cultured on either 
geltrex or agarose in the presence of different lactogenic hormone 
combinations (no hormones (NH), insulin (I), cortisol (C), prolactin (Prl) and 
insulin/cortisol (IF)), and mammosphere formation was observed over 7 days.
After 7 days in NH media HMECs grown on geltrex or agarose did not form 
mammosphere but formed unorganised clumps (Figure 2.4A/B). In media
containing cortisol the HMECs showed a similar response to NH media and 
failed to form mammospheres on both geltrex and agarose (Figure 2.4 C-D).
In contrast, HMECs formed tightly rounded mammospheres on geltrex (Figure 
2.4 E) in media containing insulin and a similar structure was also observed 
with cells cultured on agarose under these experimental conditions (Figure 
2.4F)., this was also seen in media containing insulin and cortisol (IF) the
HMECs formed mammospheres on both geltrex and agarose with similar 
results to HMECs response to I. (Figure 2.4I-J). In media containing prolactin 
HMECs formed small unorganised cell clumps (Figure 2.4 G-H). 
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 Figure 2.4 Hormone requirements for HMEC mammosphere formation.
HMECs were cultured on geltrex (A, C, E, G, I) or agarose (B, D, F, H, J) in 
the presence of different hormone combinations. Mammosphere formation 
was not observed in (A, B) the absence of hormones, or in the presence of (C, 
D) cortisol or (E, F) prolactin alone. Mammosphere formation was observed in 
the presence of insulin (G, H) and insulin/cortisol (I, J). The experiment was 
conducted in triplicate. 
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 2.4.4 Hormone induction for milk protein gene expression
A characteristic function of mammospheres is the ability to express milk protein 
genes in response to lactogenic hormone stimulation of insulin, cortisol and 
prolactin (Blatchford et al. 2002; Dontu et al. 2003). To examine whether
HMEC mammospheres were hormone responsive, mammospheres were 
formed under the influence of insulin/cortisol (IF) media with cells cultured on 
either agarose or geltrex for 7 days. The mammospheres were then subjected 
to stimulation by insulin/cortisolȕ-oestradiol/prolactin (IFE2Prl) media for a 
further 3 days to examine expression of the ȕ-casein gene. 
HMEC mammospheres formed in IF media on both agarose and geltrex 
showed no detectable expression of the ɴ-casein gene but with the addition of 
ɴ-oestradiol and prolactin to the IF media (IFE2Prl) significant expression 
(P<0.05) of ɴ-casein was observed in mammospheres cultured on both 
agarose and geltrex (Figure 2.5).
.
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 Figure 2.5 Lactogenic hormone induction of HMEC mammospheres.
HMEC mammospheres were formed in insulin/cortisol (IF) media for 7 days 
then treated with lactogenic hormone induction media insulin/cortisol/ɴ-
oestradiol/prolactin (IFE2Prl) for a further 3 days. The control of IF formed 
mammospheres cultured on agarose or geltrex failed to induce expression of 
ȕ-casein while addition of E2Prl to the media showed significant ȕ-casein gene 
induction P<0.05. Gene expression shown relative to GAPDH and conducted 
in triplicate. 
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 2.4.5 Characterisation of HMEC mammosphere structure
In all experiments HMECs cultured on both agarose and geltrex showed 
similar results by responding to insulin to form mammospheres and in the 
presence of lactogenic hormones on both substrates ɴ-casein gene 
expression was observed suggesting the formation of functional HMEC 
mammospheres using both substrates. Therefore, all subsequent experiments 
were performed using HMEC mammospheres grown on either geltrex or 
agarose. Electron micrographs showed that each mammosphere was 
comprised of a multicellular aggregation of cells in a smooth and spherical 3D 
structure of approximately 500μM (Figure 2.6).
To examine central lumen formation in HMEC mammospheres formed in 
media containing IF, cells were stained with Hoechst nuclei stain and 
examined with a confocal microscope using z-stack to image sections through 
the mammosphere. The top of the mammosphere showed nuclei staining 
indicating a dense area of cells. Subsequent sections through the 
mammosphere showed that mammospheres had a single layer of HMECs 
surrounding a central lumen that was completely cleared of cells (Figure 2.7). 
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 Figure 2.6 SEM of mammospheres.
HMEC mammosphere (n=2) formed in media containing insulin/cortisol (IF) on
agarose. 150x magnification. Scale bar is shown.
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 Figure 2.7 Lumen identification in HMEC mammospheres.
(A) Mammosphere (n=3) viewed under light microscopy before staining (B-H) 
Immunofluorescent images showing nuclear staining by Hoechst (blue) of 
HMEC mammospheres. (B) View of the top of the mammosphere and (C-H) 
sections through the mammosphere until the centre is reached (H). Each 
section shows multiple layers of cells that surround a central lumen that is 
completely cleared of any cells.
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 2.4.6 Expression of Extracellular matrix proteins in mammospheres 
Previous studies have shown that mammosphere formation is dependent on 
the presence of ECM factors (Sharp et al. 2006). The current studies show that 
HMECs can form mammospheres in the absence of exogenous ECM (ie. in 
the presence of agarose), but only in the presence of insulin. This suggests 
that in the presence of insulin HMECs most likely produce endogenous ECM 
to support mammosphere formation. To test this, ECM expression by HMECs 
grown on agarose was determined in the presence and absence of insulin. 
HMEC were plated on agarose in the presence of either NH, F, I or IF. After 7 
days the cells were analysed by RT-PCR to detect the expression of two major 
ECM components, laminin and collagen IV. Expression levels were normalized 
using the GAPDH housekeeping gene.
Gene expression profiles from HMECs grown on agarose in either NH or F, 
showed there was no detectable expression of laminin and collagen IV genes.
Whereas HMECs cultured in media containing I showed induction of both 
laminin and collagen IV genes (Figure 2.8A and B), but in the presence of IF 
laminin and collagen IV gene expression in mammospheres was significantly 
higher than with I alone. To confirm secretion of collagen IV by HMEC 
mammospheres, immunocytochemistry techniques were used. Antibodies
against collagen IV were used to show collagen IV staining around the 
periphery of the mammosphere (Figure 2.8C).
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 Figure 2.8 Laminin and collagen IV expression by HMECs grown on 
agarose.
ECM gene expression of HMECs grown on agarose in the presence of cortisol 
(F), insulin (I) or insulin/cortisol (IF) compared to no hormone (NH) control. (A) 
Laminin gene expression. (B) Collagen IV gene expression. Gene expression 
shown relative to GAPDH and conducted in triplicate. Significance *P<0.05. 
(C) Immunocytochemistry showing collagen IV secretion on the peripheral 
surface of a mammosphere detected by an anti-collagen IV antibody (red). 
100x magnification. 
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 2.4.7 Transcriptional regulation of insulin-induced HMEC
mammosphere formation 
In order to define the role of insulin in the formation of HMEC mammospheres, 
human Illumina microarrays were used to analyse biofunction pathways. We 
have previously determined that mammosphere formation only occurs in the 
presence of insulin on either geltrex or agarose. Here cell clumps formed by 
HMECs grown on geltrex in the absence of hormones (n=4) were compared 
to HMEC mammospheres grown on geltrex in the presence of insulin (n=4). 
Genes were considered differentially expressed if p<0.05 compared to the no 
hormone treated cell clumps. To validate the levels of epithelial cells in the two 
groups (mammospheres formed in insulin media and cell clumps formed in NH 
media) epithelial cell markers e-cadherin (CDH1) and keratin 16 (KRT16) 
showed there was no significant difference in these two genes showing similar 
levels of epithelial cells (Figure 2.9b).
Hierarchical cluster analysis was performed in order to determine the 
similarities of global gene expression profiles between samples. Cluster 
dendograms showed that all four insulin-induced HMEC mammospheres 
clustered together and the HMEC clumps grown in the absence of hormones 
clustered on a separate branch of the tree (Figure 2.9a). Insulin-induced 
mammospheres showed a total of 1166 up-regulated genes; (448 of these
genes were up-regulated over 2 fold), and 1385 down-regulated genes (371 of 
these genes were down-regulated over 2 fold) compared to the no hormone 
treated cell clumps. 
77 
 
 Figure 2.9 Cluster dendogram of relationship between genes expressed in the 
mammospheres formed in the presence of insulin and cell clumps formed in 
no hormones.
(A.) Hierarchical clustering of differential gene expression profiles of HMEC
cell clumps grown in the absence of hormones (NH, n=4) compared to insulin 
induced HMEC mammospheres (I, n=4) on geltrex cultured for 14 days. (B) 
Expression of epithelial markers e-cadherin (CDH1) and keratin16 (KRT16) in 
mammospheres formed in I media and cell clumps formed in NH media 
showing similar distribution of epithelial cell markers.
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 2.4.8 Pathway and Biofunction analysis of differentially expressed 
genes in insulin-induced mammosphere formation
Gene expression datasets were interrogated and analysed to investigate 
biofunction pathways associated with insulin induction of mammosphere
formation. An analysis of functional annotation based on DAVID and Ingenuity 
pathway analyses showed HMECs grown as mammospheres in the presence 
of insulin underwent changes in cellular organisation compared to HMEC cell 
clumps formed in the absence of hormones (Table 2.3). These changes were 
related to biofunctions associated with cellular development, cell 
differentiation, cell-cell junctions, adherens junctions, cell adhesion, 
cytoskeleton organization, apical junction complex pathways. There were also 
increases in steroid biosynthesis, lipid synthesis and glycolysis suggesting 
there is increased cellular activity in mammospheres.
Analysis of the top genes showing the largest fold change showed that many 
of these genes are associated with differentiation and cell junctions; loricin 
(LOR), keratinocyte differentiation-associated protein (KRTDAP), keratin 1 
(KRT1) and late cornified envelope 1C (LCE1C), are involved in cell 
differentiation and desmoglein 1 (DSG1) and desmocollin 1 (DSC1) are 
involved in desmosome cell-cell junctions in differentiating cells (Table 2.4).
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 Table 2.3 Ontology and pathway analysis of functions associated with 
differential gene expression of insulin induced mammospheres.
Category Term count % P Benjamani
goterm_bp_fat ectoderm development 37 4.1 1.50E-11 4.20E-08
goterm_bp_fat epidermis development 34 3.8 1.40E-10 1.90E-07
goterm_mf_fat structural molecule activity 65 7.3 4.60E-08 4.00E-05
goterm_bp_fat epidermal cell differentiation 17 1.9 4.00E-07 3.70E-04
goterm_bp_fat keratinocyte differentiation 16 1.8 6.80E-07 4.60E-04
goterm_cc_fat cell-cell junction 28 3.1 9.70E-07 1.50E-04
goterm_cc_fat apicolateral plasma 
membrane 
19 2.1 2.90E-06 3.30E-04
goterm_cc_fat desmosome  9 1 2.90E-06 2.70E-04
goterm_bp_fat cell adhesion 64 7.2 4.30E-06 2.30E-03
goterm_bp_fat epithelial cell differentiation 22 2.5 4.50E-06 1.80E-03
goterm_cc_fat anchoring junction 25 2.8 5.30E-06 4.10E-04
goterm_bp_fat cell motion 48 5.4 6.40E-06 2.20E-03
sp_pir_keywords lipoprotein 54 6 1.20E-05 8.40E-04
goterm_mf_fat structural constituent of 
cytoskeleton 
15 1.7 1.40E-05 6.20E-03
goterm_cc_fat apical junction complex 17 1.9 3.20E-05 2.10E-03
goterm_mf_fat endopeptidase inhibitor 
activity 
21 2.3 3.30E-05 9.50E-03
sp_pir_keywords actin-binding 27 3 4.50E-05 2.20E-03
sp_pir_keywords GTP-binding 36 4 1.80E-06 1.60E-04
goterm_mf_fat cytoskeletal protein binding 47 5.3 5.10E-05 7.40E-03
sp_pir_keywords keratinization 10 1.1 5.20E-05 2.30E-03
Kegg_pathway Glycolysis/Gluconeogenesis 14 1.6 7.30E-05 1.10E-02
goterm_bp_fat epithelium development 27 3 7.30E-05 2.00E-02
goterm_bp_fat glycolysis 11 1.2 9.10E-05 2.20E-02
goterm_cc_fat cell junction 47 5.3 1.20E-04 6.30E-03
goterm_mf_fat GTPase activity 25 2.8 1.40E-04 1.20E-02
goterm_bp_fat cell migration 30 3.4 1.40E-04 3.00E-02
goterm_bp_fat protein oligomerization 22 2.5 1.70E-04 3.50E-02
goterm_bp_fat protein complex biogenesis 45 5 2.60E-04 4.30E-02
goterm_bp_fat protein complex assembly 45 5 2.60E-04 4.30E-02
goterm_mf_fat monocarboxylic acid 
binding 
11 1.2 2.90E-04 2.10E-02
sp_pir_keywords extracellular matrix 24 2.7 5.00E-04 1.40E-02
goterm_bp_fat glucose catabolic process 11 1.2 5.60E-04 7.70E-02
goterm_bp_fat regulation of epithelial cell 
proliferation 
12 1.3 7.70E-04 9.10E-02
goterm_bp_fat membrane organization 35 3.9 8.20E-04 9.30E-02
goterm_mf_fat calcium ion binding 68 7.6 9.90E-04 5.90E-02
goterm_bp_fat cell projection organization 33 3.7 1.80E-03 1.70E-01
goterm_cc_fat adherens junction 18 2 2.00E-03 5.10E-02
goterm_bp_fat extracellular matrix 
organization 
14 1.6 2.10E-03 1.80E-01
goterm_bp_fat cytoskeleton organization 37 4.1 2.30E-03 1.90E-01
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 sp_pir_keywords Intermediate filament 11 1.2 2.40E-03 4.80E-02
goterm_mf_fat fatty acid binding 8 0.9 2.40E-03 1.10E-01
goterm_mf_fat protein kinase binding 17 1.9 2.70E-03 1.20E-01
goterm_bp_fat monosaccharide catabolic 
process 
11 1.2 2.70E-03 2.10E-01
goterm_cc_fat proteinaceous extracellular 
matrix 
29 3.2 3.10E-03 6.40E-02
sp_pir_keywords calcium/phospholipid-
binding 
5 0.6 3.60E-03 6.10E-02
Kegg_pathway Focal adhesion 24 2.7 3.90E-03 1.90E-01
goterm_cc_fat lateral plasma membrane 5 0.6 4.20E-03 8.20E-02
sp_pir_keywords cell adhesion 32 3.6 4.60E-03 7.20E-02
goterm_cc_fat actin cytoskeleton 25 2.8 4.60E-03 8.30E-02
goterm_bp_fat programmed cell death 46 5.1 6.40E-03 3.70E-01
goterm_bp_fat cell morphogenesis 30 3.4 7.10E-03 4.00E-01
goterm_bp_fat macromolecular complex 
assembly 
49 5.5 7.10E-03 3.90E-01
goterm_cc_fat cell-cell adherens junction 7 0.8 7.40E-03 1.20E-01
goterm_bp_fat cell death 52 5.8 7.50E-03 3.90E-01
goterm_bp_fat apical part of cell  18 2 8.80E-03 1.20E-01
goterm_bp_fat cellular component 
morphogenesis 
32 3.6 9.90E-03 4.40E-01
goterm_bp_fat actin filament-based 
process 
22 2.5 1.00E-02 4.30E-01
goterm_mf_fat lipid binding 35 3.9 1.00E-02 3.20E-01
sp_pir_keywords lipid synthesis 11 1.2 1.20E-02 1.40E-01
goterm_bp_fat collagen fibril organization 6 0.7 1.40E-02 4.80E-01
goterm_cc_fat apical plasma membrane 14 1.6 1.60E-02 1.70E-01
goterm_bp_fat extracellular structure 
organization 
16 1.8 1.70E-02 5.20E-01
goterm_bp_fat response to cAMP  7 0.8 1.80E-02 5.20E-01
goterm_bp_fat response to hormone 
stimulus 
29 3.2 1.80E-02 5.20E-01
goterm_bp_fat apoptosis 43 4.8 1.90E-02 5.30E-01
Kegg_pathway Steroid biosynthesis 5 0.6 2.00E-02 4.10E-01
goterm_bp_fat cell morphogenesis 
involved in differentiation 
21 2.3 2.10E-02 5.60E-01
goterm_bp_fat fatty acid metabolic process  18 2 2.20E-02 5.60E-01
Kegg_pathway Galactose metabolism 6 0.7 2.20E-02 3.50E-01
Kegg_pathway Tight junction 16 1.8 2.20E-02 3.20E-01
goterm_cc_fat basolateral plasma 
membrane 
18 2 2.70E-02 2.50E-01
Kegg_pathway ECM-receptor interaction 12 1.3 1.60E-02 4.80E-01
Kegg_pathway Regulation of actin 
cytoskeleton 
21 2.3 5.30E-02 5.10E-01
Kegg_pathway Wnt signalling pathway 16 1.8 5.50E-02 5.00E-01
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 Table 2.4 Top 15 fold gene changes in insulin induced mammospheres.
Up-regulated Fold change Down-regulated Fold change
DSC1
LOR
LCE1C
KRTDAP
DSG1
KRT1
FLG
CD36
VSNL1
LGALS7B
MAL
55.193
50.736
49.396
42.358
40.854
39.925
33.722
25.720
23.991
23.029
22.608
 
CYP1A1
RN7SK
MFNG
CSF2
ISLR2
NMB
CORO6
KLF2
STC2
KIAA1641
WFDC2
-21.863
-12.071
-6.925
-6.849
-6.640
-5.950
-5.686
-5.128
-5.126
-4.793
-4.707
 
GJB6 20.769 FOXA1 -4.702
IGFL2 20.682 TXNRD1 -4.594
FABP4 20.099 RNU1G2 -4.485
TMEM45A 17.900 VNN1 -4.242
82 
 
 2.4.9 Canonical pathways and upstream regulators of insulin-induced 
mammospheres
In order to predict possible pathways involved in the formation of HMEC 
mammospheres through the regulation of insulin, canonical pathway analysis 
was carried out using Ingenuity software. Genes examined were either up- or 
down-regulated by 2 fold with significance p<0.05 in insulin treated 
mammospheres compared to cell clumps formed in NH. The top significant 
(p<3.9e-6) pathway predicted was integrin linked kinase (ILK) signalling that is 
involved in differentiation through integrin-matrix interactions. Other pathways 
identified that were considered significant (p<0.05) were involved in cell 
adherent junctions, cholesterol biosynthesis and cyclin cell cycle regulation 
(Table 2.8). Typical pathways involved in insulin signalling were identified, 
such as phosphatidylinositol 3-kinase/protein kinase B pathway (PI3K/AKT) 
and mechanistic target of rapamycin (mTOR) signalling and also the EGF 
signalling pathway extracellular signal regulated kinase 5 (ERK5) was also 
identified. 
In order to further investigate functional changes within the cells of HMEC
mammospheres a list of predicted activation status of transcription factors and 
upstream regulators was generated (Table 2.9). Differentiation factors Rho-
associated, coiled-coil containing protein kinase 2 (ROCK2), jagged 2 (JAG2), 
tribbles pseudokinase 3 (TRIB3) and the catenin-ɴ/T-cell specific transcription 
factor/lymphoid enhancer-binding factor (&711ȕ7&)/()) complex were 
predicted to be activated and also insulin receptor substrate 2 (IRS-2) which is 
the insulin receptor substrate 2, involved in the insulin signalling pathway, was 
predicted to be activated whereas the NF-ț% FRPSOH[ZDVSUHGLFWHG WR EH
inhibited. Insulin has been shown to down-regulate insulin receptor substrate-
83 
 
 2 expression through the PI3K/Akt pathway (Hirashima et al. 2003). The 
expression profile of IRS2 was examined in insulin-induced mammosphere 
formation and was shown to be down regulated compared to NH-treated 
HMEC cell clumps (appendix 2).
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 Table 2.5 Predicted canonical pathways involved in insulin formed 
mammospheres.
Canonical pathway prediction P-value
ILK signalling 3.90E-06
Xenobiotic metabolism signalling 6.20E-06
Aryl hydrocarbon signalling 1.50E-04
PI3/AKT signalling 3.90E-04
Cyclin and cell cycle regulation 3.95E-04
Cholesterol biosynthesis 1 4.90E-04
Cholesterol biosynthesis 2 4.96E-04
Cholesterol biosynthesis 3 4.99E-04
Tight junction signalling 6.18E-04
ERK5 signalling 7.94E-04
14-3-3 mediated signalling 9.59E-04
p38 MAPK signalling 1.23E-03
Modelling of epithelial adherens junctions 1.56E-03
RAR activation 2.32E-03
AMPK signalling 2.81E-03
Glycolysis 1 3.94E-03
Epithelial adherens junctions signalling 3.99E-03
ATM signalling 3.69E-03
ERK/MAPK signalling 5.25E-03
WNT/B-CATENIN signalling 5.27E-03
PPAR signalling 7.10E-03
mTOR signalling 8.65E-03
Death receptor signalling 7.12E-03
Table 2.6 Predicted activation status of upstream regulators.
Gene Predicted Activation Z-
score
Molecular type P-value
IL-13 Activated 2.223 Cytokine 2.63e-13
ROCK2 Activated 2.248 Kinase 7.68e-10
TRIB3 Activated 2.391 Kinase 5.06e-09
SCD Activated 2.328 Enzyme 8.42e-09
IL-4 Activated 2.285 Cytokine 4.78e-08
IRS2 Activated 2.992 Enzyme 2.71e-06
PTPN11 Activated 2.193 Phosphatase 1.96e-04
GAS6 Activated 2.011 Growth factor 8.35e-08
JAG2 Activated 2.360 Growth factor 2.39e-03
&711ȕ7&)/() Activated 2.000 Complex 8.24e-03
1)ț%FRPSOH[ Inhibited -2.411 Complex 1.94e-11
MAPK8 Inhibited -2.814 Kinase 1.98e-08
XIAP Inhibited -2.508 Enzyme 6.43e-08
TRADD Inhibited -2.375 Other 3.30e-05
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 2.4.10 Cell adhesion/ junction markers and cell polarity markers
To determine if HMEC mammospheres express cell adhesion/junction 
markers and cell polarity markers, RT-PCR analysis examined expression of
two cell adhesion and junction markers; integrin A6 (ITGA6) and tight junction 
protein 1 (TJP1) and two cell polarity markers; scribble (SCRIB) and crumbs3
(CRB3). Gene expression was normalized to the GAPDH housekeeping gene.
Gene expression profiles of HMECs grown in either in no hormones (NH),
insulin (I) or insulin/cortisol (IF) showed there was detectable gene expression 
of ITGA6, TJP1, SCRIB and CRB3 in HMECs grown in the absence of 
hormones (NH). However, these genes were significantly up-regulated in 
mammospheres produced in the presence of I and further up-regulated in 
mammospheres cultured in media with IF (Figure 2.10). 
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 Figure 2.10 Gene expression analysis of cell adhesion/junction markers and 
polarity markers.
Gene expression was determined for cell adhesion and junction makers ITGA6
(A) and TJP1 (B) as well as cell polarity markers SCRIB (C) and CRB3 (D) for 
HMECs cultured in no hormone (NH), insulin (I) or insulin/cortisol (IF) media. 
Gene expression analysis showed gene expression of these markers in 
HMECs formed cell clumps cultured in NH media but HMEC mammospheres 
in the presence of I showed a significant up-regulation which was further up-
regulated in HMEC mammospheres cultured in IF media. Gene expression 
shown relative to GAPDH and conducted in triplicate. Significance *P<0.05.
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 2.4.11 Insulin vs IGF-1
Insulin like growth factor (IGF-1) is a hormone similar in molecular structure to 
insulin. (Bondy & Cheng 2004; Siddle 2011). Binding to each of their respective 
receptors insulin receptor (IR1) and insulin-like growth factor receptor (IGF-
1R) activates multiple signalling pathways in common between insulin and 
IGF-1 (Werner et al. 2008). The studies here showed insulin has a role in 
HMEC mammosphere formation, but to test if IGF-1 also shares this ability 
HMECs were cultured on agarose or geltrex in media that contained either 
insulin or IGF-1. In the presence of IGF-1 HMEC formed mammospheres 
similar in size and shape to those observed with insulin, however, IGF-1-
induced structures were less organized, less compact and contained a greater 
amount of cellular debris on the out edge of the mammospheres (Figure 2.11). 
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 Figure 2.11 Morphology of mammosphere formation in the presence of 
insulin or IGF-1.
HMECs were cultured on either (A and C) geltrex or (B and D) agarose in the 
presence of insulin or IGF-1. (A and B) Insulin treated HMEC mammospheres
and (C and D) IGF-1 treated HMEC mammospheres showing less uniformity 
and more cell debris. Magnification x100. Conducted in triplicate.
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 2.4.12 NVP-AEW541 receptor blocking of IGF-1R and IR
The observation that both insulin and IGF-1 can activate mammosphere 
formation made it necessary to dissect these pathways by determining if both 
insulin and IGF-1 were binding to their respective receptors. IGF-1 can bind to 
at least two cell surface receptors: the IGF-1 receptor (IGF-1R), and the insulin 
receptor (IR) but has a higher affinity for IGF-1R than IR. (Siddle 2011).
Both IR and IGF-1R are tyrosine kinase receptors. NVP-AEW521 is a selective 
kinase inhibitor which prevents IGF-1 mediated IGF-1R autophosphorylation 
and reduces activation of IGF-1 signalling pathways. NVP-AEW541 has an 
IC50=0.086μM to block the IGF-1R and at a higher concentrations NVP-
AEW541 can inhibit the IR IC50=2.3 μM *DUFÕғD-(FKHYHUUÕғDHWDO.
HMECs were plated on geltrex in either insulin or IGF-1 media and with NVP-
AEW541 (0μM, 0.1μM, 0.5μM, 1μM, 2μM). HMEC, in the presence of IGF-1,
formed mammospheres at 0μM and 0.1μM. At 0.5μM NVP-AEW541 or higher 
mammospheres failed to be produced suggesting the IGF-1R had been 
blocked and was inactive. HMECs in the presence of insulin, formed 
mammospheres with 0μM, 0.1μM, 0.5μM, 1μM NVP-AEW541, and 
mammospheres failed to be produced at 2μM when the IR was blocked (Figure 
2.12). These results suggest that both IGF-1 and insulin are binding to their 
respective receptors to induce mammosphere formation.
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 Figure 2.12 IGF-1R and IR receptor blocking using NVP-AEW541.
IGF-1R and IR blocking using NVP-AEW541. HMEC were plated on geltrex in 
either insulin or IGF-1 media +/- NVP-AEW541. Insulin binding to the IR 
showed a loss of mammosphere formation at 2μM NVP-AEW541 (A, C, E, G, 
I) and IGF-1 binding to the IGF-1R showed a loss of mammosphere formation 
at 0.05μM NVP-AEW541 (B, D, F, H, J). Magnification 40x. Experiment 
performed in duplicate.
91 
 
 2.4.13 Hormone induction for milk protein gene expression of insulin 
and IGF-1 induced mammospheres
To compare the ability of insulin and IGF-1 to induce milk protein gene 
expression, the expression of the ɴ-casein gene was examined by RT-PCR 
following the addition of ɴ-oestradiol and prolactin. HMECs were cultured in 
media containing either insulin/cortisol (IF) or IGF-1/cortisol (IGF-1F) for 7 
days to allow for mammospheres to form, then for a further 3 days ɴ-oestradiol 
and prolactin (E2Prl) was added to either the IF or IGF-1F cultures. Controls
included media with IF or IGF-1F only. After the 3 day incubation period RNA 
was extracted and RT-3&5 DQDO\VLV IRU ȕ-casein was performed. GAPDH
expression was used to normalize the data (Figure 2.13). Mammospheres 
formed in IF alone VKRZHGQRGHWHFWDEOHJHQHH[SUHVVLRQRIȕ-casein, but with 
the addition of ɴ-oestradiol and prolactin (IFE2Prl) ȕ-casein was up-regulated 
in the presence of IFE2Prl. In contrast mammospheres formed in the presence 
of IGF-1F alone showed no detectable gene expression of ȕ-casein and were 
not induced by IGF-1FE2Prl. The lack of induction of ɴ-casein in IGF-1FE2Prl 
shows that insulin and IGF-1 don’t share the same roles in mammosphere 
functionality.
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 Figure 2.13 Hormone induction of HMEC mammospheres formed in the 
presence of insulin or IGF-1.
Mammospheres formed in media containing IF or IGF-1F over 7 days were 
further treated with the addition ɴ-oestradiol and prolactin for 3 days to induce 
ɴ-casein expression. Mammospheres in the presence of IF media failed to 
induce expression of ɴ-casein while the addition of IFE2Prl to the 
mammospheres showed significant ȕ-casein gene induction. The 
mammospheres in the presence of IGF-1F showed no detectable expression 
of ɴ-casein and the addition of IGF-1FE2Prl failed to induce the ɴ-casein gene. 
Significance *p<0.05. Expression is shown relative to GAPDH and conducted 
in triplicate.
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 2.4.14 Cell junction markers and cell adhesion markers
To determine if there were differences in cell adhesion and polarity between 
HMEC mammospheres formed in either insulin or IGF-1 media the cell 
adhesion marker integrin A6 (ITGA6) and the polarity marker scribble (SCRIB) 
were analysed by RT-PCR and normalized to GAPDH gene expression
(Figure 2.14).
Gene expression profiles of HMECs grown in media with either NH, IF or IGF-
1F showed there was detectable gene expression of both ITGA6 and SCRIB 
genes in HMECs grown in the absence of hormones. ITGA6 was significantly
up-regulated 2.3 and 2.4 fold by both IF and IGF-1F respectively and there 
was no significant difference between the level of up-regulation between these 
two treatments (Figure 2.14a). SCRIB failed to be up-regulated by the addition 
of IGF-1F, but was significantly up-regulated 2.5 fold by IF compared to 
HMECs grown in the absence of hormones (Figure 2.14b). Absence of SCRIB
up-regulation in IGF-1F induced mammospheres suggest these structures are 
not correctly polarized.
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 Figure 2.14 Cell adhesion and polarity marker expression by insulin and IGF-
1 induced HMEC mammospheres.
Relative gene expression (% of GAPDH) for cell adhesion marker (A) ITGA6 
and cell polarity maker  (B) SCRIB for HMEC cells grown in the absence of 
hormones (NH), insulin/cortisol (IF) or IGF-1/cortisol (IGF-1F). N=3 with error 
bars present. Gene expression shown relative to GAPDH and conducted in 
triplicate. Significance *P<0.05.
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 2.5 Discussion
The use of in vitro mammospheres has become a widely utilized model to 
mimic mammary gland alveoli to study cell development and differentiation in 
mice and cows (Ip & Darcy 1996; Kozlowski et al. 2009; Sobolewska et al. 
2011), but there are limited studies using human primary cells in defining a 
human mammosphere model. Mammosphere development can be divided 
into stages as defined in the MCF-10A cell line culture on matrigel (Debnath & 
Brugge 2005). The first stage is the aggregation of cells and ECM secretion 
around the aggregated cells. The second apical/basal polarization forms within 
cell clusters. This polarization forms two cell populations, an outer layer of cells 
in direct contact with the matrix and an inner subset of cells lacking matrix 
contact. The outer cell layer remains polarized. Signalling dichotomies 
between these two populations is also observed and the centrally located cells 
undergo cell apoptosis. This cell death leads to the formation of a hollow lumen 
(Debnath & Brugge 2005). However the stages of mammosphere formation in 
primary human mammary epithelial cells has not been well characterized.
In the mammary gland the basement membrane constitutes the mammary 
extracellular matrix (ECM) which is a proteinaceous network that is mainly 
composed of laminin, collagen IV, glycoproteins and proteoglycans (Frantz et 
al. 2010; Schedin et al. 2004). A cell-matrix interaction is required during 
different developmental stages of the mammary gland which is necessary for 
ductal outgrowth and alveogenesis by regulating mammary cell survival, 
proliferation, polarity, differentiation, adhesion and migration (Frantz et al. 
2010; Glukhova & Streuli 2013; Schedin et al. 2004; Schmeichel et al. 1998; 
Wicha et al. 1980). This study showed primary human mammary epithelial 
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 cells (HMECs) are capable of forming polarized mammospheres with intact 
tight junctions that are capable of milk protein gene expression on two different 
substrates, geltrex and agarose, but failed to from mammospheres on collagen 
or Matrigel. The composition of geltrex and agarose vary greatly; geltrex is a 
reduced growth factor basement membrane matrix that is purified from mouse 
Engelbreth-Holm-Swarm (EHS) tumours and agarose is devoid of grown 
factors or ECM components and provides a non-adherent surface which has 
been shown in cancer line studies to create spheroids that are homogenous in 
shape and size (Morales & Alpaugh 2009). The use of geltrex as a substrate 
allows mammary epithelial cells to be in direct contact with ECM. Geltrex is 
similar to matrigel which is derived mouse EHS (Baker 2011; Danoviz & 
Yablonka-Reuveni 2012) but HMECs were not able to form polarised 
mammospheres on matrigel. This could be due to variations in ECM 
composition between geltrex and matrigel preparations. It is known that mouse 
primary epithelial cells and bovine (BME-UV1) cells will polarize and form 
mammospheres on matrigel (Kozlowski et al. 2009; Murtagh et al. 2004; 
Williams et al. 2008), however fur seal and wallaby mammary epithelial cells 
fail to form mammospheres on Matrigel and instead form stellate outgrowths 
(Sharp et al. 2006; Sharp et al. 2008b). These experiments demonstrate the 
species specific requirements of mammary epithelial cells for mammosphere 
formation, as fur seal and wallaby MECs require their own endogenous ECM 
expression for mammosphere formation. Agarose has recently been used to 
promote mammosphere and tumoursphere cultures, however these structures 
were not characterised for hormone responsiveness by induction of lactation 
by lactogenic hormones (Korkaya et al. 2009; Morales & Alpaugh 2009). This 
method was adapted for our HMECs study where growth of HMECs on 
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 agarose allowed cells to aggregate without the interaction of ECM. HMEC 
mammospheres formed on agarose allowed for rapid mammosphere 
formation with spherical structures observed by 24 hours of culture, whereas 
on geltrex the cells required 4 days before the structures became round and 
symmetrical. The formation of HMEC mammospheres were not only 
dependent on the substrate used, but also required the presence of insulin in 
the media. Without insulin in the media (no hormones) HMECs formed viable 
unorganised cell clumps. The functionality of HMEC mammospheres was 
validated by the expression of the milk protein gene, ɴ-casein in the presence 
of lactogenic hormones.
Hormone induction of milk protein synthesis and secretion has been well 
characterized in mouse models (Kabotyanski et al. 2009; Murtagh et al. 2004).
In vitro studies have shown that under the influence of the lactogenic hormones 
insulin, glucocorticoid and prolactin, milk proteins were synthesized and 
secreted into the luminal space (Dontu et al. 2003; Mailleux et al. 2008; Neville 
et al. 2002; Romagnolo & DiAugustine 1994). HMEC mammospheres formed 
on both agarose and geltrex in the presence of insulin and cortisol showed 
hormone responsiveness and milk protein gene expression after induction for 
3 days LQ WKH SUHVHQFH RI LQVXOLQ FRUWLVRO SURODFWLQ DQG ȕ-oestradiol. The 
requirements of these hormones to induce milk protein expression has been 
well documented. Studies using mice have shown that ȕ-oestradiol is required
to induce expression of milk protein genes including ZKH\DFLGLFSURWHLQȕ-
FDVHLQ DQG ț-casein (Miousse et al. 2013). Insulin has been shown to be 
required for synthesis and maintenance of milk protein genes in both cultured 
cells and in explants (Bolander et al. 1981; Menzies et al. 2009; Neville & 
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 Morton 2001; Nicholas et al. 1983). Glucocorticoids are required for mammary 
differentiation and milk secretion (Chomczynski et al. 1986; Neville & Morton 
2001; Nguyen et al. 2001) and prolactin regulates the transcription of milk 
protein genes and is necessary to initiate and maintain milk production in the 
mammary gland (Norman & Litwack 1997; Trott et al. 2008). The response 
observed in HMEC mammospheres to lactogenic hormones on both agarose 
and geltrex is consistent with findings in other species reporting hormone 
regulation of milk protein gene expression in mammospheres formed from 
mouse, bovine and seal MECs (Mukhina et al. 2006; Sharp et al. 2006; 
Sobolewska et al. 2011; Talhouk et al. 1990).
Apart from the implication of lactogenic hormones for milk protein synthesis 
and secretion, these hormones also have a role in development of the 
mammary gland. During pregnancy and lactation it is known there is a series 
of highly ordered events regulated by complex interactions with many 
hormones and growth factors (Gjorevski & Nelson 2011; Hovey et al. 2002). In 
mice models glucocorticoid is needed for mammary development and tight 
junction formation (Stelwagen et al. 1999; Woo et al. 1996; Zettl et al. 1992)
and insulin has recently been reported to play a role a role in mouse mammary 
gland development  (Neville et al. 2013). This study showed that insulin 
regulated HMEC mammosphere formation on both agarose and geltrex 
substrates, and mammospheres that formed in the presence of insulin and 
cortisol had defined lumens cleared of cells. Cortisol did not regulate 
mammosphere formation in this study, but in mice was shown to have a role 
in lumen formation (Murtagh et al. 2004). Mammospheres formed in a 
combination of insulin and cortisol showed increased cell adhesion marker 
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 expression compared to mammospheres formed in insulin media alone, this 
increase in gene expression of adhesion markers in insulin formed 
mammospheres in the presence of cortisol is consistent with literature which 
has shown glucocorticoid is required for tight junction formation during 
lactogenesis (Murtagh et al. 2004; Zettl et al. 1992).
The role of insulin in mammosphere development was also shown to involve
the regulation of expression of the major mammary gland ECM proteins 
collagen IV and laminin. A role for insulin in regulating collagen has been 
previously described in bovine keratocytes (Musselmann et al. 2006) and 
human vascular smooth muscle cells (Ruiz-Torres et al. 1998) but function has 
not been previously been identified in primary human mammospheres. Insulin-
stimulated mammosphere formation on agarose showed collagen IV protein 
was secreted around the periphery of the mammosphere. This suggests
HMEC secrete ECM in order to promote and develop differentiated 
mammospheres.
To elucidate the potential involvement of insulin signalling in mammosphere
formation, microarray analysis was carried out by comparing cells grown in the 
presence and absence of insulin. Biofunctions associated with insulin and 
mammosphere formation were identified in the categories of cell development, 
cell differentiation, cell morphogenesis, cell-cell junctions, desmosomes, cell 
adhesion, adherens junctions, focal adhesion, ECM organization, cytoskeleton 
organization, glycolysis and apoptosis. These gene ontology functions suggest 
that insulin regulates mammosphere formation by promoting appropriate cell-
cell interactions through adhesion, junctions and formation of desmosomes as 
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 well as defining the structures undergoing differentiation while forming apical 
junction complexes. Epithelial cell markers e-cadherin and keratin 16 were 
used to validate that cells grown in the absence of insulin which formed cell 
clumps contained epithelial cell populations although not organized structures. 
Upstream regulators interleukin-4 (IL-4) and interleukin-13 (IL-13) were 
predicted to be activated in mammospheres formed in insulin compared to cell 
clumps formed in the absence of hormones. IL-4 and IL-13 along with signal 
transducer and activator of transcription 6 (STAT6) are important mediators for 
differentiation of the immune cell type naïve T cells into the TH2 phenotype 
(Ansel et al. 2006; Watson 2009). Studies in mouse mammary epithelial cells 
have shown an up-regulation of IL4, IL-13 and STAT6 as mammary epithelial 
cells commit to a luminal epithelial phenotype under the influence of insulin, 
glucocorticoid and prolactin. Mice deficient for STAT6 and IL-4/IL-13 also 
revealed mammary differentiation and alveolar morphogenesis was reduced 
in these mice (Khaled et al. 2007). These studies using mice models confirm 
that IL-4 and IL-13 which are predicted to be activated in human 
mammospheres are a defining feature of differentiation in mammary epithelial 
cells.
The top canonical pathway predicted to be up-regulated in mammospheres 
grown in insulin was integrin-linked kinase (ILK) signalling. ILK has been 
shown to play crucial roles in actin rearrangement, cell polarization, migration, 
proliferation and survival (Legate et al. 2006). In the mammary gland cell-
matrix adhesion is necessary for epithelial development (Rooney & Streuli 
2011). The ȕ-integrins have been shown to control terminal differentiation 
through interactions with endocrine signalling in mouse mammary epithelial 
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 cells (Naylor et al. 2005)6WXGLHVKDYHVKRZQ0(&VWKDWGRQRWH[SUHVVȕ1-
integrin have no lumen and don’t differentiate or express milk proteins even 
after induction with prolactin (Naylor et al. 2005). This was shown through 
conditional deletion of ILK in both in vivo and in vitro models resulting in 
reduced differentiation which prevented phosphorylation and nuclear 
translocation of STAT5, a transcription factor required to induce expression of 
most milk proteins genes (Akhtar et al. 2009; Naylor et al. 2005; Rooney & 
Streuli 2011). The functional role of ILK signalling in mouse mammary 
epithelial differentiation supports this study where human mammospheres 
formed under the influence of insulin are polarised and develop a lumen.
Human mammosphere formation may be directed by ILK signalling.
Pathway analysis also predicted phosphatidylinositol 3-kinase/protein kinase 
B pathway (PI3K/AKT) signalling was up-regulated which is consistent with an
insulin signalling pathway. A study using BMEC showed insulin induced the 
expression of genes associated with milk protein synthesis through 
PI3K/Akt/mTOR and JAK2/STAT5 pathways and regulated milk fat synthesis 
through PI3K/Akt/mTOR pathway  (Wang et al. 2013). Another study using 
normal hepatocytes have shown insulin down-regulated insulin receptor 
substrate-2 (IRS-2) which is an adapter protein of the insulin receptor and is 
mediated through the PI3K/AKT pathway (Hirashima et al. 2003; Zhang et al. 
2001). We observed a down-regulation of IRS-2 while IRS-1 remained 
unchanged in mammospheres formed in the presence of insulin and this is 
possibly a result of insulin signalling through PI3K/AKT in mammospheres. In 
breast cancer IRS-2 up-regulation has been associated with increased cancer 
cell motility and contribute to breast cancer metastasis (Cui et al. 2006; Nagle 
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 et al. 2004). A study using the breast cancer cell line MDA-MB-468 showed 
siRNA directed towards IRS-2 repressed the induction of IRS-2 synthesis and 
prevented EGFs role in cell motility (Cui et al. 2006). In a normal HMEC 
mammosphere model the down-regulation of IRS-2 may be required to reduce 
cell motility while the cells are organising into polarised structures. 
Interestingly, studies in mice have shown the IRS 1/2 proteins are up-regulated 
during lactation and decrease during involution (Hadsell et al. 2007; Lee et al. 
2003). Dams with germline mutations of IRS-1 or IRS-2 showed a reduced
lactation capacity, but with a higher reduction in the IRS-1 knockout. However,
expression of milk protein genes had no significant reduction (Hadsell et al. 
2007). It would be interesting to speculate if the HMEC mammospheres up-
regulate the IRS 1/2 genes upon addition of the lactogenic hormone prolactin 
to induce milk protein synthesis.
Insulin and insulin-like growth factors (IGF-1 and IGF-2) are closely related 
hormones that have similar molecular structure and function and which are 
involved in regulating multiple metabolic and developmental processes (Bondy 
& Cheng 2004; Hadsell & Bonnette 2000; Siddle 2011). Early research 
suggested insulin was mainly involved in metabolic activities such as glucose
metabolism and IGF-1/2 controlled development processes such as cell 
growth. However, recent studies have shown there is cross-talk between the 
various ligands (insulin and IGF-1) and receptors of the IGF family. Therefore,
IGF-1 can regulate glucose metabolism in states of insulin resistance such as 
in diabetes, where people with type 2 or type 1 diabetes can respond to IGF-1
with a beneficial effect on glucose homeostasis (Boucher et al. 2010; 
Clemmons 2006; Moses et al. 1996). To determine if IGF-1 also had a role in 
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 mammosphere formation, HMEC were incubated on both agarose and geltrex 
in the presence of either insulin or IGF-1. This study showed that while insulin 
regulated HMEC mammosphere formation, IGF-1 was also able to regulate 
the formation of mammospheres that expressed genes associated with cell 
adhesion such as integrin A6. However, IGF-1 induced mammospheres were 
not functional and lacked gene expression markers necessary for polarization
and failed to induce milk protein gene expression under lactogenic hormone 
stimulation.
Previously published data by (Neville et al. 2013) used mouse models and 
mouse derived MECs for mammosphere cultures to show insulin was the main 
regulator secretory of differentiation in the mouse mammary gland. The role 
for insulin in secretory differentiation for expression of milk protein genes has 
also been observed in explant culture models from both the mouse and bovine 
where insulin regulated the expression of two transcription factors associated 
with milk protein synthesis STAT5a and E74-like factor 5 (ELF5) (Menzies et 
al. 2010; Menzies et al. 2009). The mouse MEC mammosphere model showed
the inclusion of insulin in media resulted in increased acinar size and lumen 
formation of mammospheres. IGF-1 also had a significant effect on 
mammosphere diameter but not luminal diameter at high concentrations of 
50nM (Neville et al. 2013). However results in this study using human MECs 
varied from the mouse study (Neville et al. 2013). IGF-1 showed an effect on 
mammosphere formation at low concentrations of approximately 6.5nM. The 
variation in response to hormones stimulating mammosphere formation may 
be due to variation of functional roles for hormones between different species 
104 
 
 as this is the first study to define the regulatory role of insulin in human 
mammosphere cultures.  
Insulin and IGF-1 bind to specific tyrosine kinase receptors IR and IGF-1R 
(Ullrich et al. 1986; Werner et al. 2008). Most receptor tyrosine kinases (RTKs)
are single-chain monomeric transmembrane polypeptides, however the insulin 
and IGF-1 receptors are dimers made of two extracellular alpha subunits and 
two transmembrane beta subunits containing the tyrosine kinase domain. The 
alpha subunits contain the ligand binding sites. In the ligand-activated form, all 
RTKs are dimeric or oligomeric, a mechanism that allows for trans-
phosphorylation of the kinase domains and triggers the signalling cascade. 
The residues of insulin involved in receptor binding form at least two major 
epitopes that partially overlap with the dimer and hexamer forming surfaces of 
the insulin molecule, and it is proposed that insulin is using these surfaces to 
cross-link the receptor alpha subunits. This mechanism provides a structural 
basis for negative cooperativity in binding, and probably also operates in the 
IGF-receptor interaction (De Meyts et al. 2004). Once activated these
receptors undergo a conformational change which leads to ATP binding and 
autophosphorylation of the tyrosine kinase domain of the receptor (Siddle 
2011). Insulin and IGF-1 fully activate their own receptor, although the binding 
occurs both can also bind and activate the other receptor but with reduced 
affinity (Boucher et al. 2010; Siddle 2011). To determine if insulin and IGF-1
were binding to their respective receptors to elicit mammosphere formation; 
NVP-AEW521 was used which as a selective kinase inhibitor that prevents 
IGF-1 mediated IGF-1R autophosphorylation resulting in reduced activation of 
IGF-1 signalling pathways. NVP-AEW541 has an IC50=0.086μM to block the 
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 IGF-1R and at a higher concentrations NVP-AEW541 can inhibit the IR 
IC50=2.3 μM *DUFÕғD-(FKHYHUUÕғDHWDO. Mammosphere formation was 
inhibited in the presence of IGF-1 and 0.5μM of NVP-AEW541 and in the 
presence of insulin and 2μM of NVP-AEW541 suggesting that insulin and IGF-
1 were binding to their respective receptors to stimulate mammosphere 
formation. However, polarisation was not achieved in HMEC mammospheres 
formed in the presence of IGF-1; this may be the result differential activation 
of downstream pathways and IGF-1 most likely does not induce expression of 
necessary factors for regulating polarisation (Boucher et al. 2010; Werner et 
al. 2008).
An important criteria of mammosphere function is the ability to differentiate into 
a secretory state. Mammospheres cultured in the presence of insulin and 
cortisol and further induced by lactogenic hormones (prolactin and ȕ-
oestradiol) expressed the milk protein gene, ȕ-casein but mammospheres
cultured in IGF-1 and cortisol failed to express ȕ-casein after addition of 
SURODFWLQ DQG ȕ-oestradiol. This showed insulin is necessary for secretory 
differentiation, while IGF-1 failed in this role. In a study using BME-UV1 cells 
mammospheres grown in the presence of IGF-1 had disrupted polarity and no 
lumen (Gajewska et al. 2013). The loss of polarity is consistent with the 
findings of this study with polarity markers not being up-regulated. Typically 
binding to IR or IGF-1R leads to autophosphorylation of the receptors on 
tyrosine residues (Siddle 2011; Werner et al. 2008). The phosphotyrosines are 
docking sites for SH2 domain-containing substrates such as the insulin 
receptor substrates (IRS) (Werner et al. 2008). These substrates also 
phosphorylate which leads to the activation of the PI3K-Akt/PKB and Ras-Raf-
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 MAPK pathways (Werner et al. 2008). Most components of these pathways 
are shared by the IR and IGF-1R (Dupont & LeRoith 2001). However there are 
some signalling mediators that are activated preferentially by either insulin or 
IGF-1, such as PP120 and GRB10 which interacts with the IR and not the IGF-
1R (Laviola et al. 1997; Najjar et al. 1997). Differential activation of some of 
these substrates may explain the differences in polarization and secretory 
differentiation of the insulin or IGF-1 formed mammospheres.
This study has shown a comprehensive analysis of the requirement needed 
for primary human mammospheres to differentiate into the secretory state to 
mimic breast functionality. The agarose mammosphere system provides a cost 
effective and rapid method to achieve functional mammospheres which 
showed results consistent with mammospheres formed on an ECM (geltrex). 
This study has defined a role for insulin in human mammosphere formation
with expression analysis suggesting that insulin induced mammospheres
utilize the PI3K/AKT and ILK signalling pathways.
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 Chapter 3 : Innate immune response to 
mastitis: comparison between in vivo 
milk cells and in vitro mammospheres.
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3.1 Summary
Mastitis is a common condition during lactation with an incidence of up to 33 
% of lactating mothers. Mastitis causes a reduction in milk secretion and is one 
of the leading causes for a mother to start weaning her child early. The bacteria 
most commonly isolated from mastitis infected breast milk is Staphylococcus 
aureus and sometimes Staphylococcus epidermidis and Escherichia coli.
Mastitis has been well studied in the bovine species but studies in human have 
been limited, for example, it is not known how the human mammary gland 
responds to infection. To study this response at the transcriptional level, cells 
collected from human breast milk during a bout of S. aureus induced mastitis
and a human mammosphere model of mastitis were employed.  Mastitic milk 
cells were examined by microarray analysis and showed an increase in 
expression of antimicrobial genes, inflammatory genes and 
immunomodulatory genes. Gene pathway analysis suggest this response is 
mediated through interferon signalling and toll-like receptor signalling. Similarly 
gene expression analysis by RT-PCR of mammospheres challenged with 
lipopolysaccharide (LPS) from E. coli or lipoteichoic acid (LTA) from S. aureus 
for 4-24 hours showed the same genes were up-regulated. This correlation of 
gene expression patterns suggest that mammary epithelial cells play a role in 
immunity against infection.
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 3.2 Introduction
Breastfeeding is recommended for the first six months of an infants life (Amir 
et al. 2011; WHO 2001), but infection can impact on breastfeeding success.
Mastitis is a common inflammatory condition of the breast that occurs during 
lactation (Arroyo et al. 2010; Michie et al. 2003; Osterman & Rahm 2000).
Symptoms are usually characterized by swelling, nipple pain, fatigue and flu-
like symptoms. Mastitis causes a reduction in milk secretion and is one of the 
leading causes for a mother to start weaning (Contreras & Rodriguez 2011).
Mastitis is typically caused from a blocked milk duct that results in milk stasis 
and subsequent infection when the milk isn’t removed (WHO 2000). Studies 
have identified that in mastitis cases 75% began in the first seven weeks after 
birth (Kinlay et al. 1998) impacting on lactation length.
Studies showed that women with mastitis testing positive for potentially 
pathogenic S. aureus DQGJURXS%DQG*ȕ-haemolytic streptococci had a poor 
lactational outcome (Osterman & Rahm 2000). A large proportion of the 
women (81%) experienced poor lactation outcomes with symptoms persisting 
for over a week, and antibiotic therapy was necessary. Severe complications 
in some of these women resulted in breast abscess and septic fever and 31% 
of the women in this group chose to wean the infant as a consequence of 
infection. This highlights the need for further investigation into S. aureus and
ȕ-haemolytic-induced streptococci mastitis to understand the immune 
response in the breast and to improve lactation outcomes to prevent early 
weaning.
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 Analysis of immune response to mastitis using gene expression analysis and
somatic cell counts (SCC) has been well studied in the bovine, using both 
whole animal and in vitro culture models (Barkema et al. 2009; Borm et al. 
2006; Danielsen et al. 2010; Delgado et al. 2011; Günther et al. 2009; 
Strandberg et al. 2005). It has been shown that bovine mammary epithelial 
cells (BMEC) induce different immune responses when challenged with either
lipoteichoic acid (LTA), a major cell wall component in gram positive bacteria 
or lipopolysaccharide (LPS), an endotoxin and a major component of the outer 
membrane of gram negative bacteria (Strandberg et al. 2005). Treatment with 
LPS resulted in an up-regulation of cytokine genes such as TNF and IL-8 that 
was sustained over a 24 hour time course, however, LTA showed an initial up-
regulation of these cytokines but they returned to resting levels after 8-16 hours 
of challenge (Strandberg et al. 2005). There are currently no studies identifying 
immune response to bacterial challenge in the human breast. It could be 
speculated that gram positive S. aureus, the main etiological agent causing 
mastitis in humans, may result in poor lactation outcome due to an unsustained 
immune response to S. aureus LTA. 
Studies identifying immune response to mastitis in the human are limited. One 
study of mastitic breast milk showed an increase in the pro-inflammatory 
cytokine interleukin-6 (IL-6) and larger milk fat globules compared to healthy 
milk (Mizuno et al. 2012). It is not known how the human mammary gland 
responds to infection at the level of gene expression and how long this 
response is maintained. This chapter reports studies utilising two models; (1) 
large scale transcription analysis of cells collected from milk during healthy and 
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 mastitic infection and (2) a human mammosphere model (established in 
chapter 2) challenged with LPS and LTA.
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 3.3 Materials and Methods
3.3.1 Breast milk sample collection
Breast milk samples were obtained from volunteer mothers with clinical signs 
of mastitis (n=3) while control healthy breast milk was collected when there 
was no sign of infection (n=3). Samples were provided by Dr Lisa Amir through 
the CASTLE study and tested positive for Staphylococcus aureus. Written 
consent for samples to be used in this study and was approved by Deakin 
University human research ethics committee (2011-104). Fresh milk was 
obtained by the use of mechanical breast pumps (Medela) and milk was
immediately stored on ice for viability testing.
3.3.2 Breast milk cell viability 
Fresh breast milk (50ml) was collected during mid lactation. Breast milk cells 
were isolated through centrifugation (500 g for 10min), washed with PBS and 
resuspended in a final volume of 300μl PBS. Live/dead cell staining was 
achieved by addition of Calcein-AM (Life Technologies) to a final concentration 
of 1μM and cells were incubated at 37°C for 30min. Propidium iodide (Life 
Technologies) was then added to a final concentration of 1μg/ml and incubated
for a further 10min. Cells were washed with PBS and resuspended in 50μl of 
PBS. Wet mounts of cells were prepared by dropping cell suspensions in the 
centre of a slide and overlaying a coverslip. Cell viability and morphology was
examined with an inverted epifluorescence microscope (×10 objective, Ti-300, 
Nikon), and images were captured with a Nikon digital imaging system. Red 
(dead) and green (live) cells were counted from four random fields to calculate 
percentage of viable cells in milk.
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 3.3.3 RNA extractions
Milk was thawed on ice and cells were collected through centrifugation at 2000
JIRUPLQDWÛ&. RNA from the cell pellet was extracted using RNeasy Lipid 
Tissue kit (Qiagen) following manufacturers specifications. Briefly, cell pellets
were lysed using 1ml Qiazol lysis buffer and passed through a 21g syringe, 
after 5min 200μl chloroform was added and vortexed for 15sec then left on the 
bench for a further 3min. The mix was then centrifuged at 12,000 g for 15 min 
at 4°C. After centrifugation the upper aqueous phase was collected and mixed 
with one volume of 70% ethanol then transferred to a RNeasy mini spin column 
and centrifuged for 15sec at 8,000 g at RT. The RNA bound to the column was 
subsequently washed with buffer RW1 then RPE and eluted with 70μl RNase 
free water by centrifugation at 8,000 g for 1min. RNA concentration was 
measured using NanoDrop1000 Spectrophotometer (Thermo Scientific). 
RNA was extracted from mammospheres using PureLink RNA extraction kit 
following manufacturer’s specifications. Mammospheres were lysed and 
homogenized by adding 300μl Lysis buffer and through a 21 gauge needle five 
times. 300μl 70% EtOH was added and mixed by vortexing. The mix was then 
passed through a spin cartridge and centrifuged 12,000 g for 15sec. Bound 
RNA in the column was washed with 700μl wash buffer I and centrifuged 
12,000 g for 15sec, then 500μl wash buffer II was added and centrifuged 
12,000 g for 15sec and repeated once. The spin cartridge was dried by 
centrifugation 12,000 g for 1min. To elute RNA 50μl RNase-free water was 
added to the spin cartridge and centrifuged 12,000 g for 2min. Total RNA was 
analysed on the Agilent 2100 bioanalyzer to ensure RNA integrity (appendix 
3).
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 3.3.4 Microarray analysis
Total RNA (~1.2μg) was used to hybridize to an Illumina HumanHT-12 v4 
Expression BeadChip under contract through the Australian Genome 
Research Facility (AGRF). Data was normalized against background and 
analysis carried out using LIMMA software. To identify differentially expressed 
genes between mastitis and healthy samples a two sided t-test was used a 
significance threshold of P<0.05. Datasets were analysed for function using 
the Ingenuity Pathways Analysis software (http://www.ingenuity.com) and the 
use of DAVID Bioinformatics tool (http://david.abcc.ncifcrf.gov/summary.jsp).
3.3.5 Mammosphere culture challenge with LTA and LPS
Human mammary epithelial cells (HMECs) were maintained in HuMEC ready 
medium (Life technologies, Australia) in a 5% CO2 incubator at 37°C. 80% 
confluent cells were dissociated using 1x Tryple (Life technologies) and 
pelleted by centrifugation at 100 g for 5min. The pelleted cells were 
resuspended in HuMEC basal media containing 25mg/500ml bovine pituitary 
extract (Life technologies), 100ng/ml recombinant human insulin (Lonza),
50ng/ml hydrocortisone (Lonza), 2μg/ml bovine transferrin (Sigma) and 2ng/ml 
EGF (Lonza). 1x104 cells were plated on top of solidified agarose (40μl) in a 
96 well plate for seven days. 1μg/ml human prolactin isolated from the pituitary 
(AFP6266B; Provided by Dr. A.F Parlow, National Hormone and Pituitary 
Program, USA) and 100pg/ml ȕ-oestradiol (Sigma) was then added and 
incubated for a further 3 days. Mammospheres were challenged with 20μg/ml 
lipoteichoic acid (LTA) isolated from S. aureus or 20μg/ml lipopolysaccharide 
(LPS) isolated from E. coli for 4 hours and 24 hours (n=10 wells per challenge).
Mammospheres were then collected by pipetting and RNA extracted for RT-
PCR analysis
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 3.3.6 MTS assay
Mammospheres (n=3) as described above (section 3.3.5) were challenged 
with 20μg/ml of either LPS or LTA for 24hrs. MTS/PMS solution (Promega, 
Australia) was added to the mammosphere cultures for 1hr and absorbance 
read at 490nm using the xMark plate reader (Bio-Rad, Australia). 
3.3.7 cDNA synthesis
cDNA was synthesized from total RNA using the iScript protocol (BioRad). 
Briefly 5μl (100ng) of RNA was mixed with 4μl 5x iScript reaction mix and 11μl 
nuclease free water. cDNA was synthesised by incubation at 25°C for 5min, 
42°C for 30min and 85°C for 5min. cDNA concentrations were measured using 
a nanodrop 1000 (Thermo fisher) and stored at -20°C until required.
3.3.8 RT-PCR analysis 
Reverse transcriptase polymerase chain-reaction (RT-PCR) was used to 
quantitate gene expression associated with an immune response. Primers 
were designed for genes of interest using the Primer 3 program 
(http://bioinfo.ut.ee/primer3-0.4.0/) where primer size range of 18-23 bases 
with an optimal tm of 60°C. Genes of interest were tumour necrosis factor 
(TNF) (NM_000594.3), defensin alpha 1 (DEFA1) (NM_004084.3), elafin (PI3) 
(NM_002638.3), secretory leukocyte protease inhibitor (SLPI) 
(NM_003064.3), tumour necrosis factor alpha induced protein 6 (TNFAIP6) 
(NM_007115.3), interleukin 1 beta (IL-1B) (NM_000576.2), interleukin 8 
(NM_000584.3), nuclear factor of kappa light polypeptide gene enhancer in B-
cells 1 (NF-kB1) (NM_003998.3) and housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (NM_002046.5). 1μg cDNA was used for 
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 PCR and was performed using GoTaqGreen master mix (Promega) along with 
1μM each of a gene specific forward and reverse primer (Table 3.1). PCR 
FRQGLWLRQVXVHGZHUHLQLWLDOGHQDWXUDWLRQÛ&IRUPLQIROORZHGE\F\FOHV
Û&VecÛ&Vec DQGÛ&Vec IROORZHGE\DILQDOH[WHQVLRQRIÛ&
for 5 min in a BioRad C100 Thermocycler. The PCR products were 
electrophoresed at 100v for 45min on a 1.5% agarose gel in a 1xTAE buffer 
and subsequently the agarose gel was stained with SYBR safe (Life
technologies, Australia). The PCR products were visualized under a UV light 
by a ChemiDoc XRS+ Imaging system (Bio-Rad). Densitometry semi-
quantitation was performed using the ChemiDoc software. The house keeping 
gene GAPDH was used to normalize the data. Gene expression analysis was 
carried out in triplicate.
Table 3.1 Primer List.
Primer Product size Sequence 5’-3’
GAPDH-fwd GTCAGTGGTGGACCTGACCT
GAPDH-rev 245 TGCTGTAGCCAAATTCGTTG
NF-ț%-fwd CCTGGATGACTCTTGGAAA
NF-ț%-rev 386 CTTCGGTGTAGCCCATTTGT
TNF-fwd AGCCCATGTTGTAGCAAACC
TNF-rev 420 CCAAAGTAGACCTGCCCAGA
DEFA1-fwd AGGCAAGAGCTGATGAGGTT
DEFA1-rev 212 GCAGAATGCCCAGAGTCTTC
PI3-fwd AGCTTCTTGATCGTGGTGGT
PI3-rev 296 TTATATCGCATCGGCCTTTC
SLPI-fwd CTGTGGAAGGCTCTGGAAAG
SLPI-rev 390 AAAGGACCTGGACCACACAG
TNFAIP6-fwd ACCACAGAGAAGCACGGTCT
TNFAIP6-rev 347 ATTTGGGAAGCCTGGAGATT
IL-8-fwd GTGCAGTTTTGCCAAGGAGT
IL-8-rev 210 ACTTCTCCACAACCCTCTGC
IL-1B-fwd TTCGACACATGGGATAACGA
IL-1B-rev 420 TTCTGCTTGAGAGGTGCTGA
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 3.4 Results
3.4.1 Isolation of cells from breast milk and cell viability
To evaluate the viability of breast milk cells that were to be used for subsequent 
microarray analysis, isolated breast milk cells were stained with Live/Dead 
stain using Calcein AM and propidium iodide. Cells isolated from milk 
appeared as single cells from a smear on the slide (Figure 3.1a). Viability 
staining revealed the vast majority of the cells were viable (green) with
approximately 98% viability and 2% dead cells visible (red) (Figure 3.1b/c). 
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 Figure 3.1 Viability of cells isolated from human milk.
Fresh breast milk was used to determine viability of cells. (A) Bright field image 
of single cells isolated from breast milk. 100x magnification (B) Fluorescent 
image of milk cells stained with calcein AM (green) for viable cells and 
propidium iodide (red) for dead cells at x200 magnification, and (C) Percentage 
viability of cells collected from breast milk. Error bars are shown.
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 3.4.2 Gene expression analysis of breast milk cells from healthy and 
mastitic milk
In order to characterize the genes and associated functional pathways 
activated in the mastitic milk cell population, and to characterize the different 
cell types secreted in milk during mastitis compared to healthy milk, human 
illumina microarrays were used to examine transcript profiles of cells collected 
from mammary secretions. Genes were considered differentially expressed if
P-<0.05 for either up or down regulated genes compared to the healthy breast 
milk cells. Gene expression profiles of cells collected from healthy (n=3) and 
mastitic milk (n=3) were compared.
Compared to healthy milk cells, milk cells collected during a bout of mastitis 
showed 327 genes were up-regulated with 191 of these genes up-regulated 
over 2 fold. 643 genes were down-regulated with 180 of these genes down-
regulated over 2 fold compared to healthy milk cells (Figure 3.2).
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 Figure 3.2 Global transcriptional changes in mastitic breast milk cells.
Number of significant differentially expressed genes with p<0.05 (blue) or a 
p<0.05 and 2 fold change cut-off (red) of cells collected from mastitic milk (n=3)
compared to healthy milk (n=3).
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 3.4.3 Milk protein gene expression of cells isolated from breast milk
In order to confirm that isolated breast milk cells from healthy and mastitic 
women represent the mammary gland during lactation, and to analyse the 
effect of mastitis on milk protein gene expression, the expression of Į6-
FDVHLQ &616 ț-casein &61 ȕ-FDVHLQ &61 DQG Į-lactalbumin 
(LALBA) was analysed (Figure 3.3a). The observed expression levels of milk 
protein genes were consistent between milk cells from healthy women and the 
milk cells isolated during mastitic infection (Figure 3.3b).
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 Figure 3.3 Milk protein gene expression of milk cells.
0LFURDUUD\H[SUHVVLRQSURILOHVRIPLONSURWHLQJHQHVĮ6-FDVHLQ&616ț-
FDVHLQ&61ȕ-casein (CSN2), ɲ-lactalbumin (LALBA) from breast milk cells 
isolated from mastitis (n=3) and healthy milk (n=3) from individual women (A).
Averages of the groups for healthy and mastitis showed no significant 
difference in milk protein gene expression (B).
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 3.4.4 Identification of cell populations isolated from breast milk
It has been well documented that milk contains an array of cell types 
(Boutinaud & Jammes 2002; Cregan et al. 2007) with only one report so far 
describing the change in cell population during the lactation cycle and mastitis 
(Sharp et al. Unpublished data). Microarray data was analysed for gene 
expression of specific cell markers for mammary and immune cell types. 
 
Housekeeping genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 
ribosomal protein S-15 (RPS15) and ȕ-actin (ACTB) were analysed for 
suitability as reference gene. Both GAPDH and RPS15 gene expression levels
were uniform between samples, however ACTB showed greater variation 
between samples (Fig 3.4a). GAPDH has been used as a house keeping gene 
to study the relative expression of many genes in the mammary gland during 
pregnancy and lactation (Li et al. 2012; Miller et al. 2006). However, it has 
been reported that housekeeping genes can have variable expression under 
different systems; hence the stability of housekeeping gene expression should 
be validated for each experimental system (Huggett et al. 2005). RPS15 has 
been shown to be a suitable reference gene for quantitative RT-PCR in the 
bovine and buffalo mammary gland (Bionaz & Loor 2007; Yadav et al. 2012).
Here both GAPDH and RSP15 were reliably expressed at similar levels in all 
samples and relative gene expression profiles of experimental genes did not 
change if GAPDH or RPS15 were used for normalization. 
Epithelial cells in mammary tissue have been well characterized by using the 
luminal mammary epithelial cell markers such as cytokeratin 19 (KRT19). This
marker was used to observe relative amounts epithelial cells within each 
sample collected during mastitis or when no infection was present. The 
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 expression KRT19 showed relatively similar levels with the exception of the 
mastitis 3 (M3) sample which was observed to have less epithelial cells 
compared to other mastitis samples (M1 and M2). Overall there was no 
significant difference between the numbers of epithelial cells in milk collected 
from mastitic or healthy breasts (Figure 3.4b).
Stem cells have been noted to be present in breast milk (Cregan et al. 2007).
Markers for cluster of differentiation (CD) CD29, CD133 and CD117 were used 
to identify the stem cell population in each sample and showed that the number 
of stem cells did not significantly change in breast milk cells collected during 
mastitis compared to breast milk cells collected from healthy breasts (Figure 
3.4c). 
Cells derived from a mesenchymal lineage were characterised by vimentin 
(VIM) expression. Comparison of the average of the three samples of breast 
milk cells isolated from mastitic milk and breast milk cells isolated from healthy 
milk showed no significant difference between the two groups (Figure 3.4d).
Macrophages are immune cells that are phagocytes. Macrophages that 
express the killer phenotype are called classically activated M1 macrophages 
and macrophages involved in tissue repair are called alternatively activated 
M2 macrophages (Ho & Sly 2009; Novak & Koh 2013). Markers CD68 is widely 
used to determine macrophage markers for both M1 and M2 macrophages. 
This markers was used to detect the macrophage population in mastitis and 
healthy milk. Expression of these markers revealed relatively similar levels of 
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 macrophages present in both healthy milk and mastitic milk with no significant 
difference between the two groups (Figure 3.4e).
Neutrophils are immune cells that are part of the polymorphonuclear cell 
family. Intercellular Adhesion Molecule 1 (ICAM1) is a marker used to identify 
neutrophils (Wang et al. 1997). ICAM1 expression in the milk cell population 
showed a marked increase during mastitis compared to healthy breast milk 
cells (Figure 3.4f). In the mastitis samples, the neutrophil maker ICAM1
showed  >8 fold greater expression compared to the milk cells collected from 
healthy mothers, suggesting a larger population of neutrophils within the 
mastitis samples.
Lymphocytes make up three immune cell populations of natural killer (NK) 
cells, T cells and B cells. A common marker for these cell types is interferon 
induced transmembrane protein 2 (IFITM2). IFITM2 expression was used to 
estimate the relative levels of lymphocytes within the milk cell population 
(Figure 3.4g). Expression levels showed that the lymphocyte cell population 
was poorly represented in milk collected from healthy mothers compared to 
the samples collected during mastitis. During mastitis the lymphocyte 
population significantly increased >6 fold compared to the population collected 
from healthy mothers.
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 Figure 3.4 Identification of cell types in mastitic and healthy breast milk.
Microarray data of gene expression profiles was used for quantification of 
housekeeping genes and cell types (mastitis n=3 and healthy n=3). . Breast 
milk cells isolated from mastitic milk (M1, M2, M3) and healthy breast milk cells 
(H1, H2, H3), and the averages of the two groups are shown. (A) Expression 
of house-keeping genes GAPDH, ACTB and RPS15 were examined to 
determine the use of appropriate housekeeping genes for analysis of different 
cell types. (B) GAPDH and RPS15 expression was used to normalize cell 
number between the samples. Mammary epithelial cell markers KRT19 and 
KRT 8, (C) stem cell markers CD29 and CD133, (D) mesenchymal cell marker 
VIM, (E) macrophage marker CD68, (F) neutrophil marker ICAM1, and (G) 
lymphocyte marker IFITM2 were used to detect relative abundance of cell type 
within the population. Y axes represent expression values. Significance * 
p<0.05
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 3.4.5 Gene ontology analysis of mastitic breast milk cells
Gene expression profile datasets from microarray of breast milk cells isolated 
in mastitic or healthy milk were integrated and analysed to investigate 
biofunctions of mastitic breast milk cells. An analysis of functional annotation 
based on DAVID and Ingenuity pathway analyses showed that during mastitis 
the milk cell population underwent cellular changes in response to infection 
(Table 3.2).
Gene ontology analysis through DAVID revealed the mastitic breast milk cells 
show an up-regulation in genes associated with infection which include 
immune response, defence response, inflammatory response, chemotaxis and 
cell migration. There were also genes associated with Toll-like receptor 
signalling, NF-ț%SDWKZD\DQG chemokine signalling (Table 3.2). The gene 
ontology analysis also noted genes associated with immune cells of 
lymphocyte proliferation and chemotaxis, leukocyte proliferation, chemotaxis 
and migration, B cell receptor signalling, T cell proliferation and activation. 
Gene expression profile datasets with significantly up and down regulated 
genes in mastitis were analysed through Ingenuity (IPA) to investigate the 
biofunctions of mastitic milk cells. The biofunctions were predicted based on 
IPA downstream effects in the data with expectations derived from the 
literature. 
Biofunction analysis using of mastitic cell populations revealed molecular 
functions corresponded to the accumulation and increased function of immune 
cell types associated with the immune response. These cell types included 
lymphocytes, leukocytes, granulocytes, myeloid cells, T cells and phagocytes 
which. Biofunction analysis also showed the mammary gland responded to 
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 infection by up-regulating antimicrobial and antiviral response genes.
Interestingly there was a decrease in biofunctions for infection and viral
replication (Table 3.3).
Analysis of the top molecules that showed the largest fold change revealed 
that most of these genes were regulated by interferon (IFN). These included 
the up-regulation of interferon-induced transmembrane protein 1 (IFITM1), C-
X-C motif chemokine 10 (CXCL10), 2',5'-oligoadenylate synthetase-like gene
(OASL) and radical s-adenosyl methionine domain-containing 2 (RSAD2). IFN-
inducible GTPases were also up-regulated. These genes represent four 
families of genes encoding myxovirus resistant proteins (MX), guanylate-
binding proteins (GBP), immunity-related GTPase proteins (IRGs), and very 
large inducible GTPase proteins (VLIG). Four of the top ten up-regulated
genes GBP1, GBP4, GBP5 and MX2 were identified from this classification 
which are regulated by interferon signalling during infection (Table 3.4).
129 
 
 Table 3.2 Ontology and pathway analysis of functions associated with 
mastitis.
Category Term Count % P-value Benjaman
i
goterm_bp_fat immune response 37 14.2 1.10E-11 1.70E-08
Sp_pir_keywords host virus interaction 17 6.5 8.80E-07 2.60E-04
Sp_pir_keywords antiviral defence 9 3.4 1.20E-06 1.70E-04
goterm_bp_fat defence response 26 10 2.50E-06 1.90E-03
goterm_bp_fat response to molecule of 
bacterial origin 
9 3.4 3.20E-05 1.20E-02
goterm_bp_fat positive regulation of 
molecular function 
22 8.4 1.00E-04 2.60E-02
goterm_bp_fat inflammatory response 16 6.1 7.00E-05 2.10E-02
goterm_bp_fat positive regulation of 
immune response
10 3.8 2.40E-04 3.60E-02
Sp_pir_keywords chemotaxis 7 2.7 3.20E-04 2.30E-02
goterm_bp_fat response to wounding 19 7.3 6.20E-04 6.20E-02
goterm_bp_fat regulation of transcription 
factor activity 
8 3.1 6.90E-04 6.40E-02
goterm_bp_fat response to 
lipopolysaccharide 
7 2.7 8.20E-04 7.10E-02
goterm_bp_fat toll-like receptor signalling 
pathway 
4 1.5 9.40E-04 7.30E-02
goterm_bp_fat regulation of apoptosis 24 9.2 1.20E-03 8.80E-02
goterm_bp_fat negative regulation of 
apoptosis 
14 5.4 1.80E-03 9.50E-02
goterm_bp_fat pattern recognition 
receptor signalling 
pathway  327
4 1.5 1.70E-03 9.20E-02
goterm_bp_fat Anti-apoptosis 10 3.8 2.90E-03 1.00E-01
goterm_bp_fat I-kappaB kinase/NF-
kappaB cascade 
6 2.3 2.10E-03 9.40E-02
goterm_bp_fat positive regulation of NF-
kappaB transcription factor 
activity  
5 1.9 2.70E-03 1.00E-01
goterm_bp_fat positive regulation of nitric 
oxide biosynthetic process 
4 1.5 3.20E-03 1.00E-01
Sp_pir_keywords inflammation 4 1.5 3.90E-03 1.20E-01
goterm_bp_fat lymphocyte chemotaxis 3 1.1 4.10E-03 1.10E-01
goterm_bp_fat regulation of I-kappaB 
kinase/NF-kappaB 
cascade 
7 2.7 4.40E-03 1.20E-01
kegg_pathway Chemokine signalling 
pathway 
10 3.8 5.50E-03 1.10E-01
goterm_bp_fat Cell migration  11 4.2 6.50E-03 1.60E-01
goterm_bp_fat T cell proliferation 4 1.5 6.60E-03 1.60E-01
goterm_bp_fat response to bacterium 9 3.4 6.70E-03 1.60E-01
goterm_bp_fat regulation of lymphocyte 
proliferation 
6 2.3 6.80E-03 1.50E-01
goterm_bp_fat antigen processing and 
presentation 
6 2.3 6.80E-03 1.50E-01
goterm_bp_fat regulation of leukocyte 
proliferation 
6 2.3 7.10E-03 1.60E-01
kegg_pathway RIG-I-like receptor 
signalling pathway 
6 2.3 8.10E-03 1.30E-01
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 goterm_bp_fat positive regulation of 
leukocyte proliferation 
5 1.9 8.40E-03 1.70E-01
goterm_bp_fat leukocyte migration 5 1.9 9.00E-03 1.80E-01
goterm_bp_fat T cell activation  7 2.7 9.60E-03 1.80E-01
kegg_pathway B cell receptor signalling 
pathway 
6 2.3 1.00E-02 1.20E-01
goterm_bp_fat proteolysis involved in 
cellular protein catabolic 
process 
17 6.5 1.30E-02 2.20E-01
goterm_bp_fat positive regulation of I-
kappaB kinase/NF-kappaB 
cascade 
6 2.3 1.30E-02 2.20E-01
goterm_bp_fat regulation of kinase 
activity 
12 4.6 1.40E-02 2.30E-01
goterm_bp_fat response to extracellular 
stimulus 
9 3.4 1.40E-02 2.30E-01
goterm_bp_fat MAP kinase phosphatase 
activity 
3 1.1 1.40E-02 5.20E-01
goterm_bp_fat MAP kinase 
tyrosine/serine/threonine 
phosphatase activity 
3 1.1 1.40E-02 5.20E-01
goterm_bp_fat leukocyte chemotaxis 4 1.5 1.60E-02 2.40E-01
goterm_bp_fat antigen processing and 
presentation of exogenous 
antigen 
3 1.1 1.70E-02 2.50E-01
goterm_bp_fat cell chemotaxis 4 1.5 1.80E-02 2.60E-01
goterm_bp_fat positive regulation of 
leukocyte activation 
6 2.3 1.80E-02 2.60E-01
goterm_bp_fat regulation of chemokine 
production 
3 1.1 1.90E-02 2.60E-01
goterm_bp_fat positive regulation of 
programmed cell death 
13 5 2.20E-02 2.80E-01
goterm_bp_fat regulation of phosphate 
metabolic process 
14 5.4 2.30E-02 2.80E-01
kegg_pathway NOD-like receptor 
signalling pathway  
5 1.9 2.30E-02 2.10E-01
goterm_bp_fat response to cytokine 
stimulus 
5 1.9 2.70E-02 3.10E-01
goterm_bp_fat cell death 18 6.9 3.00E-02 3.10E-01
goterm_bp_fat positive regulation of 
interleukin-6 production 
3 1.1 3.00E-02 3.10E-01
kegg_pathway Toll-like receptor signalling 
pathway 
6 2.3 3.30E-02 2.50E-01
goterm_bp_fat release of cytochrome c 
from mitochondria 
3 1.1 3.60E-02 3.50E-01
biocarta Erythropoietin mediated 
neuroprotection through 
NF-kB
3 1.1 3.70E-02 9.80E-01
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 Table 3.3 Biofunctions increased or decreased in mastitis breast milk cells.
Category Functions 
annotation
Predicted 
activation
Activation 
Z-score
P-value
Cell cycle Polyploidy of cells Increased 2.213 6.58e-06
Tissue 
development
Accumulation of 
cells
Increased 2.772 7.28e-04
Tissue 
development
Accumulation of 
blood cells
Increased 2.949 1.18e-03
Tissue 
development
Accumulation of 
leukocytes
Increased 2.899 1.49e-03
Antimicrobial 
response
Antimicrobial 
response
Increased 2.236 1.98e-03
Cell-cell signalling 
and interaction
Response of antigen 
presenting cells
Increased 2.319 2.79e-03
Organismal 
survival
Organismal death Increased 2.714 3.18e-03
Infectious disease Endotoxin shock 
response
Increased 2.121 7.82e-03
Cell death and 
survival
Cytotoxicity of 
leukocytes
Increased 2.104 8.70e-03
Inflammatory 
response
Phagocytosis of 
leukocytes
Increased 2.526 9.18e-03
Tissue 
morphology
Quantity of 
lymphocytes
Increased 2.254 9.65e-03
Antimicrobial 
response
Antiviral response Increased 2.236 1.02e-02
Cell-cell signalling 
and interaction
Response of 
myeloid cells
Increased 2.457 1.09e-02
Inflammatory 
response
Immune response of 
leukocytes
Increased 3.200 1.13e-
02
Cell-cell signalling 
and interaction
Adhesion of 
granulocytes 
Increased 2.952 1.16e-
02
Immunological 
disease
Hypersensitive 
reaction
Increased 2.278 1.20e-02
Cellular 
development
Differentiation of 
antigen presenting 
cells
Increased 2.070 1.21e-02
Immune cell 
trafficking 
Adhesion of immune 
cells
Increased 2.154 1.23e-02
Cellular function 
and maintenance
Engulfment of 
leukocytes
Increased 2526 1.29e-02
Tissue 
morphology
Quantity of cytotoxic 
T cells
Increased 2.323 1.42e-02
Cellular function 
and maintenance
Phagocytosis of 
myeloid cells
Increased 2.337 1.55e-02
Inflammatory 
response
Immune response of 
phagocytes
Increased 2.431 1.86e-02
Infectious disease Replication of virus Decreased -2.368 2.92e-09
Cell death and 
survival
Apoptosis of 
epithelial cell lines
Decreased -2.136 9.26e-04
Infectious disease Infection of cells Decreased -3.830 3.66e-03
Infectious disease Infection of 
mammalia
Decreased -2.892 4.92e-03
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 Table 3.4 Top 10 genes significantly up or down regulated in mastitis 
(p<0.05).
Up-regulated Fold change Down-regulated Fold change
IFITM1
GBP5
GBP4
CXCL10
GBP1
OASL
IFIT3
SLCO3A1
MX2
RSAD2
45.499
29.768
19.907
19.201
17.396
16.231
14.026
12.392
11.681
11.274
 
SLC39A12
PROL1
LAMA3
SERHL
EEF1B2
UBE1DC1
BRIX1
LIPA
IMMP2L
LOC100133565
 
-4.404
-3.956
-3.704
-3.139
-2.942
-2.745
-2.697
-2.681
-2.664
-2.643
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 3.4.6 Canonical pathways and upstream regulators during mastitis
To predict potential pathways involved in the breast response to mastitis,
canonical pathway analysis was carried out through the IPA software. Genes 
used were either up- or down-regulated with significance P<0.05 in mastitis. 
The top significant canonical pathway predicted was mitochondrial dysfunction
(p=5.5e-10). Other pathways of interest were interferon signalling (p=4.03e-6) 
and activation of IRF by cytosolic pattern recognition receptors (p=2.9e-4).
There were also specific signalling for immune cell types such as CD27
signalling in lymphocytes, B cell activating signalling and 4-1BB signalling in T 
lymphocytes (Table 3.5).
Predicted activation status of transcription regulators showed an activation of 
STAT1, STAT2 and STAT3. There was also predicted activation of interferon 
regulatory factor (IRF) 1, 3, 5 and 7 as well as Toll like receptor (TLR) 3, 4 and 
7, tumour necrosis factor (TNF), RelA, NF-țB, interleukins 15, 1B, 6, 12B, 27, 
23A, 1A, Interferons (IFN) A1/A13, B1, beta and gamma. It was also shown 
that STAT6, SOCS1 and SOCS3 were predicted to be inhibited (Table 3.6).
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 Table 3.5 Predicted canonical pathway analysis.
Canonical pathway prediction P-value
Mitochondrial dysfunction 5.5e-10
Protein ubiquitination pathway 3.04e-6
Interferon signalling 4.03e-6
TCA cycle II 1.22e-5
Activation of IRF by cytosolic pattern recognition receptors 2.9e-4
Ubiquinol-10 biosynthesis 1.01e-3
CD27 signalling in lymphocytes 1.76e-3
Role of PKR in interferon induction and antiviral response 2.9e-3
B cell activating factor signalling 2.82e-3
Valine degradation I 3.91e-3
4-1BB signalling in T lymphocytes 5.45e-3
Caveolar-mediated endocytosis signalling 5.96e-3
TWEAK signalling 1.30e-2
Regulation of IL-2 expression in activated and anergic T 
lymphocytes
1.32e-2
Purine nucleotides De Novo Biosynthesis II 1.98e-2
Tumouricidal function of hepatic natural killer cells 1.51e-2
Antigen presentation pathway 1.83e-2
PTEN pathway 3.02e-2
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 Table 3.6 Predicted upstream regulators activated or inhibited during 
mastitis.
Gene Predicted Activation 
Z-score
Molecular type P-value
IRF7* Activated 6.222 Transcription regulator 2.35e-27
IFNA2* Activated 5.815 Cytokine 8.14e-18
IFN* Activated 4.675 Group 5.15e-15
IFNL1* Activated 4.522 Cytokine 1.45e-13
IFNG* Activated 6.556 Cytokine 3.07e-13
IRF1* Activated 4.370 Transcription regulator 2.89e-12
STAT2* Activated 2.559 Transcription regulator 1.56e-11
IRF3* Activated 4.582 Transcription regulator 2.07e-10
STAT1* Activated 4.477 Transcription regulator 5.82e-10
EIF2AK2 Activated 3.265 Kinase 9.04e-09
IRF5* Activated 3.517 Transcription regulator 3.67e-08
MAP4K4 Activated 3.900 Kinase 6.82e-08
IFNAR1* Activated 2.926 Transmembrane 
receptor
1.82e-07
IFNA1/IFNA1
3*
Activated 3.395 Cytokine 2.82e-07
IFNB1* Activated 4.362 Cytokine 3.87e-07
OSM Activated 3.580 Cytokine 1.13e-06
IFNAR2* Activated 2.449 Transmembrane 
receptor
1.32e-06
TLR3 Activated 2.918 Transmembrane 
receptor
1.33e-06
IFN beta* Activated 3.540 Group 2.24e-06
IFN gamma* Activated 3.400 Complex 2.46e-06
TNF Activated 5.051 Cytokine 2.78e-06
JAK1* Activated 2.392 Kinase 5.29e-06
Lipopolysacc
haride
Activated 5.939 Chemical drug 1.18e-05
STAT3* Activated 2.699 Transcription regulator 1.33e-05
JAK2* Activated 2.970 Kinase 1.45e-05
TLR4* Activated 3.159 Transmembrane 
receptor
7.38e-05
RelA Activated 3.554 Transcription regulator 8.09e-05
IL15 Activated 2.763 Cytokine 2.71e-04
IL1B Activated 4.729 Cytokine 4.06e-04
PARP9 Activated 2.213 Enzyme 4.17e-04
TRADD Activated 2.449 Other 5.75e-04
IL12B Activated 2.586 Cytokine 1.26e-03
PLAU Activated 2.180 Peptidase 1.28e-03
IL27 Activated 2.795 Cytokine 1.61e-03
MYD88* Activated 3.890 Other 1.65e-03
NF-ț%* Activated 3.201 Complex 3.90e-03
TLR7* Activated 2.957 Transmembrane 
receptor
3.98e-03
IL23A Activated 2.000 Cytokine 1.22e-02
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 TNFSF12 Activated 2.581 Cytokine 2.00e-02
IL6R Activated 2.212 Transmembrane 
receptor
2.02e-02
IL6 Activated 3.603 Cytokine 2.26e-02
IL1A Activated 3.481 Cytokine 3.77e-02
IL1-RN Inhibited -4.458 Cytokine 1.09e-12
ACKR2 Inhibited -3.742 G-Protein coupled 
receptor
1.89e-12
TRIM24 Inhibited -4.232 Transcription regulator 1.94e-12
MAPK1 Inhibited -4.465 Kinase 8.36e-11
NKX2-3 Inhibited -4.913 Transcription regulator 1.34e-08
SOCS1 Inhibited -3.270 Other 5.19e-06
MYC Inhibited -4.229 Transcription regulator 3.70e-05
SOCS3 Inhibited -2.600 phosphatase 1.80e-03
XBP1 Inhibited -3.573 Transcription regulator 2.82e-03
RPSA Inhibited -2.236 Transcription regulator 3.91e-03
STAT6 Inhibited -2.547 Transcription regulator 5.91e-03
E2F1 Inhibited -2.495 Transcription regulator 1.30e-02
ESRRA Inhibited -2.008 Ligand-dependent 
nuclear receptor
3.12e-02
* Role in interferon signalling 
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 3.4.7 Defence response genes during mastitis
Genes that were significantly up-regulated in mastitic milk cells compared to 
healthy milk cells were analysed to identify genes associated for defence 
responses to infection using Gene Ontology (GO). 
During a bout of mastitis the breast responded with an up-regulation of 
antimicrobials (antibacterials and antivirals). A total of 15 antimicrobials were 
significantly up-regulated in breast milk cells isolated during mastitis, including 
guanylate-binding protein family members (GBPs 1, 4 and 5), interferon-
induced transmembrane family members (IFITM 1, 2 and 3) and S100 genes 
(S100A 8 and 9) (Figure 3.5a).
Genes associated with an anti-inflammatory response were identified to be up-
regulated in mastitic breast milk cells, these included serine protease inhibitor
family members (SERPING1 and SERPINB1) and also serine protease 
inhibitor kazal-type 1 (SPINK1) and superoxide dismutase 2 (SOD2) (Figure 
3.5b).
There were also a subset of genes associated with an anti-apoptotic effect up-
regulated during mastitis. A total of 6 genes were predicted to have anti-
apoptotic effects, these included superoxide dismutase 2 (SOD2), interferon 
alpha-inducible protein 6 (IFI6), nuclear factor of kappa light polypeptide gene 
enhancer in B-cells inhibitor alpha (NFKBIA), chemokine ligand 2 (CCL2), 
tumour necrosis factor ligand super-family member 13 B (TNFSF13B) and 
receptor-interacting serine-threonine kinase 2 (RIPK2) (Figure 3.5c).
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 Figure 3.5 Defence response gene expression from milk cells.
Microarray expression for significantly up-regulated genes associated with a 
defence response in mastitic breast milk cells (n=3) compared to healthy 
breast milk cells (n=3). Breast milk cells isolated from mastitic milk (M1, M2, 
M3) and healthy breast milk cells (H1, H2, H3) and the averages of the two 
groups. (A) Antimicrobial gene expression. (B) Anti-inflammatory gene 
expression and (C) anti-apoptotic gene expression. Significance * p<0.05.
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 3.4.8 Use of a 3D in vitro model for validation of mastitis markers
In order to validate the role of mammary epithelial cells in the immune 
response a mammosphere culture (defined in chapter 2) was employed as a 
model of in vitro mastitis. Mammospheres were subjected to a mastitis 
challenge with the use of lipopolysaccharide (LPS) from E. coli or Lipoteichoic 
acid (LTA) from S. aureus. Mammospheres were generated by plating HMECs
on agarose for 7 days. Mammosphere integrity prior to mastitic challenge was 
visualised by light microscopy (Figure 3.6a).
To first test the impact of LPS and LTA on mammosphere cell viability, 
mammospheres were incubated with 20μg/ml of either LPS or LTA for 24hrs 
and measured for viability using the MTS assay. Viability estimates revealed 
that there was no significant difference in the viability of mammospheres either 
untreated (control) or treated with LPS or LTA (Figure 3.6b).
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 Figure 3.6 Mammosphere viability after challenge with LPS and LTA.
(A) HMECs were cultured to form 3-D mammospheres by plating on geltrex for 
7 days and visualised by light microscopy. (B) Mammospheres challenged with 
20μg/ml of either LPS or LTA (n=3) for 24 hours showed cell viability was 
maintained in the presence or absence of LPS/LTA. 
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 3.4.8.1 Mammosphere immune response: TNF/NF-ț%
After identifying genes associated with mastitis in the microarray analysis, RT-
PCR was performed on HMEC mammospheres that were challenged with LPS 
derived from E. coli or LTA from S. aureus to determine if an in vitro epithelial 
immune response is similar to the in vivo milk cell analysis. TNF and NF-ț%
were predicted to be activated in the mastitic milk cell biofunction analysis. 
These genes are also associated with bovine mastitis (Strandberg et al. 2005).
TNF expression can activate NF-ț% GRZQVWUHDP SDWKZD\V DQG 71)$,3
becomes expressed in response to the presence of TNF (Brenaut et al. 2014).
TNF expression in mammospheres challenged with LPS or LTA both showed 
13-fold and 6-fold up-regulation of TNF respectively after 4 hours and declined 
to 4-fold and 2-fold after 24 hours of challenge compared to the untreated 
mammospheres (Figure 3.7a/b). Both LPS and LTA challenge showed the 
same level of up-regulation. 
NF-ț%JHQHH[SUHVVLRQZDVREVHUYHGLQXntreated mammospheres but after 
challenge with LPS NF-ț%gene expression was up-regulated 1.8-fold after 4 
hours of LPS challenge which was maintained after 24 hours of challenge 
(Figure 3.7c). This profile was not observed with LTA challenged 
mammospheres where a significant 2.9-fold up-regulation was observed at the 
early 4 hour challenge but this was not maintained at 24 hours were there was 
a 1.1-fold change (Figure 3.7d).
TNFAIP6 gene expression showed an up-regulation of 21-fold in 
mammospheres challenged with LPS for 4hours which declined to 5-fold after 
24hours of challenge (Figure 3.7e). In comparison LTA challenged 
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 mammospheres showed a significant 3.2-fold up-regulation of TNFAIP6 after 
4 hours of challenge which was further maintained after 24 hours (Figure 3.7f).
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 Figure 3.7 TNF/NF-ț% JHQH H[SUHVVLRQ GXULQJ /36 RU /7$ FKDOOHQJH RI
mammospheres.
Gene expression analysis of mammospheres challenged with LPS (n=10) or 
LTA (n=10) for 4 or 24 hours. TNF expression in mammospheres challenge 
with (A) LPS and (B) LTA showed a >5 fold up-regulation of gene expression 
at 4hours which declined by 24 hours (C). NF-ț% H[SUHVVLRQ in 
mammospheres challenged with LPS showed a 2 fold up-regulation at both 4 
and 24 hours, while (D) LPS treatment showed a 2 fold up-regulation after 4 
hours which declined after 24 hours. (E). LPS treated mammospheres showed 
a > 8 fold up-regulation of TNFAIP6 after 4 hours which declined after 24 hours, 
while (E) LPS challenged mammospheres showed an  2 fold up-regulation of 
TNFAIP6 at both 4hours and 24hours. Significance * P<0.05. Gene expression 
was normalised to GAPDH and conducted in triplicate.
LPS challenge                       LTA challenge
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 3.4.8.2 Mammosphere immune response: inflammatory response
In order to determine the scope of the epithelial immune response other 
inflammatory gene markers were considered. Here inflammatory chemokine 
interleukin-8 (IL-8) and cytokine interleukin-1B (IL-1B) were analysed in 
mammospheres challenged with LPS and LTA which were previously 
identified as markers for bovine mastitis (Strandberg et al. 2005).
The mammospheres challenged with LPS showed a 2.7-fold up-regulation of 
IL-8 in both 4 hours and 24 hours of challenge compared to the untreated 
mammospheres (Figure 3.8a). HMEC mammosphere response to LTA 
challenge was up-regulated 2.5-fold compared to no treatment at 4 hours of 
challenge and after 24 hours of challenge the up-regulation declined to 2.3-
fold (Figure 3.8b).
IL-1B gene expression was up-regulated 3-fold in mammospheres challenged 
with LPS for 4hours and gene expression declined to 1.6-fold after 24hours 
(Figure 3.8c). Whereas, when the mammospheres were challenged with LTA, 
up-regulation of IL-1B gene expression was maintained in both 4hours and 
24hours of challenge with 2.1-fold and 2.2-fold respectively (Figure 3.8d). 
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 Figure 3.8 Inflammatory gene expression during challenge of 
mammospheres.
Gene expression analysis of mammospheres challenged with LPS (n=10) or 
LTA (n=10) for 4 and 24 hours. (A) Mammospheres challenged with (A) LPS
showed an up-regulation of IL-8 in both 4hours and 24hours challenge with 
similar expression levels in both early 4 hours and late 24hours challenge.  (B)
Mammospheres challenged with LTA showed an up-regulation of IL-8 in both 
4hours and 24hours. (C) LPS challenge of mammospheres showed an up-
regulation of IL-1B in both early and late infection but with reduced effect in la
e 24hours, and (D) LTA treatment showed an up-regulation of IL-1B in both 
early and late with highest expression in the 4hours after challenge. 
Significance * P<0.05. Gene expression was normalised to GAPDH and 
conducted in triplicate.
LPS challenge                       LTA challenge
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 3.4.8.3 Mammosphere immune response: Antimicrobial response 
To identify if mammospheres challenged with LPS and LTA elicit an 
antimicrobial response in response to bacterial challenge, RT-PCR was 
carried out for genes associated with an antimicrobial response. Defensin 
alpha 1 (DEFA1), peptidase inhibitor 3 (PI3) and secretory leukocyte protease 
inhibitor (SLPI) genes were analysed. These genes have been shown to have 
an antimicrobial role during infection and inflammation (Cullor et al. 1991; Jin 
et al. 1998; Verrier et al. 2012).
Unchallenged mammospheres were observed to have a basal level of DEFA1 
gene expression and once challenged with LPS DEFA1 was significantly up-
regulated (1.8-fold) after 24hours of challenge. (Figure 3.9a). The LTA 
challenged mammospheres showed a significant (1.08 fold) up-regulation of 
DEFA1 after 4 hours of challenge which was further maintained at 24 hours of 
challenge (1.5 fold) (Figure 3.9b).
Following mammosphere challenge with LPS, PI3 expression was up-
regulated 1.8-fold after 4hours, and 1.2 fold at 24hours (Figure 3.9c). The LTA 
challenged mammospheres responded with a 1.7-fold up-regulation of PI3 
after 4 hours, but a larger increase of 2.2-fold was observed after 24 hours 
(Figure 3.9d). 
The mammosphere response to LPS showed untreated mammospheres 
express the SLPI gene but once challenged with LPS the expression of the 
SLPI gene was up-regulated 2.4 fold within 4 hours of challenge and was also 
1.8-fold up-regulated at 24 hours of challenge (Figure 3.9e). In contrast the 
LTA challenged mammospheres showed a 1.6 fold up-regulation of SLPI gene 
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 expression in the 4 hour immune response which was further seen in the 24 
hour immune response at 1.18 fold up-regulation (Figure 3.9f).
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 Figure 3.9 Antimicrobial gene expression during challenge of 
mammospheres.
Gene expression analysis of mammospheres challenged with LPS (n=10) or 
LTA (n=10) for 4 and 24 hours. (A)LPS challenge of mammospheres showed 
no significant difference in DEFA1 expression between challenged and 
unchallenged mammospheres. (B) Mammospheres challenged with LTA 
showed significant up-regulation of DEFA1 after both 4 and 24 hours. (C) PI3
expression in mammospheres challenged with LPS showed an up-regulation
at similar expression levels at both 4 hours and 24hours. (D) Following LTA 
challenge PI3 was up-regulated in both 4 and 24 hours with the highest 
expression at 24hours. (E) LPS challenge of mammospheres showed an up-
regulation of SLPI at both 4hours and 24hours. (F) LTA treated 
mammospheres showed an up-regulation of SLIPI at both 4hours and 24hours 
of challenge. Significance * P<0.05. Gene expression was normalised to 
GAPDH and conducted in triplicate.
LPS challenge                       LTA challenge
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 3.5 Discussion
The molecular response to human mastitis is poorly understood and has not 
been previously studied. Here human milk cells collected during healthy 
lactation and during mastitis were used to study the molecular responses of 
the mammary gland to infection. In addition a human mammosphere model 
was also used to further define and validate these responses. The option of 
using human milk as a source of MECs is a clear improvement on the use of 
biopsy procedures as it is non-invasive and more economical. The collection 
of milk cells also provides a means of obtaining mammary cells free of 
fibroblasts, and an opportunity to assess the responsiveness of the mammary 
gland to infection. Similarly, the use of mammospheres as a model to study 
human mastitis is an important step towards defining a human in vitro model 
of mastitis. To date, global changes in transcription and translation that 
accompany major changes in response to mastitis in the mammary gland have 
been provided largely by mouse and bovine models (Anderson 1983; 
Boulanger et al. 2003; Danielsen et al. 2010; Glynn et al. 2014; Swanson et al. 
2009). Currently there are no studies of global expression in the mastitis 
infected human mammary gland. This study provides the first insight into the 
global expression pattern from cells shed from the human mammary gland 
during mastitis and the use of a human mastitis mammosphere model.
3.5.1 Cell types associated with mastitis 
Analysis of cells collected in milk during healthy lactation and mastitis revealed 
that cells remained viable within the milk. The proportion of the epithelial cell 
population in breast milk did not change between mothers that were healthy or 
had mastitis. These cells also showed no difference in milk protein gene 
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 expression between healthy and mastitic mothers. Cells collected during 
mastitis infection comprised a comparatively higher population of neutrophil 
and lymphocyte cells compared to cells collected in healthy milk. This result is 
comparable to studies in bovine mastitis. Bovine mastitis has been well 
characterised and has shown mammary epithelial cells and the macrophages 
present in milk respond to pathogens by expressing chemo-attractants that 
direct immune cells such as lymphocytes, neutrophils and macrophages to the 
sight of infection through a process known as chemotaxis (Burton & Erskine 
2003; Lahouassa et al. 2007; Paape et al. 2002). In the bovine after an
inflammatory response has been initiated neutrophils become the predominant
cell type observed during mastitis which accounts for approximately 90% of
total somatic cell count (SCC) in milk (Leitner et al. 2000; Riollet et al. 2002).
These cells are required to recognize, adhere, and phagocytize invading
pathogens in the mammary gland (Paape et al. 2003; Zhao & Lacasse 2008)
and appears to be similar during human mastitis where it was observed there 
was a neutrophil influx during mastitis compared to the healthy breast.
This study did not identify a difference in the population of macrophages 
present in breast milk of women with mastitis compared to healthy women. 
This varies to previous reports of mastitis in the bovine whereby an increase 
in the macrophage population in milk has been reported (Lewandowska-Sabat 
et al. 2013). A small population of resident macrophages is present in the 
healthy bovine mammary gland, and these macrophages are the first line of 
defence against infection of invading microorganisms. Upon recognition of 
pathogens an infiltration of immune cells including macrophages occurs 
(Rainard & Riollet 2006). It was observed in this chapter that macrophages are 
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 present in healthy breast milk which is consistent with observations in the 
bovine mammary gland but the change in macrophage populations during 
bovine mastitis was not reflected in the current study during mastitis in the 
human. This study observed that the macrophage population was not 
significantly altered compared to the milk cell population collected during 
healthy lactation. This may be due to differences between species and immune 
response or another method of identifying cell types in the milk may need to 
be employed such as FACS analysis which has been used to identify cell types 
in breast milk (Hassiotou et al. 2013b).
3.5.2 Biofunctions associated with mastitis
Analysis of genes associated with mastitis using gene ontology and ingenuity 
programs revealed genes up-regulated in mastitis were mainly associated with 
immune cell function such as leukocyte proliferation, migration, activation and 
chemotaxis as well as lymphocyte chemotaxis, T cell proliferation and 
activation. This result was consistent with our findings where increased 
leukocyte (neutrophils and lymphocytes) populations were observed from 
women with mastitis. These biofunctions suggest the major immune functions 
in the breast during mastitis are associated with the influx of immune cells 
which is consistent with the typical early immune response associated with 
bovine mastitis (Dohoo et al. 1984; Paape et al. 2002; Riollet et al. 2002).
Transcriptional profiling of the heterogeneous population of breast milk cells 
during mastitis revealed biofunctions associated with mitochondrial 
dysfunction. This results in the production of reactive oxygen species (ROS)
and nitric oxide radicals (NO) in lymphocytes or epithelial cells leading to cell 
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 apoptosis (Chakraborty et al. 2011; Garrabou et al. 2012; Krzyminska et al. 
2011). Elevated levels of reactive oxygen species (ROS) have been reported 
during mastitis in the bovine and in the goat -yĨZLNHWDO5LQDOGLHWDO
2007; Silanikove et al. 2014). In some cases the ROS cause the tearing of one 
or of both DNA strands that inevitably leads to the death of the cell. Oxidation
of proteins leads to the inactivation of enzymes, while oxidizing fats leads to 
the disintegration of cell membranes. This way ROS modifying biologically 
active substances (e.g. DNA, fatty acids, peptides and vitamins) leads to the 
destruction of cells and whole tissue structures (Bagnicka et al. 2008; Poulsen 
2005). The presence mitochondrial dysfunction in these cells validates that 
these samples were collected from infected mammary glands.
The canonical pathway analysis also predicted interferon signalling to be up-
regulated as a response to mastitic infection in the breast. This included IFNs
ɲ/ɴȖ and factors that regulate IFN such as IRFs 1, 3, 5 and 7, and STATs 1,
2 and 3 as well as TLRs 3, 4 and 7 genes which were predicted to be activated 
during mastitis in the breast. These transcription factors serve as activators of 
IFN and IFN inducible genes. Type I IFN (IFNɲ/ɴDQGW\SH,,,)1,)1ȖDUH
well studied cytokines with antiviral and immunomodulatory functions that are 
highly expressed during infection (González-Navajas et al. 2012; Goodbourn 
et al. 2000). IRFs are transcription factors necessary for IFN ɲȕ VLJQDOOLQJ
(Honda et al. 2005; Mamane et al. 1999; Taniguchi et al. 2001). Studies had 
shown both NF-ț%DQG ,5)-3 activate IFN-ȕJHQH WUDQVFULSWLRQZKLOH ,)1-Į
gene expression is regulated by IRFs (Gunthner & Anders 2013; Tamura et al. 
2008). Type I IFNs are typically considered necessary for the induction of an 
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 antiviral response but they also respond to bacterial pathogens which act 
mainly through TLR dependent pathways (Monroe et al. 2010; Trinchieri 2010).
Type II IFN-Ȗ LVDOVRSUHGLFWHG WREHDFWLYDWHGGXULQJPDVWLWLV LQ WKHEUHDVW
IFN-ȖSOD\VDNH\UROHLQPDFURSKDJHDFWLYDWLRQLQIODPPDWLRQKRVWGHIHQFH
T helper 1 cell response and immunoediting and also functions to limit tissue 
damage associated with inflammation (Mosser 2003; Oppenheim et al. 2003; 
Schroder et al. 2004). Signalling of IFN-Ȗ LVPDLQO\ WKURXJK WKH -$.67$7
pathway to regulate the transcriptional activation of IFN-Ȗ-inducible genes 
(Goodbourn et al. 2000; Rothfuchs et al. 2006; Schroder et al. 2004). In this 
chapter it was observed that both JAK 1 and 2 as well as STATs 1, 2 and 3 
were predicted to be activated during mastitis. Many functions of IFN-ȖKDYH
been due to direct STAT1 mediated induction of immune effector genes, which
include genes that encode proteins for antibacterials, antivirals, cytokines, 
chemokines and antigen-presenting molecules (Hu & Ivashkiv 2009; Salins et 
al. 2001; Schroder et al. 2004; Tsuyuki et al. 1998; Zhou 2009). The immune 
response in the mammary gland through interferon signalling may regulate 
expression of a cascade of genes associated with a defence response such 
as antibacterials to fight infection in the lactating breast.
3.5.3 Mastitis gene markers: Immune response genes
3.5.3.1 Inflammatory chemokines/cytokines
Challenge of HMEC mammosphere cultures with either LPS or LTA resulted 
in the inflammatory cytokines TNF and IL-1B and the inflammatory chemokine 
IL-8 being up-regulated in response to challenge. It has been shown that 
bovine mammary epithelial cells (BMEC) induce an immune response when 
challenged with LTA or LPS (Strandberg et al. 2005). The studies in bovine 
have identified a differential immune response to LTA and LPS in a bovine 
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 mammary epithelial cell culture, revealing an immune response is not 
sustained with challenge of LTA but is maintained when challenged with LPS 
(Strandberg et al. 2005). For instance IL-8 expression in BMEC challenged 
with LPS showed up-regulation that was maintained over a time course of 24 
hours but challenge with LTA resulted in a lower level of up-regulation that was 
highest at 2-4 hours of challenge. However in this current study using human 
mammospheres the same expression patterns weren’t observed, HMEC 
mammospheres challenged with either LPS or LTA resulted in a similar level 
of up-regulation of IL-8 at both the 4 and 24 hour time points. This may be due 
to either variation in methods used, such as the bovine study used 2D cultures 
whereas this study used 3D cultures and there may also be species variation 
resulting in differing innate immune response.
TNF is expressed by resident mammary alveolar macrophages in response to 
LPS/ TLR4 signalling, which is an essential mediator to help drive blood 
neutrophil migration into the milk spaces (Elazar et al. 2010). TNF has been 
reported to elicit production and release of high levels of the chemokine IL-8
by mammary alveolar epithelial cells which signals neutrophil influx (Brenaut 
et al. 2014; Fitzgerald et al. 2007). Studies in the mouse showed IL-8 signalling 
is essential for recruitment of blood neutrophils across the mammary alveolar 
epithelium into the milk spaces (Elazar et al. 2010). Similar results were also 
observed with IL-1B which has previously been identified as being up-
regulated in the milk of mastitic animals (Persson Waller et al. 2003; 
Rambeaud et al. 2003) and have shown IL-1B signalling was necessary for 
recruitment of blood neutrophils across the mammary alveolar epithelium
(Elazar et al. 2010). Taken collectively TNF, IL-8 and IL-1B are essential to 
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 elicit an immune response to signal neutrophil recruitment during mastitis in 
mice. TNF, IL-8 and IL-1B were observed to be up-regulated with LPS and 
LTA challenge in the human and may be responsible for the inflammatory state 
of the breast during mastitis and have a role in neutrophil recruitment into the 
breast as observed through microarray analysis.
3.5.3.2 Mastitis gene markers: Antimicrobial response genes
An antimicrobial response was also identified in the microarray analysis of 
mastitic breast milk cells which was further identified in the HMEC 
mammospheres challenged with LPS or LTA, with an up-regulation of DEFA1
and the WFDC (WAP four disulphide core) family members PI3 and SLPI.
However, interestingly, the antibacterials PI3 and SLPI were more highly up-
regulated during a gram negative LPS challenge than a gram positive LTA 
challenge. DEFA1 is a broad spectrum antibacterial that is found in the 
granules of neutrophils and also by mucosal epithelial cells (Cunliffe et al. 
2002; Faurschou et al. 2002). PI3 and SLPI are up-regulated by bacterial LPS
and cytokines to function as antibacterials against both gram positive and gram 
negative bacteria (Sallenave 2000; Williams et al. 2006). The up-regulation of 
antibacterials for a defence mechanism against invading pathogens in the 
mammary gland as a result of mastitis may aid in preventing proliferation of 
bacteria and also kill pathogens. 
Previous studies determining the outcome of lactation as a result of mastitis 
identified women who had mastitis caused by S. aureus had poor lactation 
outcomes with the infection persisting for over a week and requiring antibiotic 
intervention. This resulted in 31% of these women weaning the infant early due 
to the symptoms (Osterman & Rahm 2000). We identified a reduced up-
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 regulation of antibacterial genes (PI3 and SLPI) during the LTA challenge 
which is isolated from S. aureus. This suggests the reduced antibacterial 
response in the breast during mastitis caused by S. aureus may be partially 
responsible for the poor lactation outcomes in these women. 
3.5.3.3 Mastitis gene markers: NF-KB
Analysis of the heterogeneous population of breast milk cells during mastitis 
revealed NF-ț% was predicted to be activated during mastitis in the breast. An 
epithelial immune response using the in vitro human mammosphere model 
challenged with LPS and LTA showed an up-regulation of NF-ț% gene. 
However, after 24 hours of challenge the NF-ț%XS-regulation was sustained 
in the LPS challenge but was not maintained in the LTA challenged HMEC
mammospheres. This result is also reflected in studies in the bovine where 
mastitis is associated with increased levels of NF-ț%DQGDFWLYDWLRQRIWKHNF-
ț% complex in both milk cells from cows with mastitis and also in in vitro
LPS/LTA challenged BMEC (Boulanger et al. 2003; Connelly et al. 2010; 
Strandberg et al. 2005). NF-ț%DFWLYDWLRQKDVEHHQ LPSOLFDWHG LQ WKH LQQDWH
immune response. Activation and nuclear translocation of NF-ț% through 
signalling by TLRs upon recognition of bacterial pathogens regulates 
transcription of genes encoding cytokines (eg. TNF), chemokines (eg. IL-8),
antimicrobials (defensin genes) and nitric oxide (NO) (Brightbill et al. 1999; 
Diamond et al. 1996; Elewaut et al. 1999; Ganz 2003; Rice et al. 1987). The 
role of NF-ț% LQ WKHPDPPDU\ JODQG GXULQJPDVWLWLV LV FRQVLVWHQW ZLWK WKH
observed up-regulation of chemokines, cytokines and antimicrobials known to 
be regulated by NF-ț%
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 The purpose of this study was to further our understanding of lactational 
mastitis in the breast. Using microarray analysis of breast milk cells we 
determined that the mammary gland undergoes immune cell infiltration during 
mastitis with a co-ordinated release of antibacterials and inflammatory 
cytokines in response to infection. This response was predicted to be mediated 
through IFN signalling through IRF and TLRs and does not interfere with milk 
protein gene expression. Through the use of a human mammosphere model 
we also showed that human mammary epithelial cells play a role in the innate 
immune response during infection by up-regulating chemokines and cytokines 
to signal for leukocyte chemotaxis as well as providing an antibacterial 
response possibly to help reduce the severity of infection when invading 
pathogens are recognised. However to further define the innate immune 
response of human mammary epithelial cells and elucidate the pathways 
involved in MECs immune response a microarray analysis would be carried 
out in the future.
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 Chapter 4 : Immune protective 
antibacterial and anti-inflammatory 
effects of milk peptides released by 
proteases.
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 4.1 Summary 
Milk contains proteins, lipids, carbohydrates and bioactive factors which are 
tailored to meet the needs of the infant. Although milk is a well-known source 
of nutrients for the infant, it also has a role in providing bioactives that function 
in immune protection (Baldi et al. 2005; Donovan 2006; Newburg 2005).
Although there are many readily available bioactives in milk some remain 
inactive until digestion by proteases. In this study skim breast milk was 
incubated over a period of 7 days to allow digestion of milk protein by 
endogenous proteases. Analysis of resultant peptides VKRZHGRQO\ȕ-casein 
was digested with 2% remaining intact while other major whey proteins 
remained undigested. Mass spectrometry analysis confirmed peptides were 
SUHGRPLQDQWO\ GHULYHG IURP ȕ-casein. Antibacterial assays using mastitis 
causing S. aureus and milk peptides show that incubating milk significantly 
increased antimicrobial activity. Peptides isolated from digested milk also 
exhibited anti-inflammatory activity towards the pro-inflammatory cytokine TNF
compared to un-incubated milk. In contrast, the peptides did not show any 
apoptotic activity. Microarray analysis of breast milk cells revealed 72 
expressed proteases predicted to be secreted in milk. This analysis suggests 
that digestion of milk proteins by endogenous milk proteases releases 
antibacterial and anti-inflammatory peptides that remain protected in 
undigested milk. These peptides may provide protection to the mother from 
infection during periods of milk stasis and may aid in suppression of 
inflammation in the early stages of involution.
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 4.2 Introduction
Breast milk contains an array of proteins with a diverse range of bioactivities 
that play a pivotal role in providing nutrients for the infant and also help to 
protect the mammary gland from infection (Lönnerdal 2010). However, some 
bioactivities remain inactive until enzymatic proteolysis releases the latent 
bioactive peptides (Lönnerdal 2010; Meisel 2004). This proteolysis occurs 
through the catalytic activity of proteases. It is known that protease activity is 
extremely selective and each enzyme is directed to a site-specific sequence 
of amino acids enabling cleavage of the protein into multiple peptides (Shen & 
Chou 2009). In addition each individual protease has optimal conditions under 
which it can exert its activity (Shen & Chou 2009). For example the gut 
protease pepsin is most active at pH 1.5-2 at 37°C to 42°C but is inactive at 
pH over 6.5 and irreversibly denatured at pH over 8 (Shen & Chou 2009). To 
add to the complexity, proteases also have their activity regulated by protease 
inhibitors that can either limit or prevent unwanted proteolysis by the protease 
enzymes (Otto & Schirmeister 1997).
Typical methods to digest milk proteins usually involves incubating either milk 
or an individual purified milk protein with proteases that are found in the 
gastrointestinal tract (pepsin, trypsin chymotrypsin) (Eriksen et al. 2010; 
Picariello et al. 2010). However, there is no comprehensive analysis showing 
proteases found in milk and their role in milk protein digestion. Bioactive milk 
peptides resulting from proteolytic digestion include functions such as 
immunomodulatory (Adel-Patient et al. 2012; Qian et al. 2011), antimicrobial 
(Dallas et al. 2013a; Gifford et al. 2005; Liepke et al. 2001), antithrombotic 
(Chabancea et al. 1995; Fiat et al. 1993), opioid agonists (Koch et al. 1985; 
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 Meisel & FitzGerald 2000; Migliore-Samour et al. 1989; Teschemacher et al. 
1997), ACE inhibitors (Wu et al. 2013) and proliferative (Kanda et al. 2007).
There are multiple well known immunomodulatory bioactive peptides such as 
Į-LPPXQRFDVRNLQLQ FDVHLQRSKRVSKRSHSWLGH ȕ-casomorphin- ȕ-
casomorphin- ȕ-FDVRNLQLQ ȕ-LPPXQRFDVRNLQLQ ț-immunocasokinin and 
lactoferricin (Bellamy et al. 1992a; Kampa et al. 1996; Kanda et al. 2007; 
Meisel 2005). One in particular; Isracidin is a peptide derived from the digestion 
of ĮS1-casein by the gut protease chymotrypsin and has been shown to be an 
effective antimicrobial after injecting the peptide into the udder of cows with 
mastitis caused from S. aureus and Streptococcus spp (Lahov & Regelson 
1996). These well studied milk peptides are produced predominantly through 
digestion by gut protease enzymes and it is not known if these peptides are 
able to form though digestion by mammary proteases and exert potential 
effects in mammary gland for immune protection. Currently there is little 
information about the ability of breast milk to process itself to release bioactive 
peptides. This chapter investigates protease and protease inhibitor expression 
of breast milk cells and the ability of proteases already present in milk to digest 
milk proteins over time to release bioactive antibacterial and anti-inflammatory 
peptides.
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 4.3 Materials and Methods
4.3.1 Sample collection and preparation
Breast milk was obtained from volunteer healthy mothers with no clinical signs
of infection at various stages of lactation (n=4). The study protocol was 
approved by the Deakin University human research ethics committee (2011-
104). Mothers collected milk using mechanical breast pumps. Samples were 
immediately stored on ice for transport to the laboratory and either used fresh 
or stored at -80°C. Cells were collected from frozen (-Û&RUIUHVKPLONE\
centrifugation at 2000 JIRUPLQDWÛ&7KHSHOOHWHGFHOOVZHUHFROOHFWHGIRU
RNA isolation and subsequent microarray analysis. Milk was further prepared 
by defatting the sample by centrifugation at 3,000 JIRUPLQDWÛ&6NLPPLON
was collected and sterilized using a 0.45μM syringe filter disc (Pall).
4.3.2 RNA extraction from milk cells and microarray
RNA was extracted from milk cells (lactation days 24, 48, 101 and involution 
days 7, 14, 21) using RNeasy Lipid Tissue mini kit (Qiagen) following 
manufacturers specifications. The pelleted cells were lysed using 1ml Qiazol 
lysis buffer and passed through a 21g syringe to break up the cell pellet, after 
5min 200μl chloroform was added and the cells vortexed for 15sec, and then 
left on the bench for a further 3min. The mix was centrifuged at 12,000 g for 
15 min at 4°C, the upper aqueous phase collected and mixed with one volume 
of 70% ethanol and transferred to a RNeasy mini spin column and centrifuged 
for 15sec at 8,000 g at RT. The RNA bound to the column was subsequently 
washed with buffer RW1, then RPE and eluted with 70μl RNase free water by 
centrifugation at 8,000 g for 1min. RNA concentration was measured using a 
NanoDrop1000 Spectrophotometer (Thermo Scientific). RNA was analysed on 
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 the Agilent 2100 bioanalyzer to ensure RNA quality and sent for microarray 
using the Affymetrix human genome U133 plus 2.0 array (AGRF, Australia). 
Known proteases and their inhibitors were identified from the MEROPS server 
(http://merops.sanger.ac.uk) and were analysed for presence in the breast milk 
cell microarray. An expression level of <200 was considered background and 
not used in the study. 
4.3.3 Incubation of milk
Filtered skim milk (10ml, 0.45 micron filter) (n=4) in a 50ml Falcon tube was 
placed in a beaker of water that was sealed with parafilm and placed on an 
orbital shaker (20USPDWÛ& WRNHHS WKHVDPSOHKRPRJHQRXV0LONZDV
collected at days 1, 4 and 7 of incubation and stored at -Û&XQWLOUHTXLUHGIRU
analysis.
4.3.4 SDS-PAGE-protein
Visualisation of degradation of milk proteins over time (n=4) was performed 
using 12% TGX precast criterion gels (Bio-Rad, Australia). Protein (60μg) was 
mixed (5:1) with 5x sample buffer (100mM Tris-HCl pH 6.8, 4% SDS, 20% 
JO\FHUROEURPRSKHQROEOXHDQG'77DQGKHDWHGIRUPLQDWÛ&
Samples were loaded on the gel alongside a protein marker Dual-Xtra (Bio-
Rad, Australia) and run at 200v for 40min in a 1x TGS buffer (0.025M Tris, 
0.192M glycine, 0.1% SDS, pH 8.5). Proteins were stained using coomassie 
brilliant blue R-25 for 1hr and destained (40% methanol, 10% acetic acid) for 
3 hours. Images were acquired through the ChemiDoc XRS+ Imaging system 
(Bio-Rad, Australia) and densitometry semi-quantitation was performed using 
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 ChemiDoc software. Protein visualisation and degradation was conducted in 
triplicate.
4.3.5 Perchloric acid protein precipitation
500μl incubated skim milk from each incubation time point (n=4) was 
centrifuged at 10,000 JIRUPLQDWÛ&WRSHOOHWFDVHLQWKHZKH\ZDVSODFHG
on ice and mixed 5:1 with 0.6M perchloric acid. Samples were vortexed for 
1min, and left on ice for 10min and centrifuged twice at 10,000 g for 5min at 
Û&WRSHOOHWSURWHLQV7KHVXSHUQDWDQWZDVFROOHFWHGDQGS+DGMXVWHGWRE\
the dropwise addition of 4M potassium hydroxide, the sample left on ice for 
10min, and centrifuged 10,000 g for 5mLQDWÛ& WRSHOOHWSHUFKORUDWHVDOWV
Protein precipitation of milk was conducted in quadruplicate. 
4.3.6 Peptide clean-up
Peptide solutions were desalted by using C18 resin spin columns (Pierce). The 
columns were prepared by loading 200μl of activation solution (50% methanol) 
and centrifugation twice at 1500 g for 1min.  The columns were equilibrated 
(0.5% TFA in 5% ACN) and centrifuged twice at 1500 g for 1min.  Peptide 
solutions (300μl) were prepared by mixing sample 3:1 with sample buffer (2% 
TFA in 20% ACN) and the sample loaded 100μl at a time to the spin column 
and centrifuged at 1500 g for 1min. Samples were run through the column 
twice to ensure maximum binding. The resin was washed 3 times with 200μl 
wash solution (0.5% TFA in 5% ACN) and centrifugation at 1500 g for 1min. 
The peptides were eluted from the column with 20μl elution solution (70% 
ACN) by centrifugation at 1500 g for 1min and the elution repeated. The 
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 eluates were combined and dried using a speedy vac, and resuspended in 
100μl Milli Q water.
4.3.7 SDS-PAGE-peptides
Peptide visualization was performed using 16.5% Tris-Tricine precast criterion 
gels (Bio-Rad, Australia). Peptide sample (15μl) was mixed 5:1 with 5x sample 
EXIIHUDQGKHDWHGIRUPLQDWÛ&6DPSOHVZHUHORDGHGDORQJZLth peptide 
marker Colour Ultra-low range (Sigma, Australia) and run at 120v for 40min in 
a 1x Tris-Tricine buffer (100mM Tris, 100mM tricine and 0.1% SDS, pH 8.2)
(Sigma, Australia). The gel was fixed in 40% methanol, 10% acetic acid for 
30min and stained using a Pierce Silver stain kit (Thermo Fisher, Australia) 
following manufacturer’s specifications.
4.3.8 Peptide identification through LC-MS/MS
Peptides were diluted 1:4 with 0.2% formic acid and separated by reverse-
phase liquid chromatography on a C18 COLUMN (Vydac, 0.15 x 150mm, 3μM, 
300Å, Hesperia, CA) using a Surveyor HPLC system (Thermo, San Jose, CA). 
The mobile phase buffer was 0.2% v/v formic acid in water (A) and 0.2% v/v 
formic acid in acetonitrile (B) run at a flow rate of 1μl/min with a linear gradient 
of 5-80% B over 75min. Effluent from the column was connected directly on-
line to the nanospray ion source of a LCQ Classic quadrupole ion-trap mass 
spectrometer (Thermo, Australia). Mass spectral data was acquired in a data-
dependent mode “triple-play” where the most intense ion in each full scan (m/z 
350-1600) was automatically selected and subjected to a high resolution zoom 
scan followed by tandem mass spectrometry (MS/MS) product ion scan (35% 
normalized collision energy). Identification of peptides was performed using 
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 TurboSequest program (V3.2) MS/MS search algorithm. Raw MS/MS spectra 
of HPLC separated peptides were matched with theoretical mass spectra 
produced by in silico “no enzyme” digestion of proteins from the human subset 
of the NCBI non-redundant database.
4.3.9 Active enzyme prediction
The software program EnzymePredictor (Vijayakumar et al. 2012) available at 
(http://bioware.ucd.ie/~enzpred/Enzpred.php) was utilized to determine which 
proteases were possibly active to digest the identified peptides. Peptide 
sequences were analysed the software for each incubation time point. The 
program determines possible protease activity based in the cleavage site 
sequence and determines the total number of cleavages at both the N- and C-
terminus of the peptides.
4.3.10 Antibacterial assay
Antibacterial assays were carried out on peptide solutions following PCA 
protein precipitation. The alamar blue (Life technologies, Australia) protocol 
was used as previously described (Wanyonyi et al. 2011; Watt et al. 2012).
Peptide solutions formed from PCA precipitation were used at concentrations 
of day 0 peptides 0.1μg/μl, day 1 peptides 0.12μg/μl, day 4 peptides 0.15μg/μl 
and day 7 peptides 0.14μg/μl and tested against gram positive Staphylococcus 
aureus ATCC25923. The bacteria were prepared in Iso-Sensitest broth 
2[RLG LQDÛ&VKDNHU LQFXEDWRURYHUQLJKW&XOWXUH (200μl) was added to 
1.8ml Iso-Sensitest broth and incubated for a further 3hrs. Cell numbers were 
determined by measuring absorbance at 600nm. Peptide solutions (10μl) at 
concentrations previously mentioned were mixed with 10μl alamar blue and 
1x104 cellsPOLQDWRWDORIO3ODWHVZHUHLQFXEDWHGDWÛ&RQDVKDNHU
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 and fluorescence measured every hours at 544nm excitation and 590nm 
emission using the Glomax plate reader (Promega). Assays were performed 
in quadruplicate and performed twice.
 
4.3.11 Anti-inflammatory assay using a 3-D mammosphere culture
4.3.11.1 Mammosphere culture and challenge 
Human mammary epithelial cells (HMECs) were maintained in HuMEC ready 
PHGLXP /LIH WHFKQRORJLHV$XVWUDOLDDWÛ& LQD&2 LQFXEDWRU
confluent cells were dissociated using 1x Tryple (Life technologies) and 
pelleted by centrifugation at 100 g for 5min. Pelleted cells were resuspended 
in HuMEC basal media containing 25mg/500ml bovine pituitary extract (Life 
technologies), 100ng/ml recombinant human insulin (Lonza), 50ng/ml
hydrocortisone (Lonza), 2μg/ml bovine transferrin (Sigma) and 1x104 cells 
plated on top of Geltrex (Life technologies) and cultured for seven days.
Human prolactin (1μg/ml) isolated from the pituitary (AFP6266B, Provided by 
Dr. A.F Parlow, National Hormone and Pituitary Program, USA) was added to 
the media. Mammospheres (n=4) were pre-treated with peptides for two hours 
before a 4-hour challenge with 10μg/ml lipoteichoic acid (LTA) isolated from S. 
aureus (Sigma, Australia). Mammospheres were collected using a pipette and 
RNA extracted.
4.3.11.2 RNA extraction and cDNA synthesis
RNA was extracted from mammospheres using a PureLink RNA extraction kit 
(Ambion) following manufacturer’s specifications. Mammospheres were lysed 
and homogenized by adding 300μl Lysis buffer and syringing the mix through 
a 21 gauge needle five times. 300μl 70% EtOH was added and mixed by 
vortexing. The mix was then transferred to a spin cartridge and centrifuged at 
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 12,000 g for 15sec. Bound RNA in the column was washed with 700μl wash 
buffer I and centrifuged 12,000 g for 15sec, then 500μl wash buffer II was 
added and centrifuged 12,000 g for 15sec and repeated once. The spin 
cartridge was dried by centrifugation at 12,000 g for 1min, to elute the RNA; 
50μl RNase-free water was added to the spin cartridge which was centrifuged 
at 12,000 g from 2min and cDNA synthesized using the iScript protocol 
(BioRad). 
4.3.11.3 PCR for gene expression
Reverse transcriptase polymerase chain-reaction (RT-PCR) was used to 
identify anti-inflammatory activity using gene specific primers for the TNF
(NM_000594.3) and NF-ț% (NM_003998.3) genes with the GAPDH
(NM_002046.5) gene used to normalize the data (Table 4.1). Primers were 
designed for genes of interest using the Primer 3 program 
(http://bioinfo.ut.ee/primer3-0.4.0/) where primer size range of 18-23 bases 
with an optimal tm of 60°C. cDNA (1μg) was used as a template for the PCR 
using GoTaqGreen master mix (Promega). PCR conditions used were initial 
GHQDWXUDWLRQÛ&IRUPLQIROORZHGE\F\FOHVÛ&VecÛ&Vec
DQGÛ&Vec and D ILQDO H[WHQVLRQRIÛ& IRUPin in a BioRad C100 
Thermocycler. The PCR products were electrophoresed at 100v for 45min on 
a 1.5% agarose gel in a 1xTAE buffer and subsequently the agarose gel was
stained with SYBR safe (Life technologies, Australia). The PCR products were 
visualized under a UV light by a ChemiDoc XRS+ Imaging system (Bio-Rad, 
Australia) and densitometry semi-quantitation was performed using the 
ChemiDoc software. Gene expression analysis was conducted in triplicate.
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 Table 4.1 Primer list.
Primer Product size Sequence 5’-3’
GAPDH-fwd GTCAGTGGTGGACCTGACCT
GAPDH-rev 245 TGCTGTAGCCAAATTCGTTG
NF-ț%-fwd CCTGGATGACTCTTGGAAA
NF-ț%-rev 386 CTTCGGTGTAGCCCATTTGT
TNF-fwd AGCCCATGTTGTAGCAAACC
TNF-rev 420 CCAAAGTAGACCTGCCCAGA
4.3.12 Statistics
Statistical analysis was carried out on antibacterial assays, anti-inflammatory 
assays and densitometry measurements using a two tailed t-test, significance 
was considered with P<0.05.
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 4.4 Results
4.4.1 Protease and protease inhibitor gene expression in breast milk 
cells
To identify proteases and protease inhibitors expressed by breast milk cells 
during lactation microarray analysis was carried out on milk cells from days 24, 
48 and 101 of lactation and days 7, 14 and 28 of involution. Identification of 
expressed genes was achieved by searching known proteases and protease 
inhibitors in the MEROPS and GO annotation databases with annotated genes 
in the microarray data and using a cut-off <200 intensity units for expression 
as background. A total of 207 proteases were identified to be expressed by 
breast milk cells, of these 72 were predicted to be secreted proteins. Predicted 
secreted proteases were further defined by class of protease. The analysis 
identified 2 Threonine proteases during lactation and one observed during 
involution (Figure 4.1A-B). There was one Aspartic protease identified in both 
lactation and involution, with an up-regulation of cathepsin D observed during 
involution (Figure 4.1C-D). There were 10 cysteine proteases expressed 
during lactation and 9 expressed during involution (Figure 4.1E-F) 15 metallo 
proteases were identified during lactation and 14 during involution (Figure 
4.1G-H) and 17 Serine proteases identified across lactation and 12 across 
involution (Figure 4.1 I-J). There were 70 protease inhibitors identified in the 
breast milk cell microarray, and 26 were predicted to be secreted proteins in 
lactating milk and 16 during involution (Figure 4.2). 
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 Figure 4.1 Protease expression during lactation and involution.
Microarray analysis of cells isolated from breast milk collected during lactation 
(n=3) at days 24, 48 and 101 and involution (n=3) at days 7, 14 and 28 were
used to analyse predicted secreted protease expression levels from different 
women. (A-B) predicted secreted Threonine protease expression. (C-D) 
predicted secreted Aspartic protease expression. (E-F) predicted secreted 
Cysteine protease expression. (G-H) predicted secreted metallo protease 
expression and (I-J) predicted secreted serine protease expression. 
Expression is shown in relative units.
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 Figure 4.2 Protease inhibitor expression during lactation and involution.
Microarray analysis of cells isolated from breast milk collected during lactation 
(n=3) at days 24, 48 and 101 and involution (n=3) days 7, 14 and 28 was used 
to analyse predicted secreted protease inhibitor expression levels from 
different women. Expression is shown in relative units.
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 4.4.2 Milk protein degradation by milk proteases and the production of 
peptides
In order to generate peptides that were specifically cleaved by endogenous 
milk proteases, skim milk was incubated in a 37°C water bath shaker from 0 
hours to 7 days. This process relied on proteases already present in milk to be 
active and capable of digesting milk proteins even in the presence of milk 
protease inhibitors. Milk protein profiles were visualized through coomassie 
stain and showed a marked reduction of total casein over time, whereas the 
PDMRUZKH\SURWHLQVĮ-lactalbumin, lysozyme, lactoferrin and serum albumin 
appeared to remain relatively unchanged resisting proteolytic digestion (Figure 
4.3A). Semi quantitation of each protein band revealed no significant changed 
in levels of the major whey protein lactoferrin (Figure 4.3B),  however, after 1 
day of incubation at 37°C WKH  ȕ-casein band was significantly digested 
3WRRIWKHRULJLQDOSURWHLQEDQGȕ-casein was detected through 
to day 4 with 18% remaining and by day 7 there only was 2% remaining 
undigested compared to time 0 (Figure 4.3C). 
To visualize the formation of peptides from the digested milk, perchloric acid 
precipitation was used to selectively precipitate proteins whilst leaving small 
proteins and peptides in solution. Remaining unprecipitated larger proteins 
were removed with a 30K nanosep column. Samples were subsequently 
electrophoresed on a peptide tris-tricine gel and silver staining showed the 
presence of only 1 peptide band at day 0, corresponding to  approximately 
1kd. After 1 day of milk incubation the same peptide band present at 1kD was 
visualized, however no further peptides were evident. By day 4 of milk 
incubation multiple new peptide bands with a size of 1-10kD were visualized. 
By day 7 the peptide profile observed differed from day 4 with additional bands 
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 forming at higher abundance and with a size of approximately 4kD (Figure 4.4).
This peptide profile correlated with the observed digestion of milk proteins in 
)LJXUHZKHUHWKHLQFUHDVLQJGLJHVWLRQRIȕ-casein resulted in more visible 
peptides forming over time.
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 Figure 4.3 Protein profiles of incubated skim breast milk.
6NLPPHGEUHDVWPLONZDVLQFXEDWHGDWÛ&IRUDQGGD\V3URWHLQV
digested by endogenous milk proteases were visualized using coomassie 
stained SDS-PAGE (12%) and bands semi quantitated to compare digested 
protein levels to day 0 (undigested). Arrows indicate major bands from 
ODFWRIHUULQ VHUXP DOEXPLQ ȕ-FDVHLQ O\VR]\PH DQG Į-lactalbumin. Whey 
proteins were considerably resistant to proteolysis. (B) Semi quantitation of 
individual protein bands showing lactoferrin levels remained constant over all 
WLPHSRLQWVZKHUHDV WKHPRVW DSSDUHQW GLJHVWLRQZDV WDUJHWHG WRZDUGV ȕ-
casein (C) which showed 50% - 2% protein reduction from day 1 to day 7 
compared to day 0. The experiment was conducted in triplicate. * indicates 
significant change P<0.05.
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 Figure 4.4 Peptides profiles generated from incubated skim breast milk.
After incubation of skim milk proteins were precipitated using perchloric acid 
extraction and samples were further cleaned by passing through a 30kD cut-
off column. Peptides were visualized by running on a 16.5% Tris-Tricine 
peptide gel and subsequently silver stained. At day 0 there is a small peptide 
band visualized running at approximately 1kD and at day 1 the same sized 
band is also present. By day 4 of incubation, multiple new peptide bands 
ranging from 1kD to 10kD were present which were also observed at day 7 in 
addition to a number of more prominent bands at approximately 4kd. The 
experiment was conducted in triplicate.
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 4.4.3 Milk peptide identification
Peptide identification at each time point of incubated milk was carried out 
through mass spectrometry analysis; this revealed that at time 0 there were 6 
SHSWLGHV LGHQWLILDEOH  IURPȕ-casein and 1 identified from immunoglobulin 
heavy chain (Table 4.2).  At 1 day of incubation there were 29 peptides 
LGHQWLILHG DQGDOO ZHUH GHULYHG IURPȕ-casein (Table 4.3). By day 4 of milk 
LQFXEDWLRQ WKHUHZHUHSHSWLGHV LGHQWLILHG WKHVHZHUHGHULYHGIURPȕ-
casein, 1 from serum albumin and 2 from osteopontin (Table 4.4). At day 7 of 
incubation 78 peptides were identified; 78 identified there were 74 from ȕ-
FDVHLQIURPRVWHRSRQWLQIURPĮ-ODFWDOEXPLQIURPț-casein and 1 from 
immunoglobulin lambda chain variable region (Table 4.5).
7KHLGHQWLILHGȕ-FDVHLQSHSWLGHVZHUHDOLJQHGZLWKWKHLQWDFWȕ-casein protein 
sequence. This analysis showed that day 0 peptides only aligned to the N-
terminal and C-WHUPLQDO HQGV RI ȕ-casein with no peptides observed 
throughout the length of the protein sequence. At day 1 of incubation the 
peptides identified were more widespread but still predominantly aligned at the 
N-terminal and C-terminal. By day 4 of incubation the peptides were observed 
to align across the entire protein sequence which was further observed at day 
7 of incubation. However at day 4 and day 7, peptides were no longer 
identifiable at the N-terminal end of the protein sequence. The observed 
protein degradation appears to begin at the flanking ends of the protein and 
over time spreads to the remaining protein sequence. It was also observed 
that larger peptides were further digested into smaller peptides (Figure 4.5). 
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 Table 4.2 Peptides identified at time 0 before incubation of milk.
Peptide Protein derived 
from
   Site
RETIESLSSSEESITEYK ȕ-Casein 16-33
ETIESLSSSEESITEYK ȕ-Casein 17-33
LLLNPTHQIYPVTQPLAPVHNPISV ȕ-Casein 202-
226
YPVTQPLAPVHNPISV ȕ-Casein 211-
226
PLAPVHNPISV ȕ-Casein 216-
226
VKPSQTLSLTCSVSGGSISGGGFSWTWLRQHPGK Immunoglobulin 
heavy chain
12-45
Total identified : 6
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 Table 4.3 Peptides identified after 1 day of incubation of milk.
Peptide Protein derived 
from
Site
RETIESLSSSEESITEYKQKVEK ȕ-Casein 16-38
ETIESLSSSEESITEYK ȕ-Casein 17-33
TIESLSSSEESITEYK ȕ-Casein 18-33
ESLSSSEESITEYK ȕ-Casein 20-33
SLSSSEESITEYK ȕ-Casein 21-33
SSSEESITEYK ȕ-Casein 23-33
PLAQPAVVLPVPQPEI ȕ-Casein 83-98
EVPKAKDTVYT ȕ-Casein 100-110
VPKAKDTVYT ȕ-Casein 101-110
GRVMPVLKSPTIP ȕ-Casein 112-124
GRVMPVLK ȕ-Casein 112-119
SPTIPFFDPQIPKLTD ȕ-Casein 120-135
VPQPIPQ ȕ-Casein 153-159
VLPIPQQVVPYPQRAVPVQALLL ȕ-Casein 176-198
VLPIPQQVVPYPQRAVPVQAL ȕ-Casein 176-196
VLPIPQQVVPYPQRAVPVQA ȕ-Casein 176-195
NQELLLNPTHQIYPVT ȕ-Casein 199-214
ELLLNPTHQIYPVTQPLAPVHNPISV ȕ-Casein 201-226
LLNPTHQIYPVTQPLAPVHNPISV ȕ-Casein 203-226   
LNPTHQIYPVTQPLAPVHNPISV ȕ-Casein 204-226
NPTHQIYPVTQPLAPVHNPISV ȕ-Casein 205-226
PTHQIYPVTQPLAPVHNPISV ȕ-Casein 206-226
YPVTQPLAPVHNPISV ȕ-Casein 211-226
PVTQPLAPVHNPISV ȕ-Casein 212-226
VTQPLAPVHNPISV ȕ-Casein 213-226
TQPLAPVHNPISV ȕ-Casein 214-226
PLAPVHNPISV ȕ-Casein 216-226
APVHNPISV ȕ-Casein 218-226
HNPISV ȕ-Casein 221-226
Total identified: 29
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 Table 4.4 Peptides identified after 4 days of incubation of milk.
Peptide Protein 
derived from
Site
YPFVEPIPYG ȕ-Casein 66-75
FVEPIPYG ȕ-Casein 68-75
VEPIPYG ȕ-Casein 69-75
ILPLAQPAVVLPVPQPEIMEVPKAKDTVYTKGRVMP ȕ-Casein 81-116
ILPLAQPAVVLPVPQPEIMEVPKAKDTVYTK ȕ-Casein 81-111
ILPLAQPAVVLPVPQPEIMEVPK ȕ-Casein 81-103
ILPLAQPAVVLPVPQPEI ȕ-Casein 81-98
ILPLAQPAVVLPVPQPE ȕ-Casein 81-97
IMEVPKAKDTVYTKGRVMP ȕ-Casein 98-116
MEVPKAKDTVYTKGRVMP ȕ-Casein 99-116
EVPKAKDTVYT ȕ-Casein 100-110
AKDTVYTKGRVMPVLKSPTIPFFDPQIPK ȕ-Casein 104-132
AKDTVYTKGRVMP ȕ-Casein 104-116
DTVYTKGRVMP ȕ-Casein 106-116
GRVMPVLKSPTIPFFDPQIPK ȕ-Casein 112-132
VLKSPTIPFFDPQIPKLTDLEN ȕ-Casein 117-138
VLKSPTIPFFDPQIPKL ȕ-Casein 117-133
VLKSPTIPFFDPQIPK ȕ-Casein 117-132
VLKSPTIPFFDPQIP ȕ-Casein 117-131
SPTIPFFDPQIPK ȕ-Casein 120-132
PFFDPQIPK ȕ-Casein 124-132
LTDLENLHLPLPLLQP ȕ-Casein 133-148
LTDLENLHLPLP ȕ-Casein 133-144
LTDLENLHLP ȕ-Casein 133-142
TDLENLHLPLP ȕ-Casein 134-144
TDLENLHLP ȕ-Casein 134-142
ENLHLPLPLL ȕ-Casein 137-146
LHLPLPLLQP ȕ-Casein 139-148
LHLPLP ȕ-Casein 139-144
HLPLPLLQP ȕ-Casein 140-148
LPLPLL ȕ-Casein 141-146
LLQPLMQQVPQPIPQT ȕ-Casein 145-160
LMQQVPQPIPQTL ȕ-Casein 149-161
LMQQVPQPIPQT ȕ-Casein 149-160
MQQVPQPIPQTL ȕ-Casein 150-161
MQQVPQPIPQT ȕ-Casein 150-160
QQVPQPIPQT ȕ-Casein 151-160
PQPIPQTL ȕ-Casein 154-161
LALPPQPLWSVPQPKVLPIPQQVVPYPQRAVPVQA ȕ-Casein 161-195
LALPPQPLWSVPQPKVLPIPQQ ȕ-Casein 161-182
LALPPQPLWSVPQPK ȕ-Casein 161-175
LWSVPQPKVLPIPQQVVPYPQR ȕ-Casein 168-189
LWSVPQPKVLPIPQQ ȕ-Casein 168-182
WSVPQPKVLPIPQQ ȕ-Casein 169-182
PQPKVLPIPQQ ȕ-Casein 172-182
VLPIPQQVVPYPQRAVPVQAL ȕ-Casein 176-196
VLPIPQQVVPYPQRAVPVQA ȕ-Casein 176-195
VLPIPQQVVPYPQR ȕ-Casein 176-189
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 VVPYPQRAVPVQAL ȕ-Casein 183-196
VVPYPQRAVPVQA ȕ-Casein 183-195
VVPYPQRAVPVQ ȕ-Casein 183-194
PYPQRAVPVQAL ȕ-Casein 185-196
PYPQRAVPVQA ȕ-Casein 185-195
AVPVQA ȕ-Casein 190-195
LLNQEL ȕ-Casein 197-202
LLLNPTHQIYPVTQPLAPVHNPISV ȕ-Casein 202-226
LLLNPTHQIYPVTQP ȕ-Casein 202-216
LLLNPTHQIYP ȕ-Casein 202-212
LLNPTHQIYPVTQPLAPVHNPISV ȕ-Casein 203-226
LLNPTHQIYPVTQP ȕ-Casein 203-216
LLNPTHQ ȕ-Casein 203-209
LNPTHQIYP ȕ-Casein 204-212
NPTHQIYP ȕ-Casein 205-212
IYPVTQPLAPVHNPISV ȕ-Casein 210-226
PVTQPLAPVHNPISV ȕ-Casein 212-226
VTQPLAPVHNPISV ȕ-Casein 213-226
VTQPLAPVHNPIS ȕ-Casein 213-225
VTQPLAPVHNP ȕ-Casein 213-223
PLAPVHNPISV ȕ-Casein 216-226
PLAPVHNP ȕ-Casein 216-223
LAPVHNPISV ȕ-Casein 217-226
APVHNPISV ȕ-Casein 218-226
PVHNPISV ȕ-Casein 219-226
FYAPELLFF Serum 
albumin
173-181
LYNKYPDAVATWLNPDPSQKQN Osteopontin 32-53
AVATWLNPDPSQKQN Osteopontin 39-53
Total identified: 76
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 Table 4.5 Peptides identified after 7 days of incubation of milk.
Peptide Protein derived 
from
Site
VKHEDQQQGEDEHQDKIYPS ȕ-Casein 39-48
LIYPFVEPIPYG ȕ-Casein 64-75
YPFVEPIPYG ȕ-Casein 66-75
FVEPIPYG ȕ-Casein 68-75
ILPLAQPAVVLPVPQPE ȕ-Casein 81-97
ILPLAQPAVVLPVPQP ȕ-Casein 81-96
LPLAQPAVVLPVP ȕ-Casein 82-94
LAQPAVVLPVPQPE ȕ-Casein 84-97
AQPAVVLPVPQPE ȕ-Casein 85-97
AQPAVVLPVPQP ȕ-Casein 85-96
VVLPVPQP ȕ-Casein 89-96
IMEVPKAKDTVYTKGRVMP ȕ-Casein 98-116
IMEVPKAKDTVYTKGR ȕ-Casein 98-113
IMEVPKAKDT ȕ-Casein 98-107
EVPKAKDTVYTKGRVMP ȕ-Casein 100-116
AKDTVYTKGRVMP ȕ-Casein 104-116
VLKSPTIPFFDPQIPKLTDLENL ȕ-Casein 117-139
VLKSPTIPFFDPQIPKLTDLEN ȕ-Casein 117-138
VLKSPTIPFFDPQIPK ȕ-Casein 117-132
VLKSPTIPFFDPQIP ȕ-Casein 117-131
VLKSPTIPFFD ȕ-Casein 117-127
VLKSPTIPF ȕ-Casein 117-125
LKSPTIPFFDPQIPK ȕ-Casein 118-132
SPTIPFFDPQIPK ȕ-Casein 120-132
PFFDPQIPK ȕ-Casein 124-132
FFDPQIPK ȕ-Casein 125-132
FDPQIPKLTDLEN ȕ-Casein 126-138
FDPQIPK ȕ-Casein 126-132
PQIPKLTDLEN ȕ-Casein 128-138
LTDLENLHLPLPL ȕ-Casein 133-145
LTDLENLHLPLP ȕ-Casein 133-144
LTDLENLHLPL ȕ-Casein 133-143
LTDLENL ȕ-Casein 133-139
LTDLEN ȕ-Casein 133-138
TDLENLHLPLP ȕ-Casein 134-144
DLENLHLPLP ȕ-Casein 135-144
LHLPLPLLQP ȕ-Casein 139-148
LHLPLPLL ȕ-Casein 139-146
LHLPLPL ȕ-Casein 139-145
LHLPLP ȕ-Casein 139-144
LMQQVPQPIPQTL ȕ-Casein 149-161
LMQQVPQPIPQT ȕ-Casein 149-160
MQQVPQPIPQTL ȕ-Casein 150-161
QQVPQPIPQT ȕ-Casein 151-160
PQPIPQT ȕ-Casein 154-160
LWSVPQPKVLPIPQQVVPYPQRAVPVQA ȕ-Casein 168-195
LWSVPQPKVLPIPQQVVPYPQR ȕ-Casein 168-189
LWSVPQPKVLPIPQQ ȕ-Casein 168-182
LWSVPQPK ȕ-Casein 168-175
WSVPQPKVLPIPQQ ȕ-Casein 169-182
PQPKVLPIPQQ ȕ-Casein 172-182
VLPIPQQVVPYPQRAVPVQA ȕ-Casein 176-195
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 VLPIPQQVVPYPQRAVPVQ ȕ-Casein 176-194
VLPIPQQVVPYPQR ȕ-Casein 176-189
VLPIPQQ ȕ-Casein 176-182
VVPYPQRAVPVQAL ȕ-Casein 183-196
VVPYPQRAVPVQA ȕ-Casein 183-195
VVPYPQRAVPVQ ȕ-Casein 183-194
VVPYPQR ȕ-Casein 183-189
VPYPQRAVPVQ ȕ-Casein 184-194
PYPQRAVPVQAL ȕ-Casein 185-196
PYPQRAVPVQA ȕ-Casein 185-195
LLLNPTHQIYPVTQP ȕ-Casein 202-216
LLLNPTHQIYP ȕ-Casein 202-212
LLNPTHQIYPVTQP ȕ-Casein 203-216
LLNPTHQIY ȕ-Casein 203-211
LLNPTHQ ȕ-Casein 203-209
NPTHQIYP ȕ-Casein 205-212
VTQPLAPVHNPISV ȕ-Casein 213-226
VTQPLAPVHNPIS ȕ-Casein 213-225
VTQPLAPVHNP ȕ-Casein 213-223
PLAPVHNPISV ȕ-Casein 216-226
PLAPVHNP ȕ-Casein 216-223
LAPVHNPISV ȕ-Casein 217-226
AVATWLNPDPSQKQN Osteopontin 39-53
AIAINNPYVPRT ț-Casein 68-79
ILDIKGIDY Į-Lactalbumin 114-122
PGQAPLLVIYK immunoglobulin 
lambda chain 
variable region
Total identified: 78
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 Figure 4.5 ȕ-casein peptide alignments.
ȕ-casein peptides identified through mass spectrometry analysis of each 
LQFXEDWLRQSRLQWZHUHDOLJQHGWRWKHLQWDFWȕ-casein protein sequence (Signal 
peptide in green). At day 0, identified peptides were flanking the N-terminal 
and C-terminal of the protein. At day 1 peptides were more dispersed but 
predominantly identified at the N-terminal and C-terminal ends. At day 4 and 
7, the peptides identified were wide spread across the protein sequence 
except at the N-terminal where they were no longer identifiable.
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 4.4.4 Enzyme activity prediction
The peptides present at each time point were analysed using the 
EnzymePredictor software program to identify the putative active proteases. 
This program predicted possible protease cleavage sites at the N-terminal and 
C-terminal of the peptides. At day 0 tKHUHZHUHSHSWLGHVLGHQWLILHGIURPȕ-
casein, these peptides were predicted to be cleaved by serine proteases. At 
the N-terminal active proteases were plasmin, pepsin or trypsin like digestion 
and at the C-terminal plasmin and tryspin like digestion occurred (Figure 4.6A). 
$IWHUGD\RI LQFXEDWLQJPLON WKHUHZHUHȕ-casein peptides, these were 
predicted to be formed through hydrolysis by cathepsin D (N-terminal 5 sites/ 
C-terminal 4 sites), plasmin (7 sites/ C-terminal 7 sites), elastase (N-terminal 
4 sites/ C-terminal 2 sites), pepsin (N-terminal 6 sites/ C-terminal 2 sites), 
trypsin (N-terminal 7 sites/ C-terminal 7 sites), proline endopeptidase (N-
terminal 1 site/ C-terminal 1) and chymotrypsin (N-terminal 6 sites/ C-terminal 
2 sites) (Figure 4.6B).
%\GD\RILQFXEDWLRQRIPLONWKHUHZHUHSHSWLGHVGHULYHGIURPȕ-casein, 
protease targets identified were cathepsin D (N-terminal 30 sites/ C-terminal 
33 sites), plasmin (12 sites/ C-terminal 10 sites), elastase (N-terminal 13 sites/ 
C-terminal 17 sites), pepsin (N-terminal 20 sites/ C-terminal 25 sites), trypsin 
(N-terminal 12 sites/ C-terminal 10 sites), proline endopeptidase (N-terminal 
14 site/ C-terminal 21) and chymotrypsin (N-terminal 15 sites/ C-terminal 10 
sites) (Figure 4.6C).
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 At day 7 of LQFXEDWLRQ  SHSWLGHV IURPȕ-casein were identified, protease 
profiles identified were similar to the day 4 profiles, with the following protease 
target sites. Cathepsin D (N-terminal 37 sites/ C-terminal 26 sites), plasmin (12 
sites/ C-terminal 11 sites), elastase (N-terminal 12 sites/ C-terminal 17 sites), 
pepsin (N-terminal 20 sites/ C-terminal 23 sites), trypsin (N-terminal 12 sites/ 
C-terminal 11 sites), proline endopeptidase (N-terminal 20 site/ C-terminal 19) 
and chymotrypsin (N-terminal 11 sites/ C-terminal 10 sites) (Figure 4.6D). This 
data had shown that at time 0 before incubation of milk there are active serine 
type proteases (plasmin and trypsin) and aspartate protease pepsin. From day 
1 of incubation through to day 7 of incubation there were more active proteases 
present predicted to be cleaved by the aspartic protease cathepsin D.
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 Figure 4.6 3UHGLFWHGFOHDYDJHVLWHVIRUȕ-casein peptides.
Predicted enzyme cleavage sites at either N- (blue) or C- UHGWHUPLQDOIRUȕ-
casein peptides. Identified enzymes predicted to be involved in proteolysis 
cleavage at (A) day 0 of incubation were plasmin, trypsin and pepsin (B) day 
1 of incubation, showing additional protease cleave sites from cathepsin D, 
elastase, proline endopeptidase and chymotrypsin (C) day 4 of incubation 
showing an increase in peptides cleaved by cathepsin D, and (D) day 7 of 
incubation showing highest cleavage sites by cathepsin D.
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 4.4.5 Bioactivity of milk peptides
 
4.4.5.1 Antimicrobial activity
Potential antibacterial activity of milk peptides generated from the proteolysis 
at day 0, day 1, day 4 and day 7 by endogenous milk proteases was tested 
against the gram positive bacterium S. aureus; the most commonly isolated 
pathogen to cause mastitis (Schoenfeld & McKay 2010). Bacteriostatic activity 
was measured for each pool of milk peptides and compared to the buffer only 
control using a two-tailed t-test where P<0.05 was considered significant
(Figure 4.7). Milk peptides identified at time 0, before the incubation of milk, 
showed no significant antibacterial activity against S. aureus, however, 
peptides identified at day 1 of incubation showed significant antibacterial 
activity P<0.05 (Table 4.6). Peptides at day 4 of incubation showed increased 
antibacterial activity compared to day 1, and was further increased with 
peptides generated from 7 days of incubation.
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 Figure 4.7 Antibacterial activity of milk peptides against S. aureus.
Growth curves of S. aureus incubated with milk peptides formed after 
incubation for 4 or 7 days showed significant inhibition of growth of S. aureus
whereas day 0 and 1 peptides showed no significant inhibition when compared 
to peptide buffer control (P<0.05). Assays were performed in quadruplicate
and performed twice. Standard error bars are shown. * Represents statistical 
significance P<0.05. 
Table 4.6 T-Test results of peptide antibacterial activity against S. aureus.
Sample P value
Day 0 peptides 0.070615
Day 1 peptides 0.000528
Day 4 peptides 8.14687E-06
Day 7 peptides 1.68574E-07
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 4.4.5.2 Apoptotic activity/toxicity
In order to test the function of milk peptides within the mammary gland we used 
an in vitro three dimensional mammosphere model which mimics the structure 
of the in vivo secretory alveoli (Mailleux et al. 2008; Romagnolo & DiAugustine 
1994). Human mammary epithelial cells (HMECs) were plated on ECM 
(Geltrex) and after 7 days formed spherical mammosphere structures (Figure 
4.8a). To test the impact of the milk peptides on mammosphere viability each 
peptide pool was incubated with mammospheres for 24hrs and the cells 
analysed for viability using the MTS assay. Viability estimates revealed that 
there was no significant difference in the viability of cells treated with peptide 
pools generated at any of the incubation time points (day 0, 1, 4 and 7) 
compared to the control (Figure 4.8b).
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 Figure 4.8 Cell viability of peptide treated mammospheres.
(A) HMECs were cultured into 3D mammospheres by plating on Geltrex for 7 
days. (B) Peptides incubated with the mammospheres showed cell viability 
was maintained in the presence or absence of peptides. Treatments: milk 
peptides (n=3) formed at day 0, 1, 4 7 of incubation and not treated (NT) with 
any peptides (n=3).
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 4.4.5.3 Anti-Inflammatory activity
Inflammatory conditions such as bacterial infection can activate the NF-ț%
signalling pathway through translocation of NF-ț% IDPLOy members such as 
p65/RelA and p105/p50 from the cytoplasm into active forms to the nucleus by
cellular stimulation of pathogens (Baldwin 1996). Activation of NF-ț%
KHWHURGLPHUVS1)ț%DQGS5HO$SOD\ a major role in inflammation by 
regulating the expression of pro-inflammatory cytokines such as tumour
necrosis factor (TNF) and interleukin 1 (IL-1) during infection (Ghosh & Hayden 
2008; Kempe et al. 2005; Schottelius et al. 1999; Tak & Firestein 2001). To 
evaluate whether the incubated milk peptides can suppress the expression of 
pro-inflammatory cytokine TNF and transcription factor NF-ț% WKH
mammosphere model was utilised to mimic breast responses to challenge with 
Lipoteichoic acid (LTA).  To test for potential anti-inflammatory activity 
mammospheres were pre-treated with peptides for 2 hours and challenged 
with LTA isolated from S. aureus to induce an inflammatory response similar 
to a mastitic infection for a further 4 hours. Semi quantitative RT-PCR was 
used to examine mRNA expression levels of TNF and NF-ț%UHODWLYHWRWKH
house keeping gene GAPDH. Significance was calculated by comparison of 
LTA only treated mammospheres vs peptide pre incubation followed by LTA 
challenge on the mammospheres using a two-tailed t-test (Table 4.7).  
This assay showed that pre-treatment with peptides formed from day 0 or 1 of 
incubating milk had no significant change in gene expression of TNF or NF-
ț%IURP/7$FKDOOHQJH7KHSHSWLGHVWKDWZHUHIRUPHGWKURXJKLQFXEDWLRQRI
milk at days 4 and 7 showed a significant down regulation of gene expression 
for TNF after LTA challenge. However, only the peptides formed from 
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 incubating milk for 4 days had a significant down regulation of NF-ț%JHQH
expression whereas the peptides formed from incubating milk for 7 days 
showed no significant change in gene expression of NF-ț%Figure 4.9). 
197 
 
 Figure 4.9 Anti-inflammatory activity of milk peptides.
Peptides were tested for their ability to suppress expression inflammatory 
cytokines TNF and NF-ț% in an inflammatory mediated infection. (A) TNF
expression. Prior to treatment with LTA (NT) some level of expression of TNF
was observed but addition of LTA showed an 80% increase in expression. 
Peptides isolated from days 0 and 1 of milk incubation showed no significant 
effect on TNF expression but peptides isolated from days 4 and 7 milk 
incubation showed significant suppression of TNF. (B) NF-ț% expression. 
Prior to treatment with LTA there was an observable expression of NF-ț%
(NT) however, with the addition of LTA there was a 100% increase in 
expression levels. Peptides isolated from days 0 and 1 of milk incubation 
showed no significant effect on NF-ț% expression but peptides isolated from 
day 4 milk incubation showed significant suppression of NF-ț%. Peptides 
isolated from day 7 milk incubation had no significant effect on NF-ț%
expression. Gene expression was normalised to GAPDH and conducted in 
triplicate. * Represents statistical significance P<0.05.
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 Table 4.7 T-Test results of peptide anti-inflammatory activity.
Sample TNF NF-KB1
Day 0 peptides 0.067672 0.260393
Day 1 peptides 0.106569 0.641847
Day 4 peptides 0.003721 0.002956
Day 7 peptides 0.006806 0.30061
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 4.5 Discussion
Breast milk contains lipids, carbohydrates and proteins that have been 
adapted to provide appropriate nutrition for a newborn infant in the first months 
of life (Ballard & Morrow 2013; Walker 2010). Although breast milk is a well-
known source of nutrients it also has a more complex role in providing 
bioactives that function in host defence mechanisms (immune protection) for 
both the infant and the lactating mammary gland (Newburg 2005). Milk also 
contains a multitude of proteases which may act on milk proteins during these 
processes to elicit otherwise hidden bioactivities. In the human genome, 
proteases account for up to 2% of all genes (Autelitano et al. 2006; Shen & 
Chou 2009) and thus far 553 proteases have been identified (Puente et al. 
2003). However, little was known about proteases in milk. There were a total 
of 207 protease genes expressed in human breast milk cells. Of the identified
proteases, a total of 45 were predicted to be secreted during lactation and 37 
during involution, while an additional 26 genes were predicted to encode for
secreted protease inhibitors during lactation and 16 expressed during 
involution, suggesting vast array of proteases and protease inhibitors are 
expressed in the mammary gland. Breast milk cells during involution generally 
showed lower numbers of proteases but the expression levels were up-
regulated compared to the lactation samples, suggesting that there could be 
increased proteolytic activity during involution.
Recently there has been increased attention focused towards milk peptides 
that have an immune protective role which are typically released through 
proteolysis from gastric enzymes (Dallas et al. 2013a; Lönnerdal 2010; Lund 
et al. 1996; Motyl et al. 2001; O'Brien et al. 2010). Recently a study by (Dallas 
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 et al. 2013a) has shown that milk peptides are present in the mammary gland 
before digestion by enzymes within the gastrointestinal tract and exhibit 
antibacterial properties. However, it was unclear if allowing the milk proteins to 
be further digested by endogenous milk proteases, such as in periods of milk 
stasis, would release more potent immune protective milk peptides.
The current study demonstrated that approximately 1 day of milk incubation is 
required to digest approximately 50% of ȕ-casein by endogenous proteases 
found in milk. Further digestion was observed to occur during the subsequent 
4-7 days of incubation and by 7 days of incubation only 2% of ȕ-casein 
remained intact. The resulting digestion produced 6 peptides which were 
identified at day 0 prior to incubation, 29 peptides at 1 day of incubation, 76 
peptides at day 4 and 78 peptides produced after incubating for 7 days. The 
number of peptides identified in this study was limited due to the limited 
availability of mass spectrometry facilities of highly sensitive mass 
spectrometry equipment. The Mass spectrometry equipment used in this study 
had limitation where the identifiable ions had to be in the range of m/z 350-
1600Da and have a maximum charge of +3, ions outside of these parameters 
were not easily identifiable. Recent studies identified 159 peptides in non-
incubated bovine milk (Dallas et al. 2013b) and 328 peptides in non-incubated 
human milk (Dallas et al. 2013a) the methods used in this study would likely 
provide a large new subset of new peptides produced through incubation of 
milk. 
$OWKRXJKPRVWRISHSWLGHVZHUHLGHQWLILHGDVȕ-casein derivatives, there were 
limited peptides identified from other milk proteins. Notably, a single peptide 
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 was identified from immunoglobulin heavy chain from the non-incubated milk, 
while two peptides from osteopontin and one from serum albumin were 
identified from 4 day incubated milk, and one peptide each was identified from 
RVWHRSRQWLQ Į-ODFWDOEXPLQ ț-casein and immunoglobulin lambda chain 
variable region IURPGD\RILQFXEDWLQJPLON7KHGHJUHHRIȕ-casein digestion 
contrasted dramatically with that observed for the whey proteins which showed 
very little digestion over the incubation time period. This may potentially be due 
to structural folding of the proteins or post-translational modifications. Caseins 
have been shown to have a degree of secondary structure but have an 
unordered tertiary structure making them vulnerable to proteases (Phadungath 
2005; Swaisgood 2003). Caseins are also less stable than globular or rod-
VKDSHGSURWHLQVVXFKDVĮ-lactalbumin, lactoferrin and lysozyme (Livney et al. 
2004; Phadungath 2005; Reddy et al. 1988; Swaisgood 2003). Other proteins 
such as lactoferrin have a globular tertiary structure and multiple sites for 
glycosylation which may protect them from proteolysis (Adlerova et al. 2008).
There is also an accumulation of some peptides observed through tris-tricine 
gel peptide separation over incubation time. It appears at approximately 4kD, 
8kD and 13kD intensity of peptides bands increase over a 7 day incubation 
period. This suggests that some peptides are not further hydrolysed over 
incubation and theses peptides may have bioactivity that is important for the 
mammary gland such as immune protection.   
Using the EnzymePredictor software, common proteases were predicted to 
GLJHVW ȕ-casein through known cleavage sites (Vijayakumar et al. 2012).
Based on the peptide cleavage sites identified in this study, the main enzymes 
SUHGLFWHGWREHLQYROYHGLQWKHGLJHVWLRQRIȕ-casein in non-incubated milk were 
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 plasmin, trypsin and pepsin like enzymes, while cathepsin D, plasmin, pepsin, 
elastase, chymotrypsin and trypsin like enzymes were predicted to be involved 
during milk incubation (1-7 days). The identification of gastro intestinal type 
proteases trypsin, pepsin and chymotrypsin was surprising as these proteases 
were not identified as being expressed in breast milk cells. However, a possible 
explanation may be due to the similarities of other proteases identified in the 
mammary gland that have similar cleavage patterns such as 
elastase/chymotrypsin, cathepsin D/pepsin and plasmin/trypsin (Ismail & 
Nielsen 2010; Tang & Wong 1987). Alternatively, it could result from proteases 
with undefined activity such as cleavage site preference, as this server does 
not include proteases identified in the microarray analysis of breast milk cells 
which may also be contributing to the digestion of milk proteins.
Proteolysis RIȕ-casein by elastase was estimated to begin from the first day 
of milk incubation onwards with a total of 6 cleavages at day 1, 30 cleavage 
sites at day 4 and 29 at day 7 of incubation. Elastase in milk has chymotrypsin 
like activity and levels in milk have been shown to increase during mastitis and 
is derived from leukocytes (Watanabe et al. 2012) and neutrophils (Okada & 
Nakanishi 1989). Putative elastase involvement in milk protein digestion was
supported by the identification of multiple elastase genes expressed at low 
levels in the breast milk cells.
Analysis of incubated milk peptides suggested other proteases such as 
cathepsin D, which was also identified as being expressed by breast milk cell 
microarray, were activated after one day of incubation. Cathepsin D is an 
aspartic protease that is a member of the pepsin family of proteases and has 
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 activities similar to pepsin (Tang & Wong 1987). Cathepsin D is expressed as 
a pre-pro-enzyme that requires proteolysis to become active in the mammary 
gland, and has been shown to be highly expressed during weaning in the rat
to play a role in protein degradation during apoptosis in the mammary gland 
(Zaragozá et al. 2009). This current study identified cathepsin D gene 
expression was more highly up-regulated during involution compared to 
lactation. The delay in peptides formed through cathepsin D in this study 
suggests that this protease may be activated after one day of incubation and 
resultant peptides may be similar to those observed during weaning when 
cathepsin D is more highly expressed.  
Plasmin is the most widely studied protease in bovine milk and is a serine 
protease with similar activity and characteristics to trypsin (Ismail & Nielsen 
2010). Peptides predicted to form through plasmin or trypsin digestion have 
the same target cleavage sites. However as there is no evidence to trypsin 
expression in the mammary gland this activity it most likely attributed to 
plasmin. Plasmin is known to digest ȕ-FDVHLQDQGĮV-casein, but has very 
OLWWOH DFWLYLW\ DJDLQVW Į-lactalbumin (Grufferty & Fox 1988; Ismail & Nielsen 
2010). Plasminogen, the inactive form of plasmin, was found to be expressed 
in milk cells and has been shown to be associated with casein micelles 
(Heegaard et al. 1997). Activation of plasminogen occurs by cleavage of 
plasmin activators urokinase-type plasmin activator and tissue-type plasmin 
activator (Heegaard et al. 1997; Heegard et al. 1994). At time 0 before 
incubation the peptides identified showed a plasmin signature of digestion, 
suggesting that before milk incubation there is active plasmin that associates 
with the casein micelle and possibly begins the digestion process. 
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 The incubation of milk performed in this study was designed to elucidate the 
potential for endogenous milk proteases to yield milk peptides after prolonged 
incubation. This in vitro incubation of milk mimics in vivo milk stasis that occurs 
naturally in the mammary gland at different stages of lactation. Milk stasis 
occurs during a bout of mastitis when a milk duct becomes blocked and fails 
to empty (2000). Mastitis is a common inflammatory condition during lactation 
that has been shown to affect from 3% to up to 33 % of lactating mothers and 
is typically caused by milk trapped in a blocked milk duct which can lead to 
bacterial infection (Arroyo et al. 2010; Michie et al. 2003; Osterman & Rahm 
2000).  Interestingly, concentrations of plasminogen and plasmin can alter
during mastitis where there is an increase in both plasmin and plasminogen in 
response to infection (Politis et al. 1989; Schaar & Funke 1986). In bovine 
mastitis, proteolytic activity was shown to increase compared to healthy milk
(Mehrzad et al. 2005). Plasmin levels increased during mastitis and once the 
infection passed the plasmin levels decreased to levels seen in healthy milk. 
(Mehrzad et al. 2005; Saeman et al. 1988). Mastitis in the breast could 
potentially have a similar effect and increase the levels of proteolytic activity 
like plasmin. Microarray analysis of mastitis breast milk cells from chapter 3 
revealed there is an up-regulation of protease genes during infection (appendix 
4) which may aid in producing peptides more rapidly. This increase in activity 
of protease during mastitis could cause a more rapid response to digest milk 
proteins to release these bioactive peptides to help the mammary gland 
recover form infection.
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 Typically the most commonly isolated pathogen associated with mastitis is S. 
aureus (Bundred et al. 1985; Dixon & Khan 2011; Schoenfeld & McKay 2010).
In the current study peptides isolated prior to milk incubation showed no 
significant antibacterial activity against S. aureus. However, peptides identified 
following 1, 4 and 7 days of incubation showed significant antibacterial activity.
This data supports previous studies showing peptides produced from milk 
proteins are capable of inhibiting the growth of mastitis-causing S. aureus after 
gut protease digestion such as lactoferricin which is derived from lactoferrin
(Bellamy et al. 1992a; Yamauchi et al. 1993). Interestingly, while whey 
proteins were resistant to proteolysis through milk incubation they were more 
easily digested by gut proteases (Eriksen et al. 2010). The peptides derived 
produced from whey proteins may provide different bioactivities to benefit the 
infant (Fiat et al. 1993; Kanda et al. 2007; Teschemacher et al. 1997).
More recent studies have also shown that peptides identified in fresh (non-
incubated) breast milk were shown to exhibit antibacterial activity towards S. 
aureus and E. coli using agar well diffusion assays at concentrations of 8 and 
ȝJȝOUHVSHFWLYHO\ (Dallas et al. 2013a). However, in the current study using 
alamar blue viability staining, concentrations used in this study showed that 
0.1μg/μl peptides isolated from unincubated milk did not show antibacterial 
activity against S. aureus whilst the peptides produced after incubation at 
similar concentrations exerted increasing antimicrobial activity over incubation 
time. This suggests that extended incubation of milk allowed additional
proteolysis of milk proteins which in turn released more potent antibacterial 
peptides. Moreover, peptides produced following 4 days of incubation in the 
current study also showed the ability to reduce an inflammatory response 
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 through down regulation of NF-ț%DQG71)JHQHVMastitis is characterized 
by an inflammatory response in the breast causing swelling and pain produced 
from immune cell infiltration such as neutrophils, lymphocytes and 
macrophages and also bacteria causing the infection. These cells elicit an 
inflammatory response through pro-inflammatory cytokine expression (TNF) 
which is mediated through the TLR4/NF-ț%VLJQDOOLQJSDWKZD\V(Glynn et al. 
2014). The bioactivities of the milk peptides may have a dual role in infection 
by providing antibacterial and anti-inflammatories that could help reduce 
infection. Together these results suggest that during milk stasis (such as 
during a bout of mastitis) the mammary gland has the potential to produce both 
antimicrobial and anti-inflammatory peptides in order to protect the gland. The
milk trapped in the blocked milk duct may potentially undergo proteolysis and 
release antibacterial and anti-inflammatory peptides to fight infection. This 
inevitably allows the gland to recover naturally and resume the process of 
lactation. 
Weaning is another period during the lactation cycle when the mammary gland 
undergoes periods of milk stasis. During the weaning period the infant ceases 
to suck the teat invoking the involution cascade. Immune cells have been 
shown to play an important role in involution. Recent studies have shown that 
the involution process is associated with an inflammatory acute phase 
response (Clarkson et al. 2004; Stein et al. 2004; Watson 2009). These studies 
showed that transcription factors STAT3 and NF-ț% UHJXODWH WKH DSRSWRWLF
factors and acute phase genes. Analyses by (Clarkson et al. 2004) and (Stein 
et al. 2004) compared mouse mammary gland tissue across lactation and 
involution (covering both reversible and irreversible involuting mammary 
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 glands) and identified that the initial change from lactation into involution 
involved an increase in pro-inflammatory cytokines genes followed by an up-
regulation of antimicrobial and innate immune genes. It was also observed that 
there was an up-regulation of anti-inflammatory genes which aids in 
suppression of the inflammatory response during the early stages of involution. 
Apart from the acute phase response releasing anti-inflammatory proteins at 
the early stages of involution, the work presented here suggest that milk 
peptides may also have the potential to reduce inflammatory cytokine 
expression. It was observed that by day 4 of incubating milk, peptides induced 
a significant down regulation of the pro-inflammatory cytokine TNF in a human 
mammosphere model that was challenged with LTA to promote an 
inflammatory response. The peptides were also shown to not induce an 
apoptotic response in human mammospheres, so these peptides wouldn’t be 
involved in the second phase of involution (Watson 2006). It could be 
speculated that the up-regulation of proteases observed in the involution 
breast milk cells may result in a new set of peptides to have a specific role in 
the involution process. Although the bioactivities of each of these peptides 
remain to be elucidated, it is tempting to speculate that those peptides with 
anti-inflammatory activity may be produced during involution to aid in the anti-
inflammatory response in the mammary gland. In order to support this 
hypothesis these peptides require identification and confirmation of their 
presence in milk collected during the involution phase. 
A principal aim of this study was to identify genes coding for secreted 
proteases using microarray analysis of breast milk cells and also identify 
putative proteases in milk by analysing the peptide cleavage sequences. This
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 is the first comprehensive study to identify expression of protease genes in the 
breast during lactation and involution. There were a total of 207 protease 
genes expressed by breast milk cells across lactation and involution, with an 
up-regulation of a number of proteases during the involution process. In this 
study skim milk from lactation was incubated over a period of 7 days to allow 
digestion of milk protein by endogenous proteases and tested for bioactivity. 
This had shown that the peptides formed through endogenous milk proteases 
have an immune protective role in the mammary gland that could aid in 
eliminating potential mastitis infection could potentially help in the anti-
inflammatory response during the early stages of involution which is 
associated with an inflammatory acute phase response. Further investigation 
is required to identify what peptides are present specific to mastitic milk and 
involuting milk and if they retain these bioactivities. It would also be necessary 
to identify other potential bioactivities, such as apoptotic peptides (for
involution) or antifungal peptides (for mastitis or breast thrush).
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Chapter 5 : General Discussion
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 5.1 Breast development
The mammary gland is a dynamic organ that undergoes significant growth and 
development which is not seen in other organs following initial development in 
utero. In preparation for milk production mammary gland development 
undergoes cycles of proliferation, secretory differentiation and involution, 
whereby maximal growth and development in the mammary gland is observed 
during pregnancy (Hennighausen 1997). The human mammary gland is a 
structure of ductal networks and alveoli surrounded by adipose tissue (Zhu & 
Nelson 2013). An outer myoepithelial cell layer is attached to the basement 
membrane and luminal epithelial cells form the ducts  and the secretory alveoli 
(Neville et al. 2002; Polyak & Kalluri 2010). These two cell types form bi-
layered ducts and alveoli that under hormonal stimulation allows the luminal 
epithelial cells to synthesize and secrete milk into the lumen where it is stored
(Riordan & Wambach 2010). Studies examining hormone regulation of human
mammary gland development and function are limited due to the ethics and 
opportunity for collecting breast tissue to use mammary gland explant cultures, 
an in vitro model that best allows an examination of the endocrine control of 
milk synthesis. Mammary gland explants retain the 3-dimensional structure of 
the tissue and have previously been used to study the hormone responses in 
the mouse, rat and tammar wallaby to identify the hormones required for milk 
protein production (Binas et al. 1992; Chomczynski et al. 1986; Nicholas et al. 
1991; Nicholas & Tyndale-Biscoe 1985). To study these responses in the 
human mammary epithelial cells requires an in vitro mammosphere culture 
model that can mimic breast functionality. Chapter 2 defined a human 
mammary epithelial cell (HMEC) mammosphere model, using commercially 
available HMECs. This in vitro mammosphere model demonstrated the 
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 capacity to create 3-dimensional mammary acini and was exploited to examine 
the role of lactogenic hormones in mammosphere formation and milk protein 
gene expression in the human, to successfully circumvent the scarcity of tissue 
available for in vivo studies. 
Hormones have been shown to play a major role in mammary gland 
development and milk protein synthesis in animal models such as the cow, 
mouse, rat, rabbit and wallaby (Akers 1985; Forsyth 1986; Houdebine & Gaye 
1975; Kwek et al. 2007; Matusik & Rosen 1978; Neville et al. 2002; Nicholas 
et al. 1991; Sheehy et al. 2004; Simpson et al. 1998; Topper & Freeman 1980; 
Zettl et al. 1992). However, the requirements of hormones is not the same in 
all species. For example the expression of milk protein genes in the mammary 
gland explants of the mouse and bovine requires insulin, cortisol and prolactin
(Andersen & Larson 1970; Bolander et al. 1981; Nagaiah et al. 1981; Sheehy 
et al. 2004) whereas in tammar wallaby mammary gland explants, ɲ-
lactalbumin and ɴ-lactoglobulin gene expression can be induced by prolactin 
alone (Collet et al. 1991; Nicholas & Tyndale-Biscoe 1985). This is also 
observed in the rabbit where prolactin alone can induce milk protein gene 
expression, however the addition of insulin and cortisol is required for maximal 
expression of milk protein genes (Devinoy et al. 1988; Duclos et al. 1989; 
Houdebine & Gaye 1975). The current study has defined a primary HMECs 
mammosphere model and most importantly has identified the need for insulin 
for the formation of mammospheres. HMEC mammospheres formed in the 
presence of insulin produced polarised spherical structures with a lumen void 
of cells. Furthermore, stimulation of the mammospheres with insulin, cortisol, 
prolactin and ɴ-oestradiol induced expression of the ɴ-casein gene. In contrast, 
212 
 
 IGF-1 a structurally related hormone to insulin, did not induce ɴ-casein gene 
expression, this suggest secretory differentiation is specifically a functional role 
of insulin. Early reports have identified insulin is necessary for milk protein 
synthesis in the rat and mouse (Nicholas et al. 1983; Nicholas & Topper 1983)
and other studies had identified that insulin was needed for cell maintenance 
in culture (Rivera 1964), and recently for secretory differentiation in the mouse 
(Neville et al. 2013). Our current study highlights the importance of insulin in 
human mammosphere formation and secretory differentiation. Interestingly 
when the insulin related growth factor IGF-I was added to the culture instead 
of insulin non-polarised spheroids formed, this showed IGF-I could not exert a 
similar function to insulin. However, we did not identify the differences in 
cellular signalling between insulin-formed mammospheres or IGF-I-formed 
spheroids which could potentially highlight the signalling mechanisms that 
direct polarisation of mammospheres. Future analysis using either microarray 
or RNA seq could determine these pathways. Overall an important outcome of 
the current study is that insulin most likely plays a major role in the 
development of mammary gland alveoli structures and for the synthesis of milk 
and will focus future studies on the role of insulin and diabetes in 
breastfeeding. Interestingly women who are insulin resistant (obese or 
diabetic) have been shown to have delayed lactogenesis (Amir & Donath 2007; 
Lepe et al. 2011; Neubauer et al. 1993).
Obesity and diabetes is a major health problem in developed countries. A
recent Australian study reported that 34% of pregnant women were either
overweight (BMI>25) or obese (BMI>30). These women had increased 
adverse maternal and neonatal outcomes, resulting in increased costs of 
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 obstetric care (Amir & Donath 2007; Callaway et al. 2006). Another study 
determined the lactation success of overweight and obese women showed 
50.2% overweight and 57.5% of obese mothers ceased breastfeeding before 
4 months compared to 37.9% of mothers in the healthy weight category. For 6 
months of breastfeeding 59.7% of overweight and 62.8% of obese mothers 
ceased breastfeeding before 6 months compared to 49% in the healthy weight 
range (Oddy et al. 2006). This study highlights that overweight/obese women 
are more likely to fail in breastfeeding for the recommendations of exclusive 
breastfeeding for 6 months. Mothers who are overweight or obese are also 
more likely to have other health conditions such as diabetes which can impact 
on breastfeeding (Jevitt et al. 2007).
There are many reports that pregnant women who are obese and/or have 
either insulin-dependent diabetes mellitus (IDDM) or gestational diabetes 
mellitus (GDM) have delayed initiation of lactogenesis II (Chapman 2014; 
Hartmann & Cregan 2001; Jevitt et al. 2007; Lepe et al. 2011; Neubauer et al. 
1993). This results in insulin resistance in the breast (Chapman 2014; Lepe et 
al. 2011; Ryu et al. 2014). Overweight or obese women are also more likely to 
have GDM during pregnancy which affects approximately 8–10% of 
pregnancies in Australia (Jevitt et al. 2007; Moses et al. 2011). Animal studies 
using overweight cows showed delayed lactogenesis, ketosis and higher 
incidence of mastitis (Morrow 1976). A study in overfed pregnant mice
revealed decreased expression of whey acidic protein, ɴ-casein and ɲ-
lactalbumin. This was due to reduced ductal side branching and decreased 
alveolar development during pregnancy (Flint et al. 2005). Women who are 
overweight or obese may have delayed lactogenesis II because insulin 
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 resistance is preventing the development of the alveoli. Our current study 
revealed insulin was necessary for formation and polarisation of MECs, and 
milk protein gene expression in the human mammosphere model, showing 
some insulin sensitivity is needed in the breast to allow for development of the 
alveoli during pregnancy. It would be interesting to speculate if any of the anti-
diabetic medications that increase insulin sensitivity (Pernicova & Korbonits 
2014; Soccio et al. 2014) have any effect on alveoli development, and this 
could be examined using the HMECs mammosphere model defined in chapter 
2. Future analysis could also use a pregnant mouse or rat that is overweight 
and insulin resistant and compare gene expression changes in mammary 
gland tissues using microarray or RNAseq to a healthy counterpart. This could 
highlight the mechanisms of insulin resistance in the mammary gland which in 
future could be a future therapeutic target.
5.2 Innate immunity
During the early stages of lactation mothers are more at risk of developing 
breast infections like mastitis that can impact on breastfeeding (Kinlay et al. 
1998). Mammary gland infections like mastitis cause swelling, pain, fatigue and 
flu like symptoms and can result in lower milk production which is a leading 
cause for the mother to cease breastfeeding and turn to formula milk (Arroyo 
et al. 2010). Despite the significant effects mastitis has on exclusive 
breastfeeding, there is very little known about how the breast responds to the 
infection to reduce inflammation and provide antibacterial support. Most 
research has been directed towards the dairy industry to limit the considerable 
cost of treating mastitis and loss in production in dairy cows and goats (Akram 
et al. 2013; Persson & Olofsson 2011; Silanikove et al. 2014; Zhao & Lacasse 
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 2008). Chapter 3 examined the effects of mastitis in the human breast using an 
alternative non-invasive method of isolating and analysing breast milk cells 
from mothers with mastitis and also utilising an in vitro mammosphere culture 
model to define a mammary epithelial innate immune response to infection. 
These studies examined the concept that the human mammary gland responds 
to infection by expressing a cascade of defence mechanisms to combat 
infection and the epithelial cell population has a role in the initial innate immune 
response to infection.
Leukocytes migrate to the site of infection to defend the body against invading 
pathogens such as bacteria, viruses or parasites (Davis et al. 2008; Falcone 
et al. 2000; Kolaczkowska & Kubes 2013; Muniz et al. 2012; Pearce et al. 
2013; Yang et al. 2014). We determined that during a bout of mastitis in the 
breast there is infiltration of lymphocytes and neutrophils into breast milk while 
the macrophage population remains relatively the same. Pathway analysis of 
the isolated breast milk cells showed interferon signalling to be involved in the 
innate immune response. This most likely releases a cascade of antimicrobials 
into breast milk to combat infection which has been observed in sheep with 
mastitis (Addis et al. 2013). However, the role of the epithelial cells in the innate 
immune response of the breast has not been defined. 
In the mammary gland the epithelial cells (MECs) are one of the first cells to 
come into contact with pathogens that cause mastitits (Brenaut et al. 2014; 
Gray et al. 2005). Studies in the goat and cow have shown the importance of 
MECs for the initiation of the innate immune response against mastitis 
(Brenaut et al. 2014; Gilbert et al. 2013; Strandberg et al. 2005). To study the 
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 human mammary epithelial innate immune response to infection we utilised 
the HMEC mammosphere (chapter 2). This provided an in vitro model that is 
physically and functionally similar to the secretory alveoli of the breast and
therefore was potentially an excellent model to assess immune response in 
the breast. This model allowed us to exploit the epithelial immune response in 
the breast by challenging the mammospheres with the bacterial components 
LPS and LTA to induce an innate immune response. In the initial innate 
response of HMEC mammospheres challenged with LPS or LTA for 4 hours 
there was an up-regulation of the chemokine interleukin-8 (IL-8) gene 
expression. The chemo-attractant activity of IL-8 is necessary for the migration 
of neutrophils from the vasculature into the mammary gland (Elazar et al. 
2010). The HMEC mammosphere rapidly expresses IL-8 most likely to signal 
for an influx of immune cells into the mammary gland to fight the infection. 
Antimicrobial expression of defensin A1 (DEFA1), secretory leukocyte 
protease inhibitor (SLPI) and peptidase inhibitor 3 (PI3) was observed to be 
up-regulated in HMEC mammospheres. The up-regulation of these 
antimicrobial genes by the HMECs in response to LPS and LTA suggests that 
the encoded proteins will probably play a major role in the first line of defence 
to inhibit bacterial growth of mastitis causing bacteria in the mammary gland 
until extra defence responses occur through the leukocytes. This highlights the 
importance of MECs in the innate immune response as the first line of defence 
before immune cell infiltration.
Antibiotic therapy is a common treatment option for women with lactational 
mastitis, however the use of antibiotics can cause adverse effects such as 
increasing the rates of breast/nipple thrush in breastfeeding mothers (Amir 
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 1991). Infants of women with thrush in the breast also more commonly had 
oral thrush (Amir 1991). Antibiotics also upset the natural balance of the milk 
microbiome which also may be of consequence to the infant (Fernández et al. 
2014). Another problem with the high use of antibiotic treatment for infections 
is the increasing resistance some bacterial strains have gained towards 
antibiotics (Arroyo et al. 2010; Barbosa & Levy 2000; Schoenfeld & McKay 
2010). Recent studies have identified the antibiotic resistant strain Methicillin-
resistant Staphylococcus aureus (MRSA) increasingly being isolated from 
breast milk of women with mastitis, particularly if the infection began in hospital 
(Schoenfeld & McKay 2010; Wilson-Clay 2008). This demonstrates the need 
for other alternatives to treat mastitis. In chapter 3 we identified through 
microarray analysis an increase in the antimicrobials being expressed by 
breast milk cells isolated from women with mastitis and also in the HMEC 
mammosphere model challenged with LPS and LTA. This shows that breast 
is responding to mastitis by expressing multiple antimicrobials to fight infection. 
These naturally occurring antimicrobials may provide an alternative 
therapeutic potential. We also identified in chapter 4 bioactive milk derived 
peptides that showed antibacterial activity directed towards mastitis causing S. 
aureus. By day 7 of incubating milk, endogenous milk proteases cleave milk 
proteins into potent antibacterial peptides. These peptides likely form naturally 
in mastitic breast milk as a part of the defence response of the breast to 
infection. However in this thesis we did not examine peptides produced in 
mastitic infected milk; further analysis and identification of peptides produced 
in milk of mastitic women could identify potentially new antimicrobial peptides 
to combat mastitis. Taken collectively these antimicrobial proteins and 
antibacterial peptides may provide naturally occurring therapeutic options to 
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 replace the use of antibiotics by use of an oral-based therapy if the peptides 
are resistant to further proteolysis.
5.3 Bioactive peptides derived from milk
Milk is a dynamic bioactive fluid which is a rich source of nutrients that contains 
proteins, lipids, carbohydrates, minerals, vitamins, cells and bioactive factors 
suited for the requirements of the infant (Baldi et al. 2005; Donovan 2006; 
Lönnerdal 1985). A role for milk proteins in providing bioactive signalling to the 
young and the mammary gland has increased the focus on the milk peptidome 
(Dallas et al. 2013b; Gauthier et al. 2006; Meisel 2004; Schmelzer et al. 2007).
These bioactivities remain latent until proteolytic release through proteases to 
form potent biologically active peptides (Meisel 2004). Some functions of milk 
peptides resulting from proteolytic digestion include immunomodulatory (Adel-
Patient et al. 2012; Qian et al. 2011), antimicrobial (Dallas et al. 2013a; Gifford 
et al. 2005; Liepke et al. 2001), antithrombotic (Chabancea et al. 1995; Fiat et 
al. 1993), opioid agonists (Koch et al. 1985; Meisel & FitzGerald 2000; 
Migliore-Samour et al. 1989; Teschemacher et al. 1997) and ACE inhibitors 
(Wu et al. 2013). Most of the previous research has been directed to a role of 
the gut and oral cavity on the proteolytic processing of milk  proteins but the 
experiments described in chapter 4 specifically examined the effects of 
proteases found in milk on processing milk proteins to mimic milk stasis for
release latent bioactive peptides. Therefore, these studies examine the 
concept that these peptides have an initial role to maintain breast function, in 
addition to a potential role in the gut and other tissues of the suckled young. 
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 Milk stasis is the accumulation of milk in the alveoli of the mammary gland. 
This may occur following less frequent suckling of the young and also occurs 
at the beginning of involution. Both these scenarios can be correlated with a 
higher incidence of mastitis (VanHouten et al. 2010; Watson 2006; WHO 
2000). This accumulation of milk in the mammary gland may cause increased 
concentrations of proteases in milk as seen in the bovine whereby in both 
mastitis and involution plasmin activity is increased (Politis et al. 1989; Schaar 
& Funke 1986). Alternatively the breast may respond to express genes for 
proteases that allow for different processing of milk proteins to provide 
bioactive peptides specifically to target infection, inflammation or other 
particular challenges to continuing breast function. In this thesis we observed 
through microarray analysis of milk cells an up-regulation of protease genes in 
both mastitis and in the first 2 weeks of involution compared to proteases 
identified during peak lactation. This up-regulation in gene expression most 
likely provides an opportunity for the breast to increase proteolytic activity in 
milk to rapidly form bioactive peptides. This provides extra antibacterial and 
anti-inflammatory peptides to help protect the mammary gland from infection 
whilst reducing inflammation from immune cells infiltrating the mammary 
gland; which is commonly observed during mastitis and in involution (Dohoo 
et al. 1984; Watson 2009).
This study focused on incubating milk collected during peak lactation to mimic 
milk stasis for the release of bioactive peptides, however the limitation of this 
experimental method is a reduced impact of the dynamic nature of the 
mammary gland whereby milk stasis is known to cause multiple signalling 
cascades (Theil et al. 2005). However, the data does demonstrate the capacity 
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 of milk to process itself to provide specific bioactivity. To extend this concept 
to provide more comprehensive data using an animal model such as a mouse 
for teat sealing experiments could be used to force milk stasis which would 
allow for protease processing of milk in vivo. This milk would be collected at 
specific time points for analysis of peptides identified through mass 
spectrometry. Sealing the teats in a mouse would initially mimic milk stasis and 
subsequently involution which occurs rapidly, whereas in the human the 
process of involution is more gradual. The focus of these studies would be to
examine the effect of milk to process itself to bioactivity without the 
complication of overriding involution. Other studies in our laboratory using 
mouse models have shown that mouse milk collected at day 1 of involution is 
apoptotic (Ramkrishnan, Sharp and Nicholas, unpublished data). However 
incubated breast milk did not show any apoptotic activity, whereas antibacterial 
and anti-inflammatory was evident. As involution is a gradual process in the 
human apoptotic peptides may not be observed even if milk is incubated for 
longer than 7 days.
To elucidate the specific role of milk peptides during either involution or mastitis 
will be a very important future initiative. The identification of specific peptides 
in involution and mastitis should be compared with the peptides identified in 
the incubated peak lactation milk to examine their potential to protect the 
mammary gland from infection and inflammation. However, it is likely new 
bioactives, possibly with a role in reducing milk synthesis and secretion and 
driving apoptosis during the early stages of involution would be also identified 
(Håkansson et al. 1995; Mader et al. 2005; Semenov et al. 2010; Zanabria et 
al. 2013). This may also provide additional therapeutic options. Indeed, an 
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 interesting concept to be explored would be the option of using the involuting 
mammary gland as an experimental model to explore new therapeutic 
approaches for the treatment of breast cancer. 
The digestion of milk protein into bioactive peptides also occurs in the stomach
of the infant to potentially exert specific effects to benefit the infant (Dallas et 
al. 2014). In breast milk the digestion of milk proteins by the endogenous 
proteases was a gradual process where increasing bioactivity was observed 
over a time period of 7 days. This digestion of milk protein was also very 
specific as only the casein proteins were targeted by milk protease during the 
7 day incubation. The gastrointestinal tract (GI) contains a range of protease 
enzymes such as trypsin, chymotrypsin and pepsin that have been shown to 
form a variety of peptides resulting from both casein and the whey proteins 
(Dallas et al. 2014; Eriksen et al. 2010; Gauthier et al. 2006; Hernández-
Ledesma et al. 2007). The peptides generated by incubating milk may not
survive the environment of the GI due to further digestion into smaller peptides 
or potentially this process may create new peptides with specific functions to 
benefit the infant. However a study by Dallas et al. 2014 had identified some 
potentially bioactive peptides in the proximal gut of an infant which were 
identified in the current study; VVPYPQR was formed after 7 days of incubation 
and is predicted to be an anti-hypertensive and YPFVEPIPYG was observed 
from days 4 to 7 of incubation and is predicted to be an opioid agonist, although 
this peptide has an additional two amino acids at the C-terminus. These 
peptides appear to be stable against gut proteolysis and may be required for 
these effects in the infant following absorption into the blood stream. This has 
been observed in early studies where an anti-thrombotic milk peptide was 
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 identified in infant plasma (Chabancea et al. 1995). This could be further 
defined by also digesting either breast milk or the milk peptides produced 
through incubation of milk with proteases that are present in the GI and 
identifying the peptides by using mass spectrometry techniques. The peptides
specifically produced through milk incubation most likely have a role in the 
breast but they may also have a role in the infant. Milk derived peptides 
produced in the gut could impact on the health and development of the infant 
such as aiding in correct micro flora colonising in the gut. Future studies are 
needed to comprehensively identify both cohorts of peptides from incubation 
of milk and gut protease digestion. It would also be interesting to determine if 
these peptides are absorbed into the bloodstream for other systemic effects 
such as observed for the anti-thrombotic peptides (Chabancea et al. 1995).
In this thesis, these studies have developed a mammosphere model for human 
breast development and function that will allow for future studies to better 
understand the relationship between hormones, growth factors and ECM in 
breast function. This allowed us to better understand the relationship between 
bioactives in milk and infectious agents on the response of the breast. These 
outcomes provide a better understanding of breast function. The 
mammosphere model has potential to further explore the possibilities of new 
therapies for treating infections (such as mastitis and breast thrush) and further 
examine non-infectious disease states of the breast such as breast cancer and 
gestational diabetes.   
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 Appendix 1
Bioanalyzer results for chapter 2 microarray
Legend: 
1. Insulin 1, 2. Insulin 2, 3. Insulin 3, 4. Insulin 4, 5. No hormones 1, 6. No 
hormones 2, 7. No hormones 3, 8. No hormones 4
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 Appendix 2
IRS-2 gene expression from microarray analysis in mammospheres formed 
in the presence of insulin (I) and or in no hormone (NH) media
268 
 
 Appendix 3
Bioanalyzer data from chapter 3
Legend:
1. Mastitis 1, 2. Mastitis 2, 3. Mastitis 3, 4. Mastitis 4, 5. Healthy 1, 6. Healthy
2, 7. Healthy 3, 8. Healthy 4
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 Appendix 4
Gene expression profile of proteases identified in microarray analysis of 
breast milk cells of healthy women or women with mastitis. (M= mastitis, H= 
healthy)
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